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GQAHGLAFSVR-80), Til (130-AGQAHSHAS-LGWETFTDK-I47), and T18
(185-APHPSPLSAHR-195) as taking part in crosslinking with oligonucleotide
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crosslinking. Other sites of crosslinking were assigned to Tyr, His1, and
His1. Tandem mass data also indicated sites of crosslinking between Ala137
and Trp141 of TI I and His187 andHis1of TI 8. Crystallographic studies by
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1. INTRODUCTION
1.1 Analysis of Protein-DNA Interactions
The study of protein-nucleic interactions is a major focus of biochemical
research because they are at the heart of such basic cellular processes as
transcription, replication, recombination, and DNA repair. Knowledge of the
structures of protein-nucleic acid complexes is important to understanding how
these biological processes occur. Numerous methods are available to study
protein-nucleic acid interactions and they can generally be categorized as either
indirect or direct methods. Gel mobility shift assays, filter binding, and
footprinting are considered indirect methods because they reveal the character
and level of interaction between proteins and nucleic acids but do not expose any
structural features of the interactions. X-ray crystallography and nuclear
magnetic resonance (NMR) spectroscopy are considered direct methods for
determining the topology of protein-nucleic acid interactions because they
provide three-dimensional structural data at the atomic level. Obtaining high-
resolution structures of protein-nucleic acid complexes by these physical
techniques, however, can be problematic. In particular, large amounts of
homogeneous sample are required to produce high quality crystals for X-ray
studies and the inherent size of many protein-nucleic acid complexes limits the
amount of information that can be obtained in NMR studies (71, 115).2
Another method important for studying protein-nucleic acid interactions
involves the use of crosslinking agents. These methods are used primarily to
gain information about amino acids and nucleobases that nearly touch at a
protein-nucleic acid interface (88). A major drawback associated with chemical
crosslinking reagents is that they have finite lengths; thus, regions within a
protein-nucleic acid complex that are not naturally in contact with one another
may become crosslinked via the length of the reagent. Another drawback
associated with chemical crosslinking is the rate of crosslinking. For bifunctional
crosslinking reagents (two reactive groups contained within a reagent separated
by a spacer length), initial crosslinking to the nucleobase (or amino acid) must be
immediately followed by crosslinking with the amino acid partner (or nucleobase).
If the second reaction is slow, the protein-nucleic acid complex may take up a
new, more stable conformation that brings nucleobases and amino acids not
originally in contact (non-native contacts) into close proximity and in turn form a
non-natural crosslink. Because of these problems, experiments using
crosslinking agents must be carefully designed and the information obtained
must be interpreted with caution. These problems can be avoided by
simultaneously forming a crosslink between a protein and a nucleic acid without
an intervening species, such as a chemical crosslinking agent. This sort of
crosslink is considered a "zero-length" bond and its formation can be catalyzed
by ultraviolet tight.3
1.2 UV-Catalyzed Crosslinking of Nucleobases
Two reports in the early I 960s established that the absorption of
ultraviolet (UV) light by living cells could induce crosslinking of protein to DNA (3,
129). Along with studying the deleterious effects of UV light on living cells,
studies over the past four decades have examined the feasibility of using UV-
crosslinking as a direct means of determining contact points between nucleic
acids and proteins. Today, photochemical crosslinking has become a powerful
biochemical procedure for characterizing protein-nucleic acid interfaces.
1.2.1 Photophysics of Crosslinking
The optimum absorption of nucleobases is around 260 nm, whereas the
optimum absorption for proteins is around 280 nm. The maximum absorption of
proteins is determined by their content of aromatic amino acids, which are
typically present in proteins at an abundance of 3-4% (136). This means that UV
irradiation of a nucleoprotein complex in the range of 250 to 270 nm will be
absorbed mainly by the nucleobases.
1.2.1.1 Low Intensity U V-Cross/inking
When a nucleobase absorbs a single photon, under typical low intensity
light (less than 1018 photons/cm2sec at 260 nm), it is promoted to the first
excited singlet state (Si) (19). From Si, which has a lifetime of about 10 ps, the
excited nucleobase can either react, relax to the ground state, or undergo4
intersystem crossing to the first excited triplet state (Ti).T1,which has a lifetime
of about I ps, can also react or relax to the ground state. The crosslinking of a
nucleobase to an amino acid can occur from either the S1 or theT1states.
Because theS1state has a very short lifetime, crosslinking from this state must
take place between groups in contact at the time of excitation. Even though the
T1state has a longer lifetime than theS1state, it is still relatively short compared
to the time scale for macromolecular motion, which is on the order of
milliseconds. Therefore, crosslinking via theT1state most likely involves groups
in close proximity at the time of excitation (19).
One drawback to conducting crosslinking experiments using low intensity
UV light sources is low sample yield. In order to obtain sufficient sample,
crosslinking times ranging from minutes, to hours, or even days, are often used.
Use of continuous UV irradiation permits side reactions to take place within the
protein and the DNA. These side reactions can result in modifications to amino
acids (e.g., destruction of tryptophan), reactions between bases (e.g., formation
of cyclobutane dimers), and modifications to the DNA (e.g. strand breaks) (19,
51). As irradiation proceeds, modified, uncrosslinked proteins and nucleic acid
residues accumulate. These modified macromolecules can take up new, non-
native conformations that can potentially crosslink. Since native complexes
crosslinked at the start of irradiation cannot be distinguished from those
crosslinked after disruption to the native structures, the crosslinking conditions
must be optimized in order to maximize crosslinking yield and minimize side
reactions.5
1.2.1.2 UV-Laser Cross/inking
During irradiation with low intensity light, only the levelsS1andT1of the
nucleobases are populated. As the intensity of light increases the probability that
a second photon will be absorbed also increases. The second photon can then
excite a molecule already in the S orT1level into higher excited levels (termed
H5andHT).This results in a population of molecules at higher excited levels, the
lifetimes of which do not exceed 25 ns (19). Photochemical reactions via higher
excited states are more efficient than via lower excited states. When lasers are
used as the high intensity light source, the efficiency of this process (the
percentage of proteins crosslinked per absorbed photon) has been estimated to
be 20-100 times higher than those originating from lower energy levels (20). Like
the crosslinks formed from low intensity UV light, the crosslinks produced from
laser crosslinking are also "zero-length" bonds.
Lasers can be used to produce a single, high intensity, short pulse
(nanoseconds) of monochromatic UV light to catalyze protein-nucleic acid
crosslinking. A single laser pulse used in crosslinking is on a timescale that is
too short to allow any large-scale motion within the macromolecules (19, 20, 51,
52). Thus, the interactions between the protein and the nucleic acid are frozen in
a native complex. This is the primary advantage of using lasers in place of low
intensity UV irradiation. The increased intensity from lasers, however, can result
in the absorption of two photons by the nucleic acid base, in turn, exceeding the
ionization potential of the molecule. This produces longer-lived ions or radicalsthat can react non-specifically with the protein or lead to strand breaks within
DNA (19). Another drawback to the use of laser irradiation is the
photodegradation of proteins (51, 73). Similar to low-intensity UV irradiation,
laser crosslinking conditions must be optimized for a given system.
1.2.2 Photochemistry of Crosslinking
1.2.2.1 Photoreactivity of Nucleobases
Radiation sources with outputs in the range of nucleobase absorption
maxima could potentially catalyze the crosslinking of any nucleobase within DNA
or RNA. A study of bacteriophage T4 gene 32 single-stranded DNA binding
protein (gp32) showed that thymine was the most reactive base (51). At a
wavelength of 252.7 nm, it was found that the crosslinking efficiency followed the
order: dT (1) >> dC (0.0084) > rU (0.0041)> rC, dA, dG (0.001).
1.2.2.2 Selectivity of Cross/inking
After excitation of the nucleobases with UV light, crosslinking reactions
within a macromolecular complex can take place with numerous amino acids.
Taking into account four common nucleobases and twenty common amino acids,
the number of nucleobase-amino acid combinations that could potentially be
formed during irradiation is large. Therefore, it is of great interest to know which,
if any, of these combinations has the potential for crosslinking. Shetlar and
colleagues performed experiments with model systems to test the reactivity ofthe nucleobases to amino acids. They showed that all 20 common amino acids
have the potential to crosslink to DNA, poly A, poly T, poly G, poly C and poly U,
with cysteine, lysine, phenylalanine, tryptophan, and tyrosine being the most
reactive. Histidine, glutamic acid, and aspartic acid were moderately reactive,
and arginine, leucine, and isoleucine were the least reactive (122-124). Other
studies have been conducted with individual amino acids and individual
nucleobases. Specifically, crosslinking reactions have produced conjugates of
uridine-cysteine (56), thymine-lysine (113), 5-methylcytosine-serine and 5-
methylcytosine-threonine (121), and thymidine-tyrosine (120). Based on the
results from these model studies, photochemical mechanisms for the formation of
each of these conjugates were proposed. It is likely that numerous mechanisms
exist between the potential nucleobase-amino acid crosslinking possibilities, the
pathways of which may be somewhat different in macromolecular systems.
1.2.2.3 U V-Catalyzed Cmsslinking of Nucleobase Analogs
An alternative to using common nucleobases as substrates for
crosslinking experiments is the use of photosensitive nucleobase analogs in their
place (for review, see (85)). Photosensitive analogs include 5-bromouracil, 5-
iodouracil, 4-thiouracil, 5-iodocytosine, and azido derivatized nucleobases. The
use of these analogs may increase the crosslinking efficiency. This permits the
study of protein-nucleic acid complexes that would not normally be detected due
to low reaction yields. An additional benefit is that the photon flux required to
obtain crosslinking is greatly reduced when using these analogs, thus minimizingEi
unwanted side reactions. Typically, these analogs are irradiated at wavelengths
greater than 300 nm, far beyond the absorption ranges of nucleic acids and
proteins, which decreases the photodegradation. It should be noted that
photosensitive nucleobases are unnatural nucleobases and as a result the
possibility for structural perturbations to the nucleoprotein complex is present.
1.3 Characterization of UV-Crosslinked Protein-Nucleic Acid Complexes
1.3.1 Methodology for Identifying Protein-Nucleic Acid Contacts
For the identification of amino acids that take part in crosslinking, a
general methodology has typically been used (146).It consists of first irradiating
the protein-nucleic acid mixture to form a nucleoprotein complex. The complex is
enzymatically broken apart into free peptides and peptides crosslinked to the
nucleic acid substrate (termed nucleopeptides). Finally, the nucleopeptides are
isolated and sequenced. Numerous biochemical techniques have been
employed to isolate nucleopeptides. Characterization of these complexes,
however, has been primarily conducted by Edman gas-phase sequencing. To
identify the site of crosslinking by Edman sequencing, a "hole" is observed in a
sequencing cycle. With prior knowledge of the primary structure of the DNA-
binding protein, and knowledge of the peptide region of the protein being
sequenced, the site of crosslinking can be inferred by the position of the hole in
the peptide sequence (146). Edrnan sequencing has proven quite successful in
this regard; however, there are drawbacks to this technique. Isolatednucleopeptides containing multiple species must be further separated into
individual species prior to analysis. This means that crosslinked species in low
abundance could be lost during extensive sample purification. Also, the harsh
conditions of gas-phase sequencing may break some labile amino acid-nucleic
acid crosslinks. Thus, it would be advantageous to have direct, sensitive, non-
destructive techniques available that could speed up the identification of
crosslinked amino acids in UV-irradiated complexes. One technique that holds
such promise is mass spectrometry.
1.3.2 Application of Mass Spectrometry to the Analysis of Protein-Nucleic
Acid Complexes
Mass spectrometry has emerged as an important tool for the study of a
wide variety of macromolecular structures. For a better part of the last two
decades, the molecular weight determinations made by mass spectrometers
have been used in numerous studies to characterize the structures of proteins,
peptides, oligon ucleotides, lipids, and carbohydrates. More recently, mass
spectrometry has been applied to the analysis of protein-nucleic acid and peptide
nucleic acid complexes.
1.3.2.1 Fast Atom Bombardment Mass Spectrometry
The first applications of mass spectrometry to characterize UV-crosslinked
protein-nucleic acid interactions used fast atom bombardment (FAB) mass
spectrometers. In one study, FAB MS was able to determine the mass of a10
modified peptide produced from a UV-catalyzed crosslinking reaction of
glyceraldehyde-3-phosphate dehyd rogenase and the nucleic acid analog
arylazido-3-alanyl-NAD (24). In a later study, FAB tandem mass spectrometry
(MS/MS) was used to sequence the peptide-nucleic acid complex of angiotensin
Ito identify the site of crosslinking to thymidine (120). Even though these studies
required large amounts of sample (greater than 50 pmol), they demonstrated the
potential of mass spectrometry for analyzing peptides crosslinked to nucleic
acids. Since these initial studies on peptide-nucleic acid complexes by FAB MS,
major advances have taken place in the development of soft ionization
techniques for mass spectrometry. Specifically, these advances have been in
MALDI MS and ESI MS.
1.3.2.2 Matrix-Assisted Laser Desorption-Ionization Mass Spectromet,y
Since the first descriptions of matrix-assisted laser desorption-ionization
(MALDI) mass spectrometry for the analysis of macromolecules (49, 50, 60, 61),
MALDI MS has become a widespread analytical technique for proteins and
peptides (34, 63, 130), as well as oligonucleotides (35, 44).
Commercially available instruments that are combined with time-of-flight
analyzers (29) can determine molecular weights to over 100 kDa from sample
amounts on the order of 0.1 to 10 pmol.
Barofsky and co-workers first demonstrated the feasibility of using mass
analysis for protein-nucleic acid complexes (57). MALDI MS was used to monitor
crude UV-catalyzed crosslinking reactions between gp32 and oligonucleotide11
dT20, and reactions between E. coil termination factor rho (Rho) and the nucleic
acid analog 4-thio-uridine-diphosphate (4-S-UDP). Mass analysis showed that
both gp32 and rho crosslinked with their nucleic acid substrates at a ratio of 1:1.
This work also presented a systematic study to identify appropriate matrix and
solvent conditions for MALDI analysis of these complexes. In subsequent
research performed by Barofsky and co-workers, MALDI MS was used in
indengifying the E. co/i uracil-DNA glycosylase (Ung) DNA binding domain (6).
Mass analysis of purified Ung:dT2o complexes established the stoichiometry of
crosslinking to be 1:1. To date, these are the only demonstrations of MALDI MS
in the analysis of protein-nucleic acid complexes.
MALDI MS has also been used in characterizing peptide-nucleic acid
complexes produced from enzymatic digestions of protein-nucleic acid
complexes. In this rote, MALDI serves as a technique to tentatively identify the
peptide portion of a complex. Subtracting the mass of the nucleic acid from the
complex and then comparing the resulting mass of the peptide to a peptide mass
map of the protein identifies the peptide region taking part in crosslinking. By
using this procedure, the DNA-binding domains of Ung (6) and rat DNA
polymerase(rat pot) (28) have been defined. In the case of Ung, four
peptides were identified as being crosslinked to dT20 by using a combination of
MALDI MS and gas-phase sequencing. The region that the peptides spanned
within the protein (amino acids 57-79 and 184-212) were proposed to make up
the DNA-binding domain (6). This was the first time MALDI had ever been used
to provide structural information on a protein-nucleic acid complex. Subsequent12
X-ray crystal structures of human uracil-DNA glycosylase in complex with double-
stranded DNA (96, 128) revealed that the regions of the human enzyme
predicted to be in contact with DNA were homologous to those regions of the E.
co/i enzyme identified by UV-crosslinking. The combination of MALDI MS and
gas-phase sequencing was also used for rat DNA polymerasef3(pot f3)(28). In
this study, nanosecond laser pulses were used as the radiation source and
MALDI was used to tentatively identify six nucleopeptides involved in
crosslinking. The regions of the protein identified as making up the DNA-binding
domain (amino acids 28-40, 55-60, and 62-81) corroborated NMR data (82) and
low intensity UV-crosslinking data obtained for the same protein-nucleic acid
complex (103).
Other studies have used MALDI MS in both tentative and definitive
identification of peptide-nucleic acid complexes. In the following two studies,
photoaffinity-Iabeled nucleic acid substrates were used. Recently, Traub and
colleagues crosslinked the protein vimentin to oligo (dGBrdU)i2dG-fluorescein
isothiocyanate (143). The protein-nucleic acid complex was proteolytically
digested and subjected to several purification steps resulting in three individually
isolated peptide-nucleic acid complexes. After tentatively identifying the peptide
portion of the complexes, they were nucleolyticalty digested individually and
subjected to carboxypeptidase Y digestion as well as manual Edman
degradation. The resulting products were analyzed by MALDI MS, which
produced sequencing ladders that identified the sites of crosslinking to Tyr2g,
Tyr37, and Tyr52 within the protein (143). Even though this methodology was13
unique in using MALDI MS to find sites of crosslinking, large amounts of purified
peptide-nucleic acid analyte was needed to conduct multiple cycles of chemical
and enzymatic sequencing. A peptide-nucleic acid complex from E. coil Rec A
has also been identified using a MALDI ion-trap instrument. The purpose of this
study was to demonstrate the capability of this specialized instrument (107).
Nonetheless, analysis of the complex in theMS1mode was used for tentative
identification, and analysis in the MS mode was used for definitive identification.
After three stages of tandem mass spectrometry,Met165was identified as a site
of crosslinking, which had been previously identified by Edman sequencing
(144).
The applications of MALDI MS to the analysis of protein-nucleic acid
complexes described thus far have all focused on characterizing the interactions
associated with the protein,It is worth mentioning one additional application in
which specific sites of crosslinking were identified in both the protein and the
nucleic acid portion of the crosslinked complexes. Urlaub and co-workers
employed MALDI MS to determine sites of contact between the rRNA and
individual ribosomal proteins of the 30 S ribosomal subunits from E. co/i (135).
Specifically, they employed N-terminal sequence analysis to determine the
modified amino acids within chemically crosslinked peptide-oligoribonucleotide
complexes. MALDI MS in conjunction with partial alkaline hydrolyses identified
the corresponding sites on the oligoribonucleotides.
The aforementioned applications of MALDI MS to characterizing
protein/peptide-nucleic acid complexes clearly demonstrates the value of this14
method in determining sites of protein-DNA contact. In summary, MALDI MS
was successfully used in measuring crosslinking stoichiometry, tentatively
identifying peptide-nucleic acid species, and definitively identifying peptide-
nucleic acid species when combined with enzymatic and chemical sequencing.
This last application, however, requires large sample quantities and digestion
procedures require optimization for each complex studied.It seems that MALDI
MS is best suited for measuring crosslinking stoichiometry and tentatively
identifying peptide-nucleic acid complexes. Tentative identification of these
complexes is important since it can be used to direct subsequent gas-phase
sequencing or tandem mass spectrometry sequencing efforts.
1.3.2.3 Electrospray Ionization Mass Spectrometry
Similar to MALDI MS analysis, electrospray ionization (ESI) mass
spectrometry has been used to characterize both protein-nucleic acid and
peptide-nucleic acid complexes. ESI-MS has shown utility in studying
noncovalent interactions of protein-nucleic acid complexes due to the ability of
ESI to generate molecular ions of intact complexes while producing littleor no
fragmentation (141). Stoichiometry of the binding partners can be deduced by
accurate mass analysis of the ligands and the intact complex. Complexes
between the DNA binding domain of human PU.1 and sequence specific double-
stranded DNA (26), bacteriophage fi gene V protein with single-stranded DNA
(25), bacteriophage T4 RegA protein with RNAs of various sizes (81), and human
XPA protein's minimal binding domain with cisplatin-adducted DNA (154)were15
studied by Smith and colleagues. The complex between the HIV-1 Tat protein
and RNA was studied by Loo and co-workers (114). ESI has also been used to
measure the stoichiometry of crosslinking. Reich and colleagues measured the
stoichiometry for the complex of EcoRl DNA methyltransferase crosslinked to 5-
iodouracil substituted DNA (152).
ESI sources are commonly coupled to triple quadrupole (87) or ion-trap
(11) mass analyzers that allow for multiple stages of mass spectrometry.
Therefore, these instruments are heavily used for the sequencing of peptides.
Barofsky and colleagues proposed a strategy that uses MALDI MS to monitor
protein-nucleic acid crosslinking reactions and ESI MS/MS sequencing of
peptide-nucleic acids species produced from proteolytic digestion of the protein-
nucleic acid complex to identify amino acids that are crosslinked (58). The same
laboratory used ESI MS/MS to characterize two synthetic peptide-nucleic acid
complexes. They were prepared by joining an eleven-residue synthetic peptide
containing one internal carboxyl group (Asp side chain) to amino-linker-5'pdT6
andamino-linker-5'pdT10to demonstrate the utility of sequencing peptide-nucleic
acid complexes by ESI MS/MS. The results of this study showed that a positive
ES! tandem mass spectrum could sequence the peptide portion of the peptide-
dT6 complex to locate the point of the oligonucleotide's covalent attachment.
This study also showed that as the size of the oligonucleotide portion of the
complex decreased from dT10 to dT6, the ionization efficiency of the complex
drastically increased in the positive ion mode. These results served as16
guidelines for the future analysis of peptide nucleic acid complexes by positive
mode ESI mass spectrometry.
Since this model study, ESI MS/MS has been successful in identifying
sites of crosslinking within two DNA-binding proteins. One of the proteins studied
was the 155-amino acid variant of basic fibroblast growth factor (38). This
protein was UV-crosslinked to a 61-mer oligonucleotide containing seven
bromodeoxyuridines. After enzymatic digestion and isolation of a single
crosslinked peptide, digestion by snake venom phosphodiesterase and alkaline
phosphatase produced a peptide crosslinked to a dinucleotide. ESI MS/MS
revealedTyr133as the site of crosslinking. The other DNA-binding protein
studied was E. coli endonuclease VIII. This protein was chemically crosslinked
to thymine glycol-containing double-stranded DNA in order to identify amino
acids taking part in the catalytic function of the enzyme (110). After proteolytic
digestion, a single crosslinked peptide was isolated (peptide covalently bound to
the thymine glycol-containing oligonucteotide) and then sequenced by ESI
MS/MS in the negative ion mode. This sequenced the oligonucleotide portion of
the DNA locating the site of crosslinking to the thymine glycol-containing
nucleotide. Analysis in the negative ion mode did not provide sufficient
information to identify the amino acid taking part in crosslinking. To accomplish
this, the complex was nucleolytically digested, and ESI MS/MS (negative ion)
sequenced the resulting product to identify the N-terminal proline of the protein
as the site of crosslinking. The results from these two proteins demonstrate the17
utility of ESI tandem mass spectrometry in identifying amino acids and
nucleotides that take part in crosslinking.
1.4 Biological Systems Studied
The research conducted for this thesis focused on elucidating the DNA-
binding domains of two proteinsE. co/i uracil-DNA glycosylase and human
replication protein A. The following sections provide biological background on
both of these proteins, with heavy emphasis being placed on the structural
features that contribute to their abilities to bind DNA.
1.4.1 Uracil-DNA Glycosylase
Uracil is continually introduced into the genome of numerous biological
systems, including bacteria, bacteriophages, yeast, mammalian cells, and
viruses (93). The buildup of uracil in DNA primarily takes place by two
processes. One is the incorporation of dUMP during DNA synthesis. DNA
polymerases of both prokaryotes and eukaryotes do not readily distinguish
between dUTP and dTTP during synthesis; thus, the intracellular pool size of
dUTP at the time of synthesis dictates the frequency of uracil incorporation. The
resulting accumulation of U'A base pairs in the genome has the potential to alter
protein-DNA interactions (93). The other process that results in the buildup of
uracil in DNA is cytosine deamination. Cytosine residues can undergo
deamination by spontaneous or by hydrolytic, chemical, or UV-radiation inducedroutes. These result in a G'U mispair from a previous GC base pair that, if left
unrepaired, can lead to a G'C to A'T transition mutation. Cytosine deamination
is a major source of spontaneous mutations in both prokaryotes and eukaryotes
(78). To counteract the effects of uracil buildup in DNA, cells contain uracil-DNA
glycosylases that recognize and remove uracil from DNA (72).
Uracil-DNA glycosylase specifically recognizes uracil in DNA and
hydrolyzes the N-Cl' glycosylic bond between uracil and the deoxyribose sugar,
beginning uracil-initiated base excision repair (72). This creates an abasic site
that is removed by an apurinic/apyrimidinic (AP) endonuclease and a
deoxyribophosphodiesterase, leaving a gap that is filled by DNA polymerase, and
closed by DNA ligase. The base excision repair pathway is a major cellular
defense mechanism against spontaneous DNA damage (79).Its importance is
strongly indicated by the facts that the occurrence of uracil-DNA glycosylase is
widespread, the protein is highly conserved between biological species, and the
base excision repair pathway is very similar in almost every organism examined
(72).
1.4.1.1E. co/i Uracil-DNA Glycosylase
Uracil-DNA glycosylase from E. co/i (Ung) was the first enzyme in its class
to be purified to apparent homogeneity (77). The native enzyme was determined
to be monomeric with an apparent molecular weight of 24,500, as determined by
denaturing polyacrylamide gel electrophoresis. The enzyme did not requirea
cofactor for activity, catalysis occurred in the presence of EDTA, and theenzyme19
was predicted to be a globular protein based on a frictional ratio f/f01.2. Ung
also displayed maximum activity at pH 8.0 with 50% activity remaining at pH 7.0
and pH 9.5 (80). Subsequently, the E. co/i ung gene was cloned and Ung was
overexpressed (9, 32). The deduced nucleotide sequence indicates that the
protein is made up of 228 amino acids with a molecular weight of 25,694. After
post-translational removal of the N-terminal methionine, the protein has a
molecular weight of 25,563 (138), which was verified by MALDI mass
spectrometry (6). Comparison of the amino acid sequence of Ung with that of
the human enzyme showed the two proteins share 56% identity (105). Ung was
shown to use a processive search mechanism for locating sequential uracil
residues on the same DNA strand (8, 48) and to prefer uracil residues located in
single-stranded DNA over uracil residues in double stranded DNA by 2 fold (8,
80). Similarly, the enzyme recognized U/G mispairs about 2.4-fold more
efficiently than U/A basepairs in oligonucleotide substrates (8). The minimum
substrate for Ung was determined to be pd(UN)p (139), with the 3'-phosphate to
deoxyuridine being essential for binding and catalysis (104).
1.4.1.2 Ctystal Structures of Human Uracil-DNA Glycosylases
The first uracil-DNA glycosylase structure solved was for the human
enzyme, termed UDG. This structure was for a recombinant UDG in which the
N-terminal 84 amino acids of the protein encoded by the UNG gene had been
replaced by three N-terminal residues encoded by the vector (91). Hereafter, the
recombinant protein is termed UDGi84. Prior to crystallization, this truncatedprotein had been determined to be active (127). Crystal structures of UDG84
and UDGt84 in complex with the inhibitor 6-aminouracil were solved to 2.0 A and
2.3A,respectively (91). The results showed the protein is made up of a central,
four stranded, all parallel 13-sheet surrounded on either side by a total of eight o-
helices. Within thisoc/13fold, a groove is present with a width of 21A,
approximately equal to the diameter of a DNA double helix, and lined with basic
amino acids. The groove narrows to almost 10Abetween residuePro150and
Pro165, suggesting that the groove floor cannot directly bind double-stranded
DNA without significant conformational change. Site-directed mutagenesis
studies and the structure of the UDGi84:6-aminouracil complex located the
catalytic site within the groove. Structural features of the groove, primarily the
presence of rigid proline residues, suggested the groove and the active site
would not undergo major conformational changes for binding DNA. The structure
of the UDGz84:6-aminouracil complex showed that the side chain of Tyr147 of the
active site sterically blocks bases substituted at the base 5 position, thus
revealing how the enzyme discriminates between uracil and thymine. Hydrogen
bonds between the protein and the 2, 3, and 4 positions of uracil allowed for
discrimination against cytosine. The overall architecture of the enzyme
suggested that for uracil to reach its binding pocket, the base must be "flipped
out" from the DNA helix. A conserved Leu272 residue directly above the uracil-
binding pocket was positioned to potentially insert its side chain into the DNA
helix to aid in melting the DNA helix. From this structure, base flipping as a
structural mechanism for UDG damage recognition was proposed (91). Base21
flipping was first observed in the co-crystal structure ofHhalDNA
methyltransferase (70) and substrate DNA and then subsequently observed in
the co-crystal structures ofHaelIlmethyltransferase (109) and T4 endonuclease
V with substrate DNA (140). Base flipping has also been suggested from crystal
structures of proteins without the presence of substrate DNA. These proteins
include human apurinic/apyrimidinic endonuclease (42), human 3-methyladenine
DNA glycosylase (74),E.coil photolyase (97),E.co/i endonuclease III (134), E.
coli exonuclease III (92), and E. co/i mismatch-specific uracil DNA glycosylase
(5).
The UDGi84 protein was used again to form a complex with the uracil-
DNA glycosylase inhibitor protein (Ugi) and the crystal structure was solved to
1.9A(90). Ugi is a 9,474 molecular weight protein product from bacteriophage
PBS2 that forms an essentially irreversible complex with UDG (90), as well as
Ung (7, 9) and uracil-DNA glycosylases isolated from other species (93). The
Ugi structure consists of a twisted five-stranded antiparallel n-sheet and two o-
helices. The first strand of the f3-sheet,ft,,was inserted into the active site
groove of UDG84 without contacting the catalytic pocket. Ugi was bound to the
enzyme via shape and electrostatic complementarity and by insertion of the UDG
Leu272residue into a hydrophobic pocket of Ugi. These interactions were thought
to mimic those suspected to take place when UDG binds to DNA. The
UDG184:Ugi structure was used to propose a model for UDG binding to DNA.
The model suggested that Leu272 penetrated the DNA base stack from the major
groove resulting in uracil flipping out of the major groove side of the DNA and into22
the catalytic pocket (90). To further access this model, UDG bound to substrate
DNA was needed.
Enzyme kinetic and DNA-binding studies showed that mutating Leu272 to
Arg enhanced the binding of UDG to double-stranded DNA and the mutation
Asp145to Asn decreased its catalytic activity (128). This resulted in the 2.9A
resolved crystal structure of a double mutant UDG84 (Leu272 to Arg andAsp145
to Asn) bound to double-stranded uracil-containing DNA with free uracil bound in
the specificity pocket (128). The structure confirmed flipping of the damaged
nucleotide since the uracil, deoxyribose, and 5' phosphate were rotated 180°
from their position in the DNA. Interestingly, the majority of the contacts with the
DNA substrate took place with the uracil-containing strand. From this structure,
five steps involved in damaged base recognition and catalysis were proposed.
First, electrostatic interactions position the UDG active-site groove along the
DNA. Damage is detected and the structural loop containing Leu272 pushes into
the base stack via the DNA minor groove to promote nucleotide flipping via the
major groove. The binding of UDG to sugar phosphates promotes DNA
backbone compression to favor the extrahelical nucleotide. Then the substrate
specificity pocket recognizes, or "pulls", the flipped-out nucteobase, deoxyribose
and phosphate. Finally, active-site hydrogen bonds polarize the N-Cl' bond
making it susceptible to attack by a water nucleophile activated by an Asp
residue (128). These steps are termed the "push-pull" mechanism.
Additionally, structures of UDG84 and a mutant of UDGz84, Leu272 to
Ala, were co-crystallized with U'A and U'G 10-base-pair oligonucleotides and23
refined to 1.9Aand 225A,respectively (96). The UDG84-DNA complexes were
shown to be trapped product complexes containing bound uracil in the catalytic
pocket and an extrahelical abasic deoxyribose. The DNA both 5' and 3' to the
flipped-out nucleotide was compressed 4Aby rigid enzyme loops causing the
DNA to kink by -45°. These loops contained Ser, Pro, and Gly residues and it
was determined that free UDG could not bind B-DNA without pinching and
bending the DNA backbone (96). This pinching mechanism defined a means for
lesion detection. In these UDGz84-DNA complexes, Leu272 penetrated into the
DNA base stack and replaced the flipped-out uracil.In the Leu272 to Ala mutant,
the small side chain of alanine could not fill the hole in the base stack, but the
protein loop containing Ala272 (normally Leu272 in UDG84) could still penetrate
the base stack as deeply as in the UDGI\84 structure to promote flipping. This
suggested that the Leu272 side chain push was not essential for nucleotide
flipping. The mutant protein-DNA structure showed only a flipped-out AP site
and the catalytic pocket contained two ordered water molecules rather than a
uracil base.It appeared as if the mutant enzyme had cleaved the uracil,
disengaged from the substrate, released the cleaved uracil from the catalytic
pocket, and rebound the AP site containing DNA. It was suggested that human
UDG might serve a role in protecting cells from the cytotoxic effects of AP sites
(96).24
1.4.1.3 Ciystal Structures of E. co/i Uraci/-DNA Glycosy/ase
The first published crystal structure for E. co/i uracil-DNA glycosylase
(Ung) was for the enzyme co-crystallized with the uracil-DNA glycosylase
inhibitor protein (Ugi). The structure was refined to3.2 Aand showed that Ung is
made up of a four-stranded parallel n-sheet and 11 separate helical stretches,
four of which are greater than 10 residues and the remaining helices are five
residues or less. The structural comparison of the Ung:Ugi complex with the
UDG:Ugi complex revealed that the nature of the binding site and mechanism of
action for the two enzymes are essentially the same (108).
A second crystal structure of the Ung:Ugi complex has also been solved
using the native enzyme and a His187 to Asp mutant (105). This study showed
that Ugi resembled an intermediate of the DNA in the base-flipping process
instead of directly mimicking DNA. This, along with the shape, charge, and
hydrophobic complementarity between the two proteins indicates how Ugi reacts
with Ung instead of other DNA-binding proteins.
1.4.2Human Replication Protein A
Single-stranded DNA-binding proteins participate in almost every aspect
of DNA metabolism, including replication, repair, and recombination. The
primary role of these proteins is to bind single-stranded DNA and reduce
secondary structure. In eukaryotic cells, this role is played by replication protein
A (RPA). As the characterization of the RPA structure and function is revealed, it25
becomes apparent that RPA plays a role in modulating DNA metabolism events
through specific interactions with other proteins and with DNA.
RPA was originally purified from human (HeLa) cell extracts and identified
as a protein required for simian virus 40 (SV4O) DNA replication (149, 151).
Analysis of human RPA (hRPA) indicated that it is a heterotrimer composed of
70-kDa (hRPA7O), 32-kDa (hRPA32), and 14-kDa (hRPAI4) subunits (150).
Since its identification in human cells, heterotrimeric homologues of hRPA have
been found in virtually every eukaryotic cell examined, including S. cerevisiae
(17), 5. pombe (98), X. laevis (1), D. melanogaster (89), and C. fasciculata (18).
Comparison of the amino acid sequence of various RPA subunits has revealed
significant homology between species, with the large subunit showing the highest
homology. Amino acid sequence comparisons have shown 44.5%, 50.0%, and
80.7% similarity for the large RPA subunits of S. cerevisiae, S. pombe, and X.
laevis, respectively, versus hRPA7O (55).
1.4.2.1 DNA Binding Domains of Human Replication Protein A
UV-crosslinking of hRPA to single-stranded DNA or oligonucleotide
probes indicated that hRPA7O is the only subunit to have significant single-
stranded DNA-binding activity (119). This result was supported by mapping a
single DNA-binding domain to the center of hRPA7O (residues -180 to 420) (40,
41, 69, 76, 101). The crystal structure of the central DNA-binding domain of
hRPA7O complexed to a single molecule of octa-dCMP has been obtained at 2.2
Aresolution (14). The crystal structure revealed a DNA binding domain26
composed of two copies of a single-stranded DNA binding subdomain that have
the same three dimensional structure. These subdomains resemble an OB fold
motif that has been previously found in various oligonucleotide- and
oligosaccharide-binding proteins (94). The subdomains are oriented in tandem,
and a DNA binding channel extends from one subdomain to the other. The two
primary types of interactions observed between the protein and the DNA were 1)
aromatic amino acids (Phe238, Phe269, Trp361, and Phe386) that stack with
individual nucleic acid bases and 2) hydrogen bonds that occur between amino
acid side chains and both the phosphate backbone and individual nucleic acid
bases (14). The importance of hRPA7O aromatic amino acids interacting with
single-stranded DNA has been questioned. Site directed mutants of hRPA7O in
which Phe238, Phe269, Trpi, of Phe386 were mutated to alanine resulted in only
slight changes in the hRPA binding constant. A double mutant, in which Phe238
and Trp36, were mutated to alanine, resulted in a decrease of the hRPA binding
constant by 3 orders of magnitude (142). The double mutant, however, was
determined by proteoytic sensitivity experiments to be structurally disrupted.
Structural perturbation makes it difficult to draw conclusions about the double
mutant phenotype, but the single aromatic residue mutants suggest that no one
aromatic residue is critical for the formation of the hRPA-DNA complex (142).
Studies have indicated that hRPA7O has a 30 nt (67, 119) and a 8 nt (12)
DNA-binding mode. They suggest the possibility that the protein may contain
multiple binding sites, possibly within the hRPA32 and/or hRPAI4 subunits.
Some direct evidence exists that this is possible since hRPA32 can be27
crosslinked to synthetic primer-template DNA moleculesin vitm(75).
AdditionaHy, a complex of hRPAI4 and N- and C-terminal deleted hRPA32
(residues 43 to 171) was found to bind single-stranded DNA weakly, as opposed
to a full length hRPAI4:hRPA32 complex that showed no significant single-
stranded DNA binding activity (15). From these results it has been suggested
that the hRPA32 single-stranded DNA-binding domain is normally cryptic, and
only becomes accessible after hRPA7O binds to single-stranded DNA. Recently,
the crystal structure of the hRPAI4:hRPA32 complex (residues 43-171 of
hRPA32) has been solved to 2.5Aresolution (13). The crystal structure
revealed that both hRPAI4 and the central part of hRPA32 are structurally
similar. Each subunit contains an OB-fold domain that resembles the DNA-
binding domains in hRPA7O. Even though limited biochemical evidence is
available to show single-stranded DNA-binding activity in hRPA32 or hRPAI4,
these structural data strongly suggest that these two subunits may harbor DNA-
binding activity.
1.4.2.2 Binding of Human RPA to Single-Stranded DNA
Heterotrimeric hRPA binds to single-stranded DNA with an intrinsic
binding constant (K) measured between _10h1 M1; thisis three orders of
magnitude higher than for double-stranded DNA and RNA (41, 67, 68). The
binding preference of hRPA has been found to be -5O-fold higher for
polypyrimidines versus polypurines. The affinity of hRPA binding to nucleic acids
is single-stranded polypyrimidines > mixed sequence single-stranded DNA>28
single-stranded polypurines>> RNA double-stranded DNA (67).
Measurements of hRPA binding to oligonucleotides are strongly dependent on
oligonucleotide length. The preference of hRPA for oligodeoxythymidine 20 or
30 residues in length (dT2o and dT3o) is high, with K 4 xM1, but as the
length decreases the affinity constant decreases to K = 1 x 1O9 M1 for dT15, K= 2
x108 M1 for dT12,and K = 7 x M1 for dT10 (66). This corresponds toa
decrease in the binding constant of almost two orders of magnitude. The strong
binding dependence of hRPA on oligonucleotide length suggests that itmay
adopt a different conformation when binding to longer oligonucleotidesor that
additional contacts occur between the protein and longer oligonucleotides. A
conformational change in the protein has been measured upon binding to single-
stranded DNA. This was demonstrated by changes in proteolytic sensitivity of
the hRPA7O and hRPA32 subunits (39).
As mentioned above, the binding affinity of hRPA for non-specific double-
stranded DNA is at least three orders of magnitude weaker than for single-
stranded DNA. High-affinity binding of hRPA to a double-stranded DNA
sequence, possibly involved in the regulation of transcription, has been reported
(131). Since no consensus sequence has been identified for hRPA binding to
double-stranded DNA, it is likely that hRPA recognizes a specific DNA structure
associated with the sequence rather than the sequence itself. hRPA has also
been shown to bind damaged double-stranded DNA. Double-stranded DNAthat
has been modified with cis-platin (99, 100), UV mimetic N-acetoxy-2-
acety)aminofluorene (45), or UV light (22) can act as substrates for hRPA. In the29
case of UV light, hRPA appears to bind preferentially to 6-4 photoproducts (22).
Since hRPA is essential for the recognition of damaged DNA in nucleotide
excision repair, this mode of binding is likely physiologically relevant.
1.5 Research Objectives
The studies of Barofsky and co-workers demonstrated the feasibility of
using MALDI MS (57, 58) and ESI MS/MS (59) to identify sites of contacts within
protein-nucleic acid interfaces. The results from the model systems, combined
with those obtained from crosslinking studies of E. co/i Ung (6) suggested that
the analytical methodology associated with analyzing protein/peptide-nucleic acid
complexes by mass spectrometry were worked out. Therefore, the primary
objective of this thesis was to continue the application of mass spectrometry to
characterizing the DNA-binding domain of Ung. Specifically, use ESI tandem
mass spectrometry to identify amino acids within the DNA-binding domain of the
protein that crosslink to dT20 and are thus in contact with DNA. This research
would give insight into how Ung binds to single-stranded DNA and the specific
amino acids that take part in binding.
After initial crosslinking experiments were conducted with Ung and dT20, it
became apparent that additional analytical methodologies were required in order
to utilize mass spectrometry for studying peptide-nucleic acid complexes of Urig.
The development of a generalized procedure for the isolation and purification of
peptide-nucleic acid complexes from protein-nucleic acid complexes was30
undertaken in order to provide sample that was appropriate for mass spectral
analysis.
At the beginning of this thesis research, only one ESI MS/MS spectrum of
a peptide-nucleic acid complex had ever been reported (59) and this spectrum
was for a synthetic peptide-nucleic acid complex. Little, if anything, was known
about the fragmentation patterns associated with peptide-nucleic acid complexes
produced from UV-catalyzed crosslinking reactions. Investigations were needed
to know what effect the oligonucleotide portions of these complexes had on the
fragmentation of the peptide portions and vice versa, how fragmentation patterns
were influenced by the charge state of these complexes, and whether the means
could be found to direct the fragmentation patterns of these types of molecules.
Thus, the ESI tandem mass spectra from peptide-nucleic acid complexes of Ung
were not only analyzed to identify sites of crosslinking, but thoroughly
characterized to gain an understanding of the fragmentation characteristics for
these types of molecules.
The final research objective was to characterize the DNA-binding domain
of human replication protein A (hRPA) using UV-catalyzed crosslinking.It was
surmised that crosslinking studies would give a better understanding of how this
protein binds to single-stranded DNA in a length dependent manner and the role
specific aromatic amino acids play in binding to DNA. The study of this protein
would also test the general applicability of the developed purification protocol and
produce additional tandem mass spectra that would give insight into the
fragmentation mechanisms of peptide-nucleic acid complexes.31
2. MATERIALS AND EXPERIMENTAL PROCEDURES
2.1 Materials
2.1.1 Chemicals
ATP, ampicillin, angiotensin (DRVYIHPFHL), bovine serum albumin
(BSA), citric acid (diammonium salt), copper (II) chloride, chloramphenicol,
ethylenediaminetetraacetic acid (EDTA), HEPES, sodium chloride, Trizma (Tris-
base) and streptomycin sulfate were purchased from Sigma Chemical Co.
Acrylamide (>99% pure), ammonium persulfate, 2-mercaptoethanol, bis N,N'-
methyl-bis-acrylamide, and N, N, N' N'-tetramethylethylenediamine (TEMED) were
from Bio-Rad. Ammonium sulfate, dithiothreitol (DTT), glycine, isopropyl-3-8-
thiogalactopyranoside (IPTG), sodium dodecyl sulfate (SDS), and urea were from
Life Technologies. Acetic acid, acetonitrile, ammonium bicarbonate, ammonium
hydroxide (50%), hydrochloric acid, isopropanol, magnesium chloride, methanol,
potassium chloride, sodium hydroxide, sodium th iosulfate, and trich loroacetic
acid were supplied by Fisher Chemical. Glycerol, potassium phosphate (dibasic
and monobasic salts) and triethylamine were from J.T. Baker.
Chlorosulfonylacetyl chloride, x-cyano-4-hydroxycinnamic acid, N, N-
diisopropylethylamine, iodoacetamide, silver nitrate, sinapinic acid, 2-
sulfobenzoic acid cyclic anhydride, tetrahydrofuran, 2',4',6'
trihydroxyacetophenone, and trimethylamine were supplied by Aldrich Chemical
Co. Calcium chloride and formic acid were from EM Science, while formalin,32
potassium chloride, potassium hydroxide, and sodium carbonate were from
Mallinckrodt. Trifluoroacetic acid was from Fluka. Agar, tryptone, and yeast
extract were supplied by Difco.
2.1.2 Enzymes
Trypsin (L-1 -tosylamide-2-phenyl chioromethyl ketone-treated) was
obtained from Worthington Biochemical as a lyophilized powder. The protease
was resuspended in 0.1 N HCI, divided into 500-pg portions in Eppendorf tubes,
dried by vacuum centrifugation, and stored at -20 °C until used. Nuclease P1
was supplied by Pharmacia as a lyophilized powder. The nuclease was
resuspended in 50 mM sodium acetate (pH 5.5) at I unit/pL, divided into 10-pL
portions, flash frozen in liquid nitrogen, and stored at -20 °C. All dilutions of the
nuclease were made with 50 mM ammonium acetate. T4 polynucleotide kinase
was purchased from New England Biolabs and used without further preparation.
2.2 General Experimental Procedures
2.2.1 Chromatographic Resin Preparation
2.2.1.1 Preparation of Sephadex G-25, Bio-Ge/ P4 Gel, and
Hydroxyapatite Bio-Gel HTP
Resins were hydrated in 6- to 10-fold volumes of the appropriate buffer,
"defined" a minimum of 3 times, and stored in the same buffer at 4 °C as 50%
(v/v) slurries, unless stated otherwise. Sephadex DEAE A-50 was hydrated in 5033
mM NH4HCO3. Sephadex G-75 (Pharmacia) was hydrated in 10 mM
triethylammonium bicarbonate (pH 7.0) and immediately poured. Bio-Gel P4 Gel
(Blo-Rad) was hydrated in DAB buffer (30 mM Tris-HCI (pH 7.4), 1 mM EDTA, I
mM dithiothreitol, and 5% (wlv) glycerol), and hydroxyapatite Bio-Gel HTP (Bio-
Rad) was hydrated in 20 mM potassium phosphate buffer (pH 7.5).
2.2.1.2 Preparation of Dowex AG 1-X8 Resin
A 1-L graduated cylinder was filled with 800 mL of 1 M NaOH and dry
Dowex I -X8 was added until the volume in the cylinder was displaced to a total
volume of I L. The slurry was mixed by inversion, allowed to settle
(approximately 30 mm), and the supernatant was removed by using an aspirator.
The cylinder was filled to I L with I M NaOH and mixed by inversion. The slurry
was allowed to settle (approximately 30 mm) and the supernatant was removed.
The addition of 1 M NaOH and subsequent removal was repeated until a total of
4 L of NaOH had been used to wash the resin. The resin was transferred toa
glass filter funnel (60-C), allowed to drain by gravity, washed with 600 mL of I M
ammonium formate (pH 4.2), allowed to drain, and washed with 2 L of 10 mM
ammonium formate (pH 4.2). After the resin fully drained, it was transferred toa
storage container and stored at 4 °C as a 50% (v/v) slurry in 10 mM ammonium
formate (pH 4.2).34
2.2.1.3 Preparation ofAffi-gel Blue Gel
One part Affi-gel Blue Gel resin slurry (Bio-Rad) was thoroughly mixed at
4 °C with six parts HI buffer (30 mM HEPES-KOH (pH 7.8), 1 mM dithiothreitol,
0.25 mM EDTA, 0.25% (w/v) inositol, and 0.01% (v/v) Nonidet P-40) containing
50 mM KCI and allowed to settle (approximately 30 mm). The buffer was
decanted and mixed with six parts Hl-30 buffer. This defining process was
repeated eight times and then the column was immediately poured.
2.2.2 Dialysis Tubing
SpectraPor dialysis tubing was cut into 30-cm lengths, placed into a 1-L
beaker, and soaked in 1% acetic acid for I h. The tubing was rinsed with water.
A solution of 1% (wlv) NaHCO3 with 0.1% (wlv) EDTA was added to the beaker
and heated to a boil. The boiled solution was replaced with a fresh solution of
1% (w/v) NaHCO3 with 0.1% (w/v) EDTA and heated to a boil again. The tubing
was washed once with water and then heated to a boil in water. The water was
removed and the treated dialysis tubing was stored in 10 mM EDTA at 4 °C.
2.2.3 Preparation of dT2o
Oligonucleotide dT20 was synthesized by the Biopolymer Core Facility at
the University of Maryland at Baltimore. To desalt the dT20, the lyophilized
sample (approximately 5 pmole) was resuspended in I mL of 10 mM35
triethylammonium bicarbonate buffer (pH 7.2) and applied to a 1.79 cm2x 10cm
Sephadex G-25 column equllthrated in the same buffer. The column was
operated at a 20 mi/h flowrate and 1.5-mi fractions were collected. Fractions
were monitored spectrophotometrically at 260 nm and the elution peak was
pooled and quantified by using a molar extinction coefficient for dT20 of 260 = 1.7
x I/molcm. The pooled peak was analyzed by MALDI MS to check for
incomplete synthesis products and then divided into 1- or 1.5-mL fractions that
were dried by vacuum centrifugation. The dried fractions were stored at -80 °C
until further use.
2.2.4 Preparation of dT10, dT30, anddT70
Oligonucleotides dT10, dT30, anddT70were synthesized and HPLC purified
by the Biopolymer Core Facility, at the University of Maryland at Baltimore.
Oligonucleotide dT10 was used without further purification. Oligonucleotides dT3o
and dT70 (-30 nmol of each) were run out on a 15% native polyacrylamide gel.
Oiigonucieotide bands were located within the gel by UV shadowing, bandswere
cut from the gel, and oligonucleotides were electroeiuted from the gel for 2 h by
using an Elutrap device and Ix TAE (40 mM Tris-acetate, 1 mM EDTA)as the
elution solution. Both oligonucleotides were buffer exchanged with 4 mL of TE
buffer (10 mM Tris-HCI (pH 7.2) and 1 mM EDTA) and concentrated to about 130
pL in a Centricon-3. The absorption at 260 nm was used to estimate the quantity
of oligonucleotide by using molar extinction coefficients of 8.4xIl/molcm for
dT10, 2.5x l/moicm for dT30, and 5.9x 1O5i/molcm for dT70.36
2.2.5 5'-End Phosphorylation of Oligonucleotides
At 4 °C, desalted oligonucleotides were resuspended in 470 pL PNKB
buffer (50 mM Tris-HCI (pH 7.6), 10 mM MgCl2, 5 mM dithiothreitol, and 0.1 mM
EDTA) and 10 pL of [y-32P]ATP (6000 Ci/mmol) and 10 pL (100 units) of 14
polynucleotide kinase were added. Reaction mixtures were incubated at 37 °C
for 15 mm at which time 10 pL of 100 pM cold ATP was added. Incubation at 37
°C was continued for an additional 45 mm. Labeling reactions were stopped by
incubating the mixture at 65 °C for 5 mm. Unreacted ATP was removed from
250-pL fractions by immediate passage through two consecutive 1-mL mini-
columns containing P4 resin equilibrated in DAB buffer (30 mM Tris-HCI (pH
7.4), 1 mM EDTA, 1 mM dithiothreitol, and 5% (w/v) glycerol). The mini columns
were operated in a clinical centrifuge (IEC) at setting 4 for 2.5 mm. The
concentrations of final [32P]-Iabeled oligonucleotide solutions were measured
spectrophotometrically and the radioactive specific activity was determined by
liquid scintillation counting using Formula 989 cocktail.
2.2.6 Polyacrylamide Gel Electrophoresis
2.2.6.1 Large Gel Denaturing Polyacrylamide Gel Electrophoresis
Denaturing polyacrylamide gel electrophoresis was conducted using 17
cm x 15 cm x 1.5 mm slab gels (Gibco-BRL). Stacking gels (3 cm) were
composed of 3% acrylamide, 0.1% N,N'-methylenebis acrylamide, 125mM Iris-
HCI (pH 6.8), and 0.1% SDS. Resolving gels were composed of acrylamide in37
0.4% N,N'-methylenebis acrylamide, 375 mM Tris-HCI (pH 8.8), 0.1% SDS.
Samples were usually mixed with 5x cracking buffer (0.125 M Tris-HCI (pH 6.8),
360 mM 2-mercaptoethanol, 25% (w/v) glycerol, 2.5% SDS, 0.1% bromophenol
blue), heated at 56 °C for 15 mm and loaded. Electrophoresis was conducted
with 25 mM Tris base, 200 mM glycine, and 0.1% SDS as the running buffer and
at 200 V and room temperature until the tracking dye had migrated to 2 cm from
the bottom of the gel. Gels were stained by Coomassie stain, copper, or silver as
described below. When needed, gels were dried and autoradiography was
performed using X-OMAT (Kodak) film. Wet gels were photographed with
Polaroid-55 or -57 film using an orange filter.
2.2.6.2 Mini Gel Denaturing Polyaciylamide Gel Electrophoresis
Denaturing polyacrylamide gel electrophoresis was also conducted using
the Mini-Protean II system (Bio-Rad) with 1 mm spacers. Stacking gels (2 cm)
were composed of 3% acrylamide, 0.1% N,N'-methylenebis acrylamide, 125 mM
Tris-HCI (pH 6.8), and 0.1% SDS. Resolving gels were composed of acrylamide
in 0.4% N,N-methylenebis acrylamide, 375 mM Tris-HCI (pH 8.8), 0.1% SDS.
Samples were usually mixed with 5x cracking buffer (0.125 M Tris-HCI (pH 6.8),
360 mM 2-mercaptoethanol, 25% (w/v) glycerol, 2.5% SDS, 0.1% bromophenol
blue), heated at 56 °C for 15 mm and loaded. Electrophoresiswas conducted
with 25 mM Tris-base, 200 mM glycine, and 0.1% SDSas the running buffer and
at 200 V and room temperature until the tracking dye had migrated 0.5cm from
the bottom of the gel. Gels were stained by Coomassie stain,copper, or silver as38
described below. When needed gels were dried and autoradiography was
performed.
2.2.6.3 Native Po!yaciylamide Ge! E!ectrophoresis
Native, continuous, polyacrylamide gel electrophoresis was conducted
using 17 cm x 15 cm x 1.5 mm slab gels (Gibco-BRL). Gels were composed of
acrylamide in 0.4% N,N'-methylenebis acrylamide and 375 mM Tris-HCL (pH
8.8). Samples were mixed with 5x loading buffer (0.125 M Tris-HCI (pH 8.8),
25% (w/v) glycerol, and 0.1% bromophenol blue) and immediately loaded.
Electrophoresis was conducted with 25 mM Tris-base and 200 mM glycine as the
running buffer and at 250 V until the tracking dye had migrated to about 2 cm
from the bottom of the gel.
2.2.7 Gel Staining
2.2.7.1 Coomassie Staining
Staining was conducted by covering gels with a solution of 0.05% (w/v)
Coomassie Brilliant Blue G-250 in 50% methanol and 10% acetic acid that had
been filtered through Whatman I filter paper. For large gels, staining was
performed overnight. For mini-gels, staining was performed for 1 h. Destaining
was carried out in 5% methanol and 7% acetic acid until the desired band
intensity was reached.39
2.2.7.2 Copper Staining
Immediately following electrophoresis, large gels were rinsed in water for
5 mm, the water was removed, and gels were stained with a solution of 300 mM
copper (II) chloride for 5 mm. The staining solution was removed and gels were
rinsed with water for 5 mm. For mini-gels, gels were immediately stained in300
mM copper (Il) chloride for 5 mm. The staining solution was removed and gels
were rinsed with water for 5 mm. Negatively stained protein gel bands were
visualized by holding a black piece of paper behind the gel and observing black
protein bands against a blue-white background.
2.2.7.3 Silver Staining
Silver staining was performed as described by Schevchenko et al. (126)
with modifications. Immediately following electrophoresis gels were fixed in 50%
methanol and 5% acetic acid for 20 mm. The fixing solution was replaced with
50% methanol, washed for 10 mm, replaced with water, and the gel was washed
for I h. Water was removed and gels were then washed with a sensitizing
solution of 0.02% sodium thiosulfate for 1 mm. The sensitizing solution was
removed and gels were rinsed for 1 mmin water, with one subsequent repetition.
Gels were stained by submerging them in a 0.1% silver nitrate solution for 20
mm. After staining, gels were rinsed twice in water, I mm for each rinse, and
then developed in a solution containing 0.04% formalin and 2% sodium
carbonate. Once bands were visible at the desired intensity, an equal volume of40
10% acetic acid was mixed with the developing solution to stop the reaction. The
stopped developing solution was removed and replaced with 5% acetic acid.
2.2.8 In-gel Reduction and Alkylation
Gel slices were dehydrated with 100% acetonitrile, the solvent was
removed, and gel slices were dried under vacuum. Once dried, the gel slices
were covered with 10 mM DTT in 100 mM NH4HCO3 and reduced for I h at 56
°C. This solution was then replaced with freshly prepared 55 mM iodoacetamide
in 100 mM NH4HCO3 and gel slices were incubated at room temperature for 45
mm.
2.2.9 In-gel Proteolytic Digestion
Gel slices were prepared for in-gel proteolytic digestion by washing them
with 100 mM ammonium bicarbonate, dehydrating with 100% acetonitrile,
rehydrating with 100 mM ammonium bicarbonate, and dehydrating again with
100% acetonitrile. Each gel preparation step was carried out for 15 mm with
vortexing. The final dehydration liquid was removed and the gel pieces were
dried under vacuum for 3 h. Gel pieces were rehydrated on ice in digestion
buffer (50 mM ammonium bicarbonate, 5 mM calcium chloride) containing 36
ng/pL trypsin. After I h, the trypsin solution was removed from each gel piece,
replaced with 40 pL digestion buffer, and the digestion was continued at 37 °C41
overnight. MALDI-MS analysis was conducted on the resulting digestion
solution.
2.2.10 Nuclease P1 Digestion
Nuclease P1 was diluted with 50 mM ammonium acetate at a nuclease to
buffer ratio of 1:25. Digestion was conducted by mixing one part of the resulting
nuclease solution (0.04 units/pL) with one part sample and incubated at 37 °C for
2 h.
2.2.11 Off-line High Performance Liquid Chromatography
The off-line HPLC system consisted of an ABI 140B syringe pump (Perkin-
Elmer) with a flow rate split to 5 p11mm and a 0.32 mm x 250 mm column packed
with 5-pm particle, 150-A pore, Beta Basic C,8 (Keystone Scientific) packing
material. An ABI 759A UV detector equipped with a 35-ni dead volume and 8-
mm pathlength flowcell (LC Packings) was used for detection. All system
connections were made with 50-pm (i.d) silica tubing. The solvent system of (A)
5 mM ammonium acetate and (B) 100% acetonitrile was delivered witha gradient
of 5% to 50% B over 45 mm. Eluted species were monitored at 217nm and
collected for identification by MALDI-MS and subsequent nano-ESI tandemmass
analysis.42
2.2.12 Matrix-Assisted Laser-Desorption Ionization Mass Spectrometry
MALDI mass spectrometry was performed at Oregon State University
(Mass Spectrometry Core Facility) using a custom-built delayed extraction time-
of-flight instrument. Samples were mixed with matrix, applied to the probe by
using the wipe-wash method, allowed to dry on the probe by slow evaporation,
and rinsed with Millipore-purified water. All mass spectra were collected in the
positive-ion mode by summing the signals generated from 30 individual laser
pulses.
2.2.12.1 MALDI Analysis of Proteins
The typical matrix solution used for the analysis of proteins (mainly Ung)
was 10 mg/mL of sinapinic acid in 50% acetonitrile and 0.1% trifluroacetic acid.
Analyte was usually mixed with matrix at a ratio of 1:3 and tx-chymotrypsinogen
(M+H=25,657) was used as an external mass calibrant.
2.2.12.2 MALDI Analysis of Peptides
MALDI analysis of peptides was conducted using a 5-mglmL solution of
the matrix o-cyano-4-hydroxycinnamic acid (HCCA) in 0.1% trifluoroacetic acid,
33% acetonitrile. Analyte was typically mixed with matrix at a ratio of 1:5
(peptides to matrix). Angiotensin I (MH=1297.5) and bovine insulin
(MH=5734.6) were used as external mass calibrants.43
2.2.12.3 MALDI Analysis of dT20 and Nucleopeptides
The matrix solution used for dT20 and peptidexdT0 samples was a
saturated solution of 2' ,4' ,6' trihydroxyacetophenone (THAP) in 50 mM
diammonium hydrogen citrate and 50% acetonitrile. Analyte was typically mixed
with matrix at a ratio of 1:1 or 1:2 (analyte to matrix) and a synthetic polymer
(M+H=5043.4) was used as an external mass calibrant.
2.2.13 Electrospray Ionization Mass Spectrometry
2.2.13.1 Nanospray Triple Quadrupole Mass Analysis
All nanospray analyses were conducted using a SCIEX (Perkin Elmer) API
III triple quadrapole mass spectrometer in which the commercial electrospray
source was replaced with a nanospray source constructed by the Protein and
Peptide Group, European Molecular Biology Laboratory, Heidelberg, Germany
(147). A curtain gas of nitrogen was used at a flow rate of 0.6 Limin, the needle
voltage was 700 V, the interface plate voltage was 100 V, and the orifice
potential was 80 V. Samples collected from off-line HPLC fractions were
adjusted to 0.1% formic acid and 40% acetonitrile and 0.6 pL of the adjusted
sample was loaded into a nanospray needle (Protana). Scans in theQ1mode
were performed with 0.3 mass unit steps for 3 seconds per scan. For operation
in the MS/MS mode,Q1was set to transmit a mass window of 2 mass units and
mass spectra were accumulated with 0.3 mass unit steps for 2 mm per scan.
Resolution was adjusted to provide maximum sensitivity and the collisiongas44
thickness (CGT) was set to 230x 1012molecules/cm2, with argon being the
collision gas. Collision energy was increased in a stepwise manner between 15
V and 35 V. Typically, the collision energy was increased in 5 V increments
every two to four scans and the resulting scans were averaged. All analyses
were performed in the positive ion mode.
2.2.13.2 LC Triple Quadrupole Mass Analysis
A Shimadzu VP HPLC system was operated at a flow rate of 80 pL/min
that was split to 5 pL/min with a splitter box (LC Packings). A column of 0.32 mm
x 100 mm packed with 5-pL particle size, 300-A pore size, Luna Cl 8 (2) packing
material was directly in-line with a SCIEX API-Ill triple quadrupole mass
spectrometer (Perkin Elmer). The solvent system used was (A) 0.1% acetic acid,
0.01% trifluoroacetic acid, 5% methanol and (B) 0.1% acetic acid, 0.01%
trifluoroacetic acid, and methanol. A curtain gas of nitrogen was used at a flow
rate of 0.8 L/min, the needle voltage was 5000 V, and the orifice potential was
100 V. Scans in theQ1mode were performed with 0.3 mass unit steps for 2
s/scan. For operation in the MS/MS mode,Q1was set to transmit a mass
window of 2 mass units and mass spectra were accumulated with 0.3 mass unit
steps for 2 s/scan. Resolution was adjusted to provide maximum sensitivity and
the collision gas thickness (CGT) was set to 230x 1012molecules/cm2, with
argon being the collision gas. The collision energy was optimized for each
peptide analyzed, but was typically between 15 V to 30 V. All analyseswere
performed in the positive ion mode.45
2.2.13.3 Quadrupole Ion-trap Mass Analysis
An ABI 1408 syringe pump (Perkin-Elmer) and a 0.17 mm x 100 mm
column packed with 5-pm particle, 100-A pore, Luna C18 (2) packing material
(Phenomenex) were directly coupled to a Finnegan ESI-LCQ quadrapole ion trap
mass spectrometer (ThermoQuest Corp). A solvent system of (A) 0.1 % acetic
acid, 0.01% trifluoroacetic acid and (B) 0.1% acetic acid, 0.01% trifluoroacetic
acid in acetonitrile was delivered at a flow rate of 2 pL/min and a gradient of 5%
to 50% B over 30 mm. The HPLC column was connected by 30 pm (i.d.) silica
tubing to a custom built ESI source in which the spray formed from the tip of a
2.5-cm length, 35 gauge, stainless steel hypodermic tubing that was positioned
approximately 5 mm from the inlet capillary. The ESI source was operated with a
needle voltage of 2300 V and a heated capillary was maintained at 180 °C. For
MS/MS operations an isolation width of 1.5 m/z for the precursor ion and a
collisional energy parameter at 27% of the highest available energy, as defined
by the LCQ software, were used. All analyses were conducted in the positive ion
mode.
2.2.14 Database Search Algorithms
Peptide sequencing and protein identifications were conducted with the
aid of Protein Prospector (http://prospector.ucsf.edu) and SEQUEST (33, 155-
157) database search algorithms.46
2.3 Experimental Procedures for Ung Project
2.3.1 Uracil-DNA Glycosylase Activity Assay
Enzymatic activity of Ung was measured using a procedure similar to that
of Bennett and Mosbaugh (7). Reaction mixtures of 100 pL containing 70 mM
HEPES-KOH (pH 8.0), 1 mM EDTA, 1mM DTT, 8.2 nmol of calf thymus [uracil-
3H]DNA (180 cpm/pmol of uracil), and 25 pL of Ung diluted in 50 mM HEPES-
KOH (pH 8.0), 1 mM EDTA, 1 mM DII and 100 pg/mI bovine serum albumin.
Reaction assays were mixed on ice and then incubated at 37 °C for 30 mm.
Assays were stopped by the addition of 250 pL of ice cold 10 mM ammonium
formate (pH 4.2). Aliquots from each stopped reaction mixture (300 pL) were
applied to Dowex AG 1-X8 columns (Pasteur pipette, 0.2cm2 x2 cm)
equilibrated in 10 mM ammonium formate. The columns were washed with 1.7
mL of 10 mM ammonium formate to elute free [3H]uracil in two 1-mL fractions
that were collected directly in separate scintillation vials. Formula 989 (5 mL)
scintillation cocktail was added to each vial and 3H radioactivity was measured in
a Beckman (LS6800) liquid scintillation counter.
2.3.2 Purification of Uracil-DNA Glycosylase
The purification of Ung was based on a procedure previously described
(6). E. co/i JMIO5/pSBIO5I were grown on LB plates (1% tryptone, 0.5% yeast
extract, 1% NaCI, and 1.5% agar) containing 0.01% ampiciltin at 37 °C. An
isolated colony was selected and grown overnight in LB medium (1% tryptone,47
0.5% yeast extract, and 1% NaCI) containing 0.01% ampicillin at 37 °C. The
saturated culture was used to inoculate 6 liters (1:100) of LB medium containing
0.01% ampicillin. The culture was shaken at 37 °C until the cell density reached
an 0D600 of 0.8 at which time IPTG was added to a final concentration of 1 mM.
The induced culture was allowed to grow for an additional 3 h and the cellswere
collected by centrifugation in a Sorvall GSA rotor at 5,000 rpm for 15 mm at 4 °C.
The cell pellets were stored at 80 °C until the start of purification.
The following purification steps were carried out at 4 °C. Cell pellets were
thawed and thoroughly resuspended in 240 mL of buffer TED (50 mM Tris-HCI
(pH 8.0), 1 mM EDTA, and 1 mM dithiothreitol). Cells were lysed by sonication
and cellular debris was pelleted by centrifugation in a Sorvall SA-600 rotor at
10,000 rpm for 15 mm. Supernatant fractions were pooled andan equal volume
of 1.6% (wlv) streptomycin sulfate in TED was added dropwise with stirringover
30 mm. Stirring was allowed to continue for an additional 30 mmat which time
the solutions were cleared by centrifugation in a Sorvall SA-600 rotor at 10,000
rpm for 15 mm. The supernatant was adjusted to 70% ammonium sulfate to
precipitate the protein and the mixture was allowed to stir foran additional 30 mm
to ensure complete precipitation. The precipitate was collected by centrifugation
in a Sorvall SA-600 rotor at 10,000 rpm for 15 mm. The precipitatewas
resuspended in 4 mL of UE buffer (10 mM Hepes-KOH (pH 7.4), 10 mM 2-
mercaptoethanol, 1 mM EDTA, I M NaCI, 5% (wlv) glycerol) and dialyzed
overnight against UE buffer. The dialyzed samplewas applied to a Sephadex G-
75 column (6cm2 x88 cm) equilibrated in UE buffer, eluted with thesame buffer,48
and 7-mL fractions were collected. Fractions containing uracil-DNA glycosylase
activity were pooled, diafiltrated with 1.4 L of HA buffer (10 mM potassium
phosphate (pH 7.4), 1 mM dithiothreitol, and 200 mM KCI), and concentrated to
30 mL with an Amicon stirred cell under 55 psi of N2 gas using a YMIO
membrane. The sample was applied to a hydroxylapatite column (4.9 cm2x15
cm) equilibrated in HA buffer, eluted with the same buffer, and 5-mL fractions
were collected. Fractions containing uracil-DNA glycosylase activity were pooled
and dialyzed overnight against DAB buffer (30 mM Tris-HCI (pH 7.4), 1 mM
dithiothreitol, 1 mM EDTA, 5% (wlv) glycerol). The sample was applied to a
single-stranded DNA agarose column (19 cm2x44 cm) equilibrated in DAB
buffer and 7-mL fractions were collected. After washing with 5 column volumes
of DAB, the enzyme was eluted with DAB containing 150 mM NaCI. Fractions
containing enzyme activity were analyzed by denaturing polyacrylamide gel
electrophorsis to monitor the level of purity in each fraction and those fractions
considered to be greater than 90% pure for uracil-DNA glycosylase were pooled,
diafiltrated against 1.4 L of buffer DAB, and concentrated to 2.5 mg/mI using an
Amicon stirred cell under 55 psi of N2 gas and a YM1O membrane. The protein
concentration was determined spectrophotometrically by using a molar extinction
coefficient for Ung as E280 = 4.2xiO l/molcm. The purified protein was stored
at 80 °C until used.2.3.3 Preparative Crosslinking of Ung to dT20
Purified Ung (36 nmol) was combined with a 3-fold molar excess of dT20
and DAB buffer was used to bring the final volume to I mL. The mixture was
placed in a 4-mL, capped, quartz, cuvette (NSG Precision Cells) and equilibrated
on ice for 15 mm prior to crosslinking. The cuvette was placed lengthwise on a
bed of ice, and irradiated with UV light (Xm=254 nm) in a Stratalinker 1800
(Stratagene Cloning Systems) for an appropriate period of time (see Chapter3
sections 3.1.1.1 and 3.1.2.1). This solution was either used immediatelyor
stored at -80 °C until future use.
2.3.4 Purification of Ung Nucleopeptides
2.3.4.1 "In-pot" Method
Five 1-mL crosslinked reaction mixtures were pooled in a I 5-mL Corex
tube on ice. Ice-cold trichloroacetic acid (TCA) was added to the pooled solution
to give a final TCA concentration of 10% in the final volume. Free protein and
crosslinked protein were allowed to precipitate on ice for 20mmand then the
solution was cleared by centrifugation at I 0,000 rpm inan SS-34 rotor at 4°C.
The supernatant was removed and the pellet was washed twice with ice-cold
10% TCA, once with 20 °C acetone, and the pelletwas dried under vacuum for
45 mm. The pellet was resolubilized in 500 ML ofa freshly prepared solution of 8
M urea, 0.4 M NH4HCO3, and 5 mM DII. This solutionwas incubated at 50 °C
for 20 mm at which time 10 ML of fresh 500 mM iodoacetamidewas added and50
the solution was incubated again at 50 °C for 20 mm. Water was added to dilute
the solution to a final urea concentration of 2 M and trypsin was added in a 1:50
(wlw) ratio of trypsin to Ung and incubated at 37 °C for 2 h. At this time, an
additional 1:50 (w/w) ratio of trypsin was added to the solution and incubation
was continued at 37 °C for 19 hr. The digestion mixture was diluted 1:4 with 50
mM NH4HCO3 and applied to a Sephadex DEAE A-50 column (1.79cm2 x9 cm)
equilibrated in the same buffer. The column was washed at 20 mLlhr with 21 mL
of 50 mM NH4HCO3, 40 mL of NH4HCO3 containing 100 mM NaCI, and eluted
with a 90-mL linear gradient of 100 mM to 800 mM NaCI in NH4HCO3. The
column was washed with an additional 30 mL of 800 mM NaCI in NH4HCO3 to
complete the gradient. Fractions of I mL were collected and surveyed
spectrophotometrically at 260 nm and 280 nm and by conductivity to generatean
elution profile. The elution peak fractions were pooled and loaded ontoa
Nensorb-20 (DuPont) column that had been prewetted with 100% methanol and
equilibrated with 20 mM triethylammonium acetate (pH 7.2). The columnwas
washed with 10 mL of equilibration buffer, then with 10 mL of water, and eluted
with 1 mL of 50% methanol. The eluate was concentrated byvacuum
centrifugation to about 10 pL and analyzed by MALDI-MS.
2.3.4.2 Gel-Based Method
Aliquots of the irradiated crosslinking mixture, typically 200 pL,were
mixed with 50 iL of 5x cracking buffer, and SDS-polyacrylamideelectrophoresis
was carried out on Gibco-BRL gels. After removing the stacking gel, the lower 3-51
cm portion of the resolving gel corresponding to the region of free dT20 was
removed with a razor blade and the remaining portion of gel was stained with
copper. Bands corresponding to UngxdT20 were cut from the gel with a clean,
sharp razorblade and placed into I .5-mI Eppendorif tubes. Gel slices were
washed by adding a volume of destain solution (Bio-Rad) to cover the gel pieces.
The tubes were vortexed for 15 mm, the solution in each tube was removed, and
the gel pieces were washed with fresh destain solution three more times. At this
time, the gel slices were considered "destained". In-gel digestion (Section 2.2.9)
was then performed on the gel-slices with one modification. After 2 h of digestion
at 37 °C, 400 iL of digestion buffer was added to the gel slices and digestion
was continued overnight. After overnight digestion, the aqueous digestion
solution was removed and saved. The organic extraction mixture of FAPH (50%
formic acid, 25% acetonitrile, 15% isopropyl alcohol, and 10% water)was added
to each tube until the gel pieces were covered and the tubes were vortexed at
room temperature for 4 h. The extraction mixture was removed from each tube
and saved. Gel slices were then crushed and dehydrated with 200 pL of
acetonitrile for 10 mm. The acetonitrile was removed, with care not toremove
any gel pieces, and added to the saved FAPH extraction solutions. The
combined organic solutions were concentrated to dryness byvacuum
centrifugation. The saved aqueous digestion solution was adjusted to 10 mM
Tris-HCI (pH 7.2), 1 mM EDTA, and 100 mM sodium chloride (TE-I00) andthe
dried organic extraction fractions were resuspended with 250 pL TE-1 00. Both
the adjusted aqueous digestion solution and the resuspended organicextraction52
solution were applied to a NAC-52 (Gibco-BRL) anion exchange cartridge that
had been activated with 3 mL TE-2000 (TE buffer containing 2000 mM sodium
chloride) and equilibrated with 5 mL TE-100. After sample loading, the cartridge
was washed with 5 mL TE-1 00 and the peptidexdT20 fragments were eluted
with I mL TE-1 000 directly into a Centricon-3 (Amicon). The Centricon-3 was
centrifuged in an SS-34 rotor at 5500 rpm. The eluate was desalted by washing
the Centricon-3 sequentially with 4.5 mL of water, 4.5 mL of 10 mM ammonium
acetate, and 3 mL of water. The washed sample was concentrated to 200 pL
and then transferred to a 750-pL Eppendorif tube and further concentrated to
about 10 pL by vacuum centrifugation.
2.4 Experimental Procedures for Sulfonic Acid Derivatization
All derivatizing steps were conducted in 500 pL Eppendorif tubes and at
ambient temperature. Peptide solutions (5 ML) were dried under a stream of
nitrogen (approximately I h) at which time 20 pL of THF:diisopropylethylamine
(4:1) and 2 pL of THF:chlororsulfonylacetyl chloride (100:1) were added to the
tube. The reaction mixture was vortexed for I mmat which time I pL of water
was added and the mixture was again vortexed for an additional 1 mm. The
reaction mixture was then thoroughly dried under a stream of nitrogen to remove
the volatile reagents. The derivatized sample was resuspended in water and
stored at -20 °C until further use.53
2.5 Experimental Procedures for hRPA Project
2.5.1 Overexpression of hRPA
2.5.1.1 Mini Cultures
The plasmid plld-tRPA, which contains a single T7 RNA polymerase
promoter followed by the coding sequences for hRPA7O, hRPAI4, and hRPA32,
was obtained as a gift from Dr. Marc Wold (University of Iowa). This plasmid was
electroporated into E. co/i strain BLR2I(DE3) and plated on LB plates (1%
tryptone, 0.5% yeast extract, 1% NaCI, and 1.5% agar) containing 100 pg/mI
ampicillin. A single colony was divided in half with a toothpick and each half was
used to inoculate two separate flasks containing 20 mL LB medium and 100
pg/mi ampicillin. The contents of both flasks were grown at 37 °C with shaking to
an O.D.600 of 0.6 at which time one was induced with IPTG to 0.4 mM for 2 h and
the other was uninduced. A fraction (5 mL) from each flask was removed and
centrifuged for 10 mm using a SS-34 rotor at 5000xg and 4 °C. The
supernatant was removed from each tube, the cells were resuspended in 10%
(w/v) glycerol, then centrifuged again for 10 mm using a SS-34 rotor at 5000xg
and 4 °C. Pellets in each tube were resuspended in 250 pL of HI buffer (30 mM
HEPES-KOH (pH 7.8), 1 mM dithiothreitol, 0.25 mM EDTA, 0.25% (w/v) inositol,
and 0.01 % (v/v) Nonidet P-40), SDS was added to a final concentration of 0.1%
to each tube, and the tubes were heated in boiling water for 10 mm. The soluble
protein (- 2 mg/mL) from the induced and the uninduced fractionswas analyzed
on a denaturing 12.5% polyacrylamide gel.54
2.5.1.2 Preparative Cultures
The plasmid p1 ld-tRPA, along with the plasmid pRIL, were electroporated
into E. co/i strain BLR2I(DE3) and plated on LB (1% tryptone, 0.5% yeast
extract, 1% NaCI, 1.5% agar) plates containing 1% glucose, 100 pg/mI ampicillin,
and 34 pg/mI chioramphenicol. A single recombinant colony was selected to
inoculate one liter of TB medium (1.25 tryptone, 2.4% yeast extract, 0.4% (w/v)
glycerol, 0.017 M KH2PO4, and 0.07 M K2HPO4) containing 1% glucose, 100
pg/mI ampicillin, and 34 pg/mI chioramphenicol. The culture was incubated
overnight at 30 °C without shaking and then placed on an orbital shaker and
shaken at 37 °C and 275 rpm. When the absorbance at 600 nm was between
0.6 and 0.8, the culture was induced by adding IPTG to 0.3 mM. After 2 h of
induction, the cells were harvested by centrifugation at 4,000xg in a GSA rotor
and frozen at -80 °C until used.
2.5.2 Purification of hRPA
All purification steps were carried out at 4 °C. Frozen cells (from 1 L of
culture) were resuspended in 50 mL of HI buffer containing 50 mM KCI, 1 mM
phenylmethylsulfonyl fluoride, and 0.1 pg/mI leupeptin. The cells were disrupted
by sonication and the resulting lysate was cleared by centrifugation at 30,000xg
for 30 mmin a SS-34 rotor. Soluble protein was applied to a 20-mL Affi-Gel Blue
Gel column (12 cmx1.77 cm2, BioRad) equilibrated in HI buffer containing 50
mM KCI. The column was washed sequentially with 3 column volumes each of55
HI buffer containing 50 mM KCI, 0.8 M KCI, 0.5 M NaSCN, 1.0 M NaSCN, and
1.5 M NaSCN. The peak of elution was determined by denaturing
polyacrylamide gel electrophoresis, visualizing protein bands with Coomassie
stain. Fractions containing the elution peak were pooled into 12,000-14,000
molecular weight cutoff tubing and dialyzed against HI buffer containing 500 mM
NaCI. It is important to note that dialysis into HI buffer containing 250 mM NaCI
resulted in extensive protein precipitation. After 6 h, the dialysis solution was
replaced with fresh buffer and dialysis was continued for an additional 14 h. The
dialyzed sample was loaded onto a 23-mL single-stranded DNA agarose column
(4.5 cmx4.91 cm2) equilibrated in HI buffer containing 500 mM NaCI. The
column was washed with 3 column volumes of HI equilibration buffer and then
eluted with a I 00-mL linear gradient of equilibration buffer from 500 mM NaCI to
3 M NaCl. The peak of elution, also monitored by denaturing polyacrylamide gel
electrophoresis, was pooled and concentrated by using a Centriprep-30
(Millipore) and the buffer was exchanged to HI buffer containing 200 mM KCl.
2.5.3 Protein Concentration Determinations
All protein concentrations were estimated by the Bradford assay (reagent
from Bio-Rad) using BSA as the standard (16).56
2.5.4 Electrophoretic Mobility Shift Assay
Varying amounts of hRPA (1 pmol to 50 pmol) were mixed with 10 pmol
each of [32P] 5'-end labeled oligonucleotide dT30, each solution was adjusted to
20 mM HEPES-KOH (pH 7.0), 1 mM DTT, and 50 pg/mL BSA, and incubated at
room temperature for 30 mm. Sucrose was added to each reaction mixture to a
final concentration of 12% (final volume of 26 tL). The samples were loaded
onto a 5% native polyacrylamide gel (BRL, 17cmx15 cmx0.5 cm), with TAE as
the running buffer, and electrophoresis was carried out at room temperature and
100 V. The gel was then dried on DE8I (Whatman) backing paper and
autoradiographed using X-OMAT film (Kodak). Quantitation of 32P in the gelwas
conducted using a Phosphorimager (Molecular Dynamics) with lmageQuant 5.0
software (Molecular Dynamics).
2.5.5 UV-Catalyzed Crosslinking of hRPA
Samples of hRPA and oligonucleotide were diluted with HI buffer
containing 50 mM KCI in Eppendorf tubes and allowed to equilibrate at room
temperature for 30 mm. Preparative samples (1 mL) were place in a capped, 4-
mL, quartz cuvette (NSG Precision Cells) or small volume samples (less than
200 pL) were placed in the cap from a 4-mL quartz cuvette (NSG Precision
Cells). Crosslinking (Xm=254nm) was conducted for the appropriate time ina
Stratalinker 1800 (see Chapter 5, Section 6.1.5).57
3. PURIFICATION OF NUCLEOPEPTIDES FROM THE UV-CROSSLINKED
UNG x dT20 NUCLEOPROTEIN COMPLEX FOR
CHARACTERIZATION BY MALDI MS
The application of MALDI MS to characterize nucleoprotein and
nucleopeptide complexes generated from UV-catalyzed crosslinking reactions
has been demonstrated as a promising technique for studying protein-nucleic
acid interactions. The main goal of this thesis was to extend the DNA-binding
characterization of Ung using mass spectrometry by identifying specific amino
acids within the protein taking part in crosslinking. In order to continue this work,
sufficient quantities of isolated nucleopeptides were required for tentative
identification by MALDI MS and definitive identification by ESI MS/MS. This
means that the isolated nucleopeptide mixture must be sufficiently concentrated
(-10 pM) and free from contaminates such as salts and surfactants. This
chapter describes two procedures, the "in-pot" and "in-gel" procedures, that were
used to isolate and tentatively identify nucleopeptides by MALDI MS analysis.3.1 Results
3.1.1 "In-pot" Purification of Ung Nucleopeptides
3.1.1.1 Cross/inking of Ung to dT20
In order to obtain sufficient quantities of nucleopeptides from the Ungx
dT20 nucleoprotein complex for mass analysis, a dose response experiment was
performed to determine the optimum time of UV irradiation. This experiment
consisted of mixing the crosslinking components of dT20 and Ung in a 3:1 molar
ratio (the molar ratio that would be used in future preparative crosslinking
experiments) and then irradiating the mixture. At increasing times of irradiation,
fractions were removed and analyzed by denaturing polyacrylamide gel
electrophoresis with the protein bands being visualized by Coomassie staining
(Figure 3.1). From this gel, one band corresponding to free Ung (Mr25,000)
and the other band migrating with an apparent molecular weight of - 32,000 were
identified. The molecular weights of Ung and dT20 were determined by MALDI
MS (Figure 3.2) to be 25,561 and 6,023, respectively, and therefore the predicted
molecular weight of dT20 covalently attached to Ung would be 31,584. The gel
band ofMr- 32,000 (Figure 3.1) increased in intensity with increasing time of
UV-irradiation. The increased intensity along with its estimated molecular weight
suggested that the band corresponded to Ung crosslinked to dT20. The optimum
crosslinking time was determined to be that which produced the largest, well-
defined, mobility-shifted band with minimum background signals. By using this
criterion, the optimum time was selected to be 45 mm (Figure 3.1, lane 7).Lane123456789 10 11
I I I I I I I .i....
MW (kDa)
66
i :
20
Figure 3.1. Effect of 254 nm irradiation time on the crosslinking of Ung to
dT20. A 1500-pL reaction mixture containing 45 nmol of Ung and 134 nmol of
dT20 in buffer DAB was irradiated at 254 nm, as described under "Experimental
Procedures." At the times indicated below, 50-pL sampleswere removed and
analyzed on a denaturing 12.5% polyacrylamide gel. Following electrophoresis,
the gel was stained with Coomassie Brilliant Blue G-250 to visualize theprotein
bands.Lane Icorresponds to 3.3 nmol of unirradiated Ung andlanes 2-Il
correspond to 254 nm exposure times of 0, 5, 10, 20, 30, 45, 60, 90, 120, and
150 minutes, respectively. The location of molecular weight standards (kDa)are
indicated to the left of the figure and the location of Ung and UngxdT2o are
indicated to the right of the figure.Figure 32. MALDI mass spectra of Ung and dT20. A, a solution of 36 pM of
Ung was mixed with the matrix sinapinic acid in a 1:3 ratio of protein to matrix
and analyzed. Matrix adduction to the protein is observed with ion species m/z
25,786 (mass sinapinic acid is 224 Da). B, a solution of 108 pM of dT2owas
mixed with the maxtrix THAP in a 1:5 ratio of oligonucleotide to matrix and
analyzed.Details of the MALDI analysis are described in more detail under
"Experimental Procedures."61
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Figure 3.2. MALDI mass spectra of Ung and dT20.62
3.1.1.2 Isolation and MALDI Analysis of Ung Nucleopeptides from the
UngxdT2o Nucleoprotein Complex
Preparative-scale crosslinking was performed with 180 nmol of Ung and
560 nmol of dT20 to isolate and analyze by mass spectrometry Ung tryptic
peptides crosslinked todT20.An "in-pot" purification scheme (Figure 3.3) was
followed to isolate nucleopeptides from the nucleoprotein complex. In this
scheme, the UV-irradiated mixture was treated with trichloroacetic acid to
precipitate the protein. The precipitated protein was then suspended in 8 M urea,
proteolytically digested, and peptidexdT20 complexes were separated from non-
crosslinked peptides by a DEAE-Sephadex column (Figure 3.4). The elution was
monitored spectrophotometrically at 260 nm and 280 nm. A peak between
fractions 150 and 180 had an elevated A260/A280 absorbance ratio and eluted at a
salt concentration of 460 mM (Figure 3.4).It was reasoned that elution peaks
containing peptides would have A260/A280 ratios of less than one and peaks
containing nucleopeptides would have A260/A2ratios greater than one.
Therefore, fractions 156 through 178 were pooled, desalted, concentrated, and
then analyzed by MALDI MS (Figure 3.5). Five prominent ion species were
observed in the m/z range of 6,000 to 9,500. The ion species at 6,025
corresponded to dT20 while the ion species 7,187.4, 7,608.1, 8,078.7, and
9,405.2 had masses that were in the range of Ung peptides crosslinked to dT20.
Further analysis of this spectrum was not pursued since the signal to background
ratio was very low and the peak widths were very large making it difficult to63
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Figure 3.4. Anion exchange chromatography elution profile of Ungtryptic
nucleopeptides. Six standard crosslinking mixtures (1 ml each)were UV
irradiated, pooled, and treated using the "in-pot" analytical schemeas described
under "Experimental Procedures." Fractions collected froma DEAE-Sephadex
A-50 column were monitored for absorbance at 260nm (A) and 280 nm (A) and
for conductivity (B).1.0
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Figure 3.5. MALDI mass spectrum of purified Ung x dT20 trypticpeptides
isolated using the "in-pot" purification" scheme. Fractions 156-178 fromthe
DEAE-Sephadex column (Figure 3.4) were pooled, desalted and concentratedby
using a Nensorb-20 column, and then analyzed by MALDI-MS,as described
under "Experimental Procedures."assign accurate masses. It was also found that reproducing this spectrum from
samples produced via the "in-pot" separation procedure was challenging since
most attempts yielded only ion signals of dT20. The dT20 ion signal might have
been a result of the oligonucleotide co-precipitating with Ung and UngxdT20
during treatment with trichloroacetic acid. Any dT20 present at this stage of the
purification scheme would have co-purified when attempting to isolate
nucleopeptides. A disproportionate ratio of dT20 to nucleopeptides (higher
concentration of dT20) could have interfered with obtaining spectra of isolated
nucleopeptides.
3.1.2 Gel-Based Purification of Ung Nucleopeptides
3.1.2.1 Cross/inking of Ung to dT20
As a result of not being able to obtain sufficient quantities of nucleopeptide
material using the "in pot" procedure, it was decided to reevaluate the effect of
UV-light on the crosslinking reaction yield and its effects on the starting
components of the reaction. The effect of UV light on the formation of the Ungx
dT20 product was reevaluated by irradiating a mixture of 20 nmol of Ung and 40
nmol of[32PJdT20for increasing times. Analysis of the reaction products on a
SDS-polyacrylamide gel (Figure 3.6A) revealed a mobility-shifted band (relative
to free Ung) of Mr -33,000 that was consistent with the predicted molecular
weight of Ungx[32P]dT2o (M.W. 31,664). Autoradiography showed that the
mobility shifted band contained [32P]dT2o and corresponded to the covalent Ungx67
Figure 3.6. Effect of 254 nm irradiation time on the crosslinking of Ung to
[32P]dT2o. A 635-pi reaction mixture containing 20 nmot of Ung and40 nmol of
[32P]dT2o in buffer DABwas irradiated at 254 nm, as described under
"Experimental Procedures." At the times indicated, 25-pi samples were removed
and analyzed on a denaturing 12.5% polyacrylamide gel. Following
electrophoresis, the gel was stained with silver (A), dried, and subjected to
autoradiography (B). Lane I contains 200 pmol of unirradiated Ung and lanes 2-
II correspond to 254-nm exposure times of 0, 5, 10, 20, 30, 45, 60, 90, 120, and
180 minutes, respectively. The location of molecular weight standards (in kDa)
and free Ung (U) are indicated to the left of pane/A and the location of Ungx
[32PJdT20 is indicated by an asterisk to the right of panel B. The amount ofUngx
[32PdT2o was quantified by cutting the bands from the dried gel andmeasuring
the 2P radioactivity by liquid scintillation counting (C).66
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Figure 3.6. Effect of 254 nm irradiation time on the crosslinking of Ung to
[32P]dT2o.
*[32P]dT2o nucleoprotein complex (Figure 3.6B). From measuring theamount of
Ungx[32PJdT2o in the crosslinked bands, the maximum crosslinking yield
was determined to take place between 20 and 30 mm of irradiation time before a
reduction in the crosslinking product took place (Figure 3.6C). Closer analysis of
the SDS-polyacrylamide gel showed that the reduction did not seem to be the
result of a reversal in the crosslinking reaction, but a result of degradation in the
nucleoprotemn complex occurring at increased doses. The onset of degradation
was observed between 10 and 20 mm with a loss in the band shape of Ungx
[32P]dT20 and an increased background of the gel, especially in the lower
molecular weight range relative to Ungx[32P]dT2o (Figure 3.6A and 3.6B).
To assess the effect of UV light on the individual components of a
crosslinking reaction, Ung or dT20 was exposed to 254-nm radiation and
characterized by MALDI MS (Figure 3.7). For both protein and oligonucleotide,
increased exposure to 254-nm radiation resulted in a decrease in the signal to
background ratio. The reduced signal to background ratio was more pronounced
for the protein than for the DNA, especially within the first 15 mm ofexposure.
Also within the first 15 mm of exposure, a distinct degradation product of the
protein was observed occurring at m/z 10,500. The effect of UV lighton the
protein and the oligonucleotide was wavelength dependent since irradiation at
312 nm showed virtually no loss in the signal to background ratio ofdT20and only
a slight reduction in that of Ung after a 45-mm dose (Figure 3.8). Combining the
results of the two dose experiments (Figures 3.6 and 3.7), a 254nm crosslinkingU,
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Figure 3.7. Effect of 254-nm tight on MALDI-MS analysis of Ung and dT20.
Separate 1-mL solutions of Ung (36 pM) or dT20 (108 pM) were exposed to 254-
nm tight for 0, 15, 30, or 45 mm(A, B, C, and D, respectively) and analyzed by
MALDI-MS, as described under "Experimental Procedures." Ung [MHJ=
25,564 and dT20 [M + HJ = 6,024, as measured at 0 mm. Anarrow indicates the
position of a specific UV degradation product from Ung.>..
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Figure 3.8. Effect of 312-nm tight on MALDI MS analysis of Ung and dT20.
Separate 1-mL solutions of Ung (36 pM) or dT20 (108 pM) were exposed to 312-
nm light for 0 or 45 mm (A and B, respectively) and analyzed by MALDI MS as
described under "Experimental Procedures." Ung [M+H4] = 25,564 and dT20 [M
H4J = 6,024, as measured at 0 mm.72
time of 15mmwas used in preparative crosslinking experiments to obtain
significant nucleoprotein complex yet minimize degradation to the nucleoprotein
complex.
3.1.2.2 Isolation of Ung Nucleopeptides from the UngxdT2o
Nucleoprotein Complex
A novel purification scheme was developed (Figure 3.9) to isolate
sufficient quantities of Ung nucleopeptides for analysis by MALDI MS. In this
scheme, the nucleoprotein complex was isolated from noncrosslinked Ung and
dT20 on a denaturing polyacrylamide gel, as a mobility shifted band, that was
then excised and digested "in-gel" with trypsin. The products of the proteolytic
digestion (tryptic peptides and tryptic peptidesxdT2o) were extracted from the
gel slice by using an organic extraction mixture and the extracted nucleopeptides
were isolated using an anion exchange cartridge. After thorough desalting and
concentration, the isolated peptidesxdT20 (termed nucleopeptides) were suitable
for analysis by MALDI MS.
3.1.2.3 Tentative Identification of PeptidexdT20 Complexes
Prior to the analysis of isolated Ung nucleopeptides, a tryptic peptide
MALDI map of Ung was produced (Figure 3.10) to use as a guide for tentatively
identifying peptide regions of the protein involved in crosslinking. In themap,
92% of the amino acid sequence was covered. The only regions of the protein73
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Figure3.10. MALDItryptic map of E. coil Ung. A band corresponding to Ungwas cut from a SDS polyacrylamide gel
and digested in-gel, as described under "Experimental Procedures."MALDI MS was conducted on the digestion products
to produce a peptide map of the protein. The mlzrange displayed is from 600 to 3000.75
absent in the map were those spanning tryptic fragments T3, T14, T15, and T16
(Table 3.1). Fragments T14 and T15 were not expected to be observed in the
map due to their small molecular weights, but T16 is accounted for in the
incomplete digestion product TI 6/117.
MALDI MS analysis of purified tryptic peptidexdT20 complexes revealed
eight distinct ion species (Figure 3.11), one of which corresponded to free dT20
(mlz 6024.4). Subtracting the molecular weight of dT20 from the seven other
experimentally measured peptidexdTo complexes resulted in the calculated
peptide molecular weight portion of the nucleopeptides. Comparison of the
calculated peptide masses to the tryptic digestion map of the protein (Figure
3.10, Table 3.1) tentatively identified four of the peptide portions of ion species,
7191.7, 7352.8, 7963.9, and 8442.4 as 118 (185-APHPSPLSAHR-195), TI I
(130-AGQAHSHASLGWETFTDK-147), 19 (106-PNHGYLESWAR-1 16), and T6
(58- WILGQ DPYHGPGQAHGLAFSVR-80), respectively. Jon species 8096.6,
7805.5, and 7711.7 did not directly correspond to the sum of a tryptic peptide and
dT20.The calculated peptide masses for these ion species were used in amass
search of the amino acid sequence of Ung. This indicated that ion species
8096.6 and 7711.7 were hydrolysis products of T6xdT20 in which three or seven
C-terminal amino acids, respectively, had been lost during sample preparation.
These truncated forms of T6 are hereafter designated as T6(..3) and T6(.T). The
ion species 7805.5 was tentatively identified as T17/118 (180-
HHVLKAPHPSPLSAHR-I 95) covalently attached to dT20. Collectively, theseTable 3.1. Tentative identification of Ung trypticnucleopeptides measured by MADLI-MS.
Experimental Mass Caluculated Masse
Peptide Predicted
Massa Ung PeptideMassb UngxdT2o
Peptidec UngxdT20 Peptide-dT20
met-TI0 1786.0
TI 1654.8 1654.6
12 1895.1 1895.8
pyroT2 1878.1 1878.9
13 1217.4 N.D9
T4 868.0 867.1
T5 908.0 907.8
T6 2418.7 2419.2 8441.2 2418.1
T6(..3)h 2075.1 N.D. 8095.6 2072.5
T6(..7)' 1686.9 N.D. 7710.7 1687.6 T7 1513.9 1513.6
18 1276.4 1276.4
T8/T9 2587.8 2589.5
T9 1329.4 1329.3 7351.8 1328.7 T10 1425.7 1425.7
pyroT10 1408.7 1408.4
TIl 1943.1 1943.9 7962.9 1939.8 T12 1079.3 1079.5
T13 1570.8 1571.3
T14 146.2 N.D.
115 615.7 N.D.
T16 302.3 N.D.
T17 632.8 631.3
T16/T17 917.1 915.9
0)Table 3.1 (Continued)
Experimental Mass CaluculatedMassd
PeDtide PredictedMassa Una Peptideb UnqxdT20Peptidec UngxdT20 Peptide- dT20
T16117/18 2067.1 2067.3
T17/T18 1784.1 1784.5 7805.5
T18 1169.3 1169.4 7190.7
T19 2165.4 2165.7
T20 1771.0 1769.7
dT20 6023.1 6023.1
1782.4
1167.6
aPredicted average masses were calculated froma predicted tryptic digestion map of E. co/i Ung using the computer
program GPMAW, version 3.13, Lighthouse Data.
bExperimental Ung tryptic peptide masseswere calculated from Figure 3.10.
CExperimental Ung peptidesxdT20 were calculated from Figure 3.11.
dThe molecular weight of crosslinked peptideswere calculated by subtracting the mass of dT20 from the experimentally
measured peptidexdTo masses.
emet-TI contains the N-terminal methionine that ispost-translationally removed in vivo (138).
Peptides T2 and TI 0 contain N-terminal glutaminethat can lose NH3 to form pyroglutamic acid. gND. refers to not detected.
h, 1
Represents truncated forms of the T6 nucleopeptide that havelost 3 or 7 C-terminal amino acids, respectively.
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Figure 3.11. MALDI mass spectrum of purified UngxdT20 tryptic peptides.
A 1 -mL reaction mixture containing 36 nmol of Ung and 108 nmol of dT20was
crosslinked and nucleopeptides were purified by using the in-gel purification
procedure. Tryptic peptides crosslinked todT20were eluted from a NAC-52
anion exchange cartridge, concentrated and desalted with a Centricon-3, and
further concentrated by vacuum centrifugation to approximately 10 pLas
described under "Experimental Procedures." The ion signal corresponding to
free dT20 is observed at m/z 6024.4. The remaining ion signals correspond to
Ung tryptic peptides covalently attached to dT20.79
results suggest that amino acids within regions 58-80, 106-116, 130-147, and
180-195 of the protein are crosslinked to dT20 (Figure 3.12).
3.2 Discussion
The ultimate goal of this work was to obtain sufficient quantities of
nucleopeptides from UV-catalyzed Ungx dT20nucleoprotein complexes for mass
spectral analysis. The important step in reaching this goal was establishing an
optimum irradiation time to minimize protein and oligonucleotide damage. The
hazards of over irradiating crosslinking samples was well-understood (37, 73,
146). However, the analytical method that would best determine the optimum
crosslinking time was not. Two optimization experiments were performed. The
first experiment used Coomassie blue staining of a polyacrylamide gel to monitor
the formation and destruction of the UngxdT20 complex with increasing UV
doses (Figure 3.1). The second experiment used silver staining and
autoradiography to monitor the formation and destruction of the Ungx[32PJdT20
complex with increasing UV doses (Figure 3.6).It was found that the Coomassie
blue visualization of the crosslinking products estimated the optimum crosslinking
time to be 45 mm (Figure 3.1, lane 7) while visualization by silver staining and
autoradiography estimated the optimum time to be 20 mm (Figure 3.6, lane 4).
An additional experiment was performed in which Ung and dT20were
independently exposed to UV light for increased doses and monitored by MALDI
MS (Figure 3.7). This experiment showed that doses above 15 mmwere
severely detrimental to the protein, and to a lesser extent the oligonucleotide.Ti-1 T2-1 T3 T4-1T5,
MANELTWHDVLAEEK+QQPYFLNTLQTVASER'QSGVTIYPPQK+DVFNAFR4fTELGDVK+57
T6-1 T7, T8-1 T9, TIO,
WILGQDPYHGPGQAHGLAFSVR+PGIAlPPSLLNMYK+ELENTlPGFTPNHGYLESWAR'QGVLLLNTVLTVR'129
dT20 TIIdT20
dT2O
113114 TI 5116117 TI 8
AGQAHSHASLGWETFTDISLINQHEGWFLLWGSHAQK tGAllDQHHVLAPHPSPLSAH195
dT2o dT20 I
dT2o 119, 120i
GFFGCNHFVLANQWLEQR3'GETPlDWMPVLPAESE29
Figure 3.12. E. coil uracil-DNA glycosylase peptides tentatively identifiedby MALDI MS as being crosslinked to
dT20. Arrows indicate the possible sites of cleavage bytrypsin and the corresponding peptide fragments are numbered
(11-120). Regions of the protein that were identified by MALDI peptidemapping as being crosslinked to dT2o are
underlined.81
This corroborated the optimum crosslinking time of 20 mmas determined by the
silver staining and autoradiography method. Theuse of Coomassie blue stain in
these types of experiments, which is about 10 times less sensitivethan silver
stain (86, 95), grossly overestimated the optimum crosslinking time.
Since previous work by Bennett et al. (6) had successfully isolated tryptic
peptides from the UV-catalyzed UngxdT20 complex for subsequent peptide
sequencing and MALDI MS analysis, the method in that study ("in-pot"method)
was initially followed. Multiple attempts to isolate Ung nucleopeptides using the
"in-pot" method showed two characteristic types of spectra. The firstwere
spectra with very weak signals from the nucleopeptides (Figure 3.5). These
spectra made mass assignments difficult and the amount of sample availablefor
further mass analysis (ESI MS/MS) was insufficient. The secondtype of spectra
were those that only produced strong signals fromdT20(data not shown). Based
on the purification scheme it was suspected that during TCA precipitationa
significant amount of dT20 precipitated with the protein and thisresidualdT20co-
purified with the nucleopeptides. From these results itwas reasoned that a new
purification method was needed. It is important to note thatcrosslinking
reactions used in the "in-pot" purification methodwere irradiated for 45 mm. This
overestimated crosslinking time may have produced significantphotodegradation
to the nucleoprotein complex thus contributing to thepoor nucleopeptide MALDI
spectra.
Besides the "in-pot" purification method, other proceduresfor isolating
crosslinked peptides from nucleoprotein complexes havebeen reported (4, 28,82
144, 146). In each case, the purification procedures were specific for isolating
nucleopeptides that would be sequenced by gas phase sequencing. It was felt
that any newly developed procedure should be designed such that the isolated
nucleopeptide sample would be suitable for mass spectrometric analysis. The
method developed here was based fundamentally on the scheme used for mass
spectrometric identification of proteins from 2D polyacrylamide gels (125, 126).
The "in-gel" method took advantage of the differing electrophoretic mobilities of
the crosslinking products, UngxdT20, Ung, and dT20, to isolate crosslinked
protein on a polyacrylamide gel for further processing. Upon discovering the
optimum crosslinking time as 15 mm, the newly developed "in-gel" purification
method reproducibly yielded sufficient quantities of nucleopeptides for mass
spectral analysis.
Nucleobase-amino acid crosslinking chemistry of protein-nucleic acid
complexes is not well understood, making a priori predictions about the expected
mass of isolated nucleopeptide species difficult. Varying masses for a given
nucleopeptide species were expected based on the potential for differing points
of attachment between the oligonucleotide and the peptide portion of the protein.
However, analysis of the seven nucleopeptides indicated that their masses were
very close to the sum of the neutral dT20 mass, the neutral peptide mass, and
one proton (Table 3.1) which is consistent with other crosslinking studies that
used dT-containing substrates (27, 28, 120). Even though the individual
nucleopeptides identified appear to be homogeneous in mass, each
nucleopeptide may not be homogeneous in structure. The mass analysis83
performed here cannot distinguish between a peptide crosslinking to identical
amino acids in different positions along the peptide or crosslinking to differing
amino acids within the peptide resulting in the same mass. In either of these
cases therefore, there may be multiple structural populations within a single
mass population that would require further elucidation.It is for this reason that
the results shown in this study can only be characterized as tentative.
The DNA binding region of E. coil Ung was first mapped by Bennettet al.
(6). The UV-catalyzed UngxdT20 complex was digested with trypsin and
crosslinked tryptic products were identified using a combination of MALDI MS
and gas-phase sequencing. Four tryptic peptides, T6, 118, T19, and T18/T19,
were identified as being crosslinked to dT20 and thus the regions of the protein
that these peptides covered were suggested to make up the DNA-binding region
of Ung. From results shown here, seven peptides from Ung, T6,T6(..3),T6(..7), T9,
Til, T18, and TI 7/1 8, were tentatively identified as being crosslinked to dT20.
Tryptic peptides T6 and Ti 8 were also identified by the original work of Bennett
et ai.(6), but peptidesT6(..3),T6(..7), T9, TI I, and Ti 7/18 were only identified in
the current work. One reason for identifying the additional nucleopeptides may
be due to the enhanced MALDI MS detection brought on by the different
purification procedures used. The "in-gel" procedure developed here could be
more thorough in removing contaminants such as denaturants and salts that
interfere with the MALDI analysis. A second reason may be the different
irradiation times used in the two procedures. In this work an irradiation time of 15
mm was used whereas in the work of Bennettet al.(6) an irradiation time of 3084
mm was used. The extended irradiation time of 30 mm may have been more
detrimental to the nucleopeptides of T6(..3), T6(..l), T9, TI I, and TI 7/18, preventing
their detection. Also from comparing the results of Bennettet al.(6) and the work
conducted here, nucleopeptides TI 8/TI 9 and TI 9, were not identified in the
present work. These nucleopeptides may have contained labile crosslinks that
were cleaved using the "in-gel" purification protocol.
The crosslinked species identified by Bennettet al.(6) defined two DNA
binding regions withinE.co/i Ung corresponding to amino acids 58-80 (T6) and
185-213 (T1811I9). Since the publication of that work, the three-dimensional
crystal structures of uracil-DNA glycosylases from E. co/i (90, 108, 153), herpes
simplex virus type-I (116-118), and human (90, 91, 96, 128) have been reported.
The two identified DNA-binding regions were directly compared to the crystal
structure of E. coil Ung and to the corresponding homologous regions of the
crystal structure of human Ung co-crystallized with DNA (Figure 3.13). The
comparison of these structures revealed that these regions are involved in
contacting double-stranded DNA and make up the catalytic region of the protein.
From the present work, the regions of the protein covering amino acids 106-116
(T9), 130-147 (TI I), and 180-184 (T17 of the T17/18 peptide) within the protein
were also identified as being crosslinked to dT20. Of the three newly identified
regions, the N-terminal portion of TI I appears to be part of the DNA-binding
region when compared to the crystal structures ofE. coilUng and human Ung
co-crystallized with double-stranded DNA (Figure 3.14). The location of T9 within
the protein does not appear to be close enough to the DNA-binding domain forA.
Figure 3.13. Correlation of Edman sequencing and MALDI MS data with thecrystal structures of uracil-DNA
glycosylase. Peptides ofE.co/i uracil-DNA glycosylase identified by Edmansequencing and MALDI MS as being
crosslinked to dT2o (6) are outlined in thecrystal structure of the enzyme (A). Based on thesequence homology between
E.co/i Ung and human Ung, regions of theE.co/i crystal structure that were identifiedas being crosslinked are
highlighted in the crystal structure of the humanenzyme co-crystallized with DNA (96) (B). Residues corresponding to T6
are highlighted in purple, T18 residues are in blue, T19 residuesare in turquoise, and DNA is in yellow.
['1A. B.
Figure 3.14. Correlation of MALDI MS data with the crystal structures of uracil-DNAglycosylase. Peptides ofE.
co/i uracil-DNA glycosylase tentatively identifiedby MALDI MS as being crosslinked to dT20 are outlined in the crystal
structure of the enzyme (A). Based on thesequence homology betweenE.co/i Ung and human Ung, regions of theE.
co/i crystal structure that were observedby MALDI MS as being crosslinked to dT20 were highlighted in the crystal
structure of the humanenzyme co-crystallized with DNA (96) (B). Residues corresponding to T6 are colored in purple, T9
residues are in red, Ti 1 residues are inorange, Ti7 residues are in turquoise, T18 residues are in blue, and the DNA is in
yellow.
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any of these amino acids to take part in. Possibly this nucleopeptide was
mistakenly identified or the static crystal structures of the protein may not
accurately represent the Ung:dT2o complex present during crosslinking.
Likewise, the TI 7 portion of the TI 7/TI 8 nucleopeptide does not appear to be
part of the DNA-binding region when compared to the crystal structures of the
protein. This nucleopeptide may have been formed by either T17 or T18 being
crosslinked to dT20 and trypsin not cleaving the site joining the two peptides or by
both peptides being crosslinked to one dT20 molecule and proteolysis not taking
place at the joining tryptic site. Further studies to sequence the amino acids of
the isolated nucleopeptides, such as Edman degradation or tandem mass
analysis (Chapter 4), would definitively identify the nucleopeptides and provide
the identification of specific crosslinked residues.4. AMINO ACID SEQUENCING OF PURIFIED UNG NUCLEOPEPTIDES
USING ELECTROSPRAY IONIZATION MASS SPECTROMETRY
4.1 Results
4.1.1 Analytical Outline for Mass Spectrometric Analysis of Ung
Nucleopeptides
After initial characterization of the isolated Ung nucleopeptides by MALDI
MS (Table 4.1), nucleolytic digestion of the nucleopeptides was carried out to
reduce the oligonucleotide portion of the molecules and simplify subsequent ESI
MS/MS spectra. The nucleolytic sample was then analyzed by one of three
analytical routes (Figure 4.1). The first route was analysis by MALDI MS to
characterize the resulting digestion products. The second route was separation
of the reaction products by HPLC and then amino acid sequencing by
nanospray/ESI MS/MS. The third route was in-line separation and amino acid
sequencing of the nucleopeptides by LC/ESI MS/MS. The results from each of
these routes are reported below.
4.1.2 MALDI MS Characterization of Nucleolytically Digested Ung
Nucleopeptides
Characterization by MALDI MS of the nuclease digestion products showed
five series of ions (Figure 4.2) with each ion species within a series increasing in
mass by one deoxyribothymidylic acid (MW=304.4). The molecular weight of
mono-, di-, tn-, tetra-, and pentanucleotides were subtracted from theTable 4.1. Summary of tentatively identified UngxdT20 tryptic peptides.
The molecular weight of dT2o ([M + H] = 6024.1) was subtracted from the
experimentally measured UngxdT20 mlz values (Figure 3.11). The resulting
calculated peptide masses were compared to a peptide map for tentative
identification of the Ung tryptic peptides that take part in crosslinking.
ExperimentalCalculated peptide mass Predicted Tryptic
EpeptidexdT2o] [peptidexdT20] - dT20 peptide massapeptide
8442.4 2418.1 2418.7 16
8096.6 2072.5 2076.3
7963.9 1939.8 1942.1 TIl
7805.5 1782.4 1784.1 117/118
7711.7 1687.6 1687.9
7352.6 1328.7 1328.6 T9
7191.7 1167.6 1169.3 T18
aPredicted average peptide masses were calculated from a tryptic peptidemap
of E. co/i Ung generated by the computer program GPMAW, version 3.1,
Lighthouse Data.
b,cComparison of these masses to a mass search of E. coil Ung indicated tryptic
peptide T6 without three and seven C-terminal amino acids, respectively.\ Ung-PeptidexdT20
Complexes
Nucleolytic Digestion
MALDI MS
Ung-PeptidexdT Complexes / (n=2to6)
HPLC/
Separated PeptidexdT Species
(n=2 to 6)
Nanospray/ES! MS/MS MALDI MS LC/ESI MS/MS
Figure 4.1. Analysis scheme for the identification of covalently attached
amino acids by mass spectrometry. After characterization by MALDI MS,Ung
peptidexdT20 complexes were nucleolytically digested and the resulting peptide
xdT complexes were first characterized by MALDI MS. The peptidexdT
mixture was then separated by HPLC and collected fractionswere analyzed by
nanospray ESI MS/MS or the peptidexdT mixture was analyzed by LC/ESI
MS/MS.0
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Figure 4.2. MALDI mass spectrum of purifiedtryptic UngxdT20 peptides after digestion with nucleaseP1. Ung-peptidexdTo complexes isolated by the "in-gel" purificationscheme (Figure 3.9) were digested with nucleaseP1
and then analyzed by MALDI MSas, described under "Experimental Procedures." The resulting ionsignals corresponded
to singly protonated forms of Ung tryptic peptidescrosslinked to varying sizes of polydeoxyribothymidylicacid. Five series
of digestion products, as signified bya, b, c, d, and e, were observed.
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experimentally measured peptidexdT ion species within a series and the
resulting peptide masses were compared to a digestion map of Ung (Table 4.2).
This analysis tentatively identified T18 (m/z 1796.0, 2100.4, and 2405.1), TI I
(m/z 2567.7, 2874.2, 3178.8, 3482.1) T6(..7)(m/z 2315.2, 2619.6, and 2924.6) and
T6(..3)(m/z 2704.1, 3008.0, 3313.3, 3616.1, and 3920.1) as peptides present in
the nucleopeptide complexes, corroborating the presence of those peptides
identified in the MALDI MS analysis of the peptidexdT20 complexes (Table 4.1).
One other ion series, m/z 2486.0, 2791.6, and 3094.4, did not directly identify a
peptide that was identified in the peptidexdT20 analysis. Using the calculated
peptide mass of 1858.6 in a mass search of Ung indicated that the peptide was a
truncated form of T6 that had lost five C-terminal amino acids, hereafter
designated T6(..5). Nucleopeptide ion series for T9xdT and Ti 7/118xdT,
which were identified in the MALDI spectrum of peptidexdT20 complexes, were
not identified in the nuclease digestion mass spectrum. The quantity of each
nucleopeptide species in this spectrum was estimated by absorbance to be in the
range of 0.5 pmol to 5.0 pmol.
4.1.3 MALDI MS Characterization of HPLC-Purified UngxdT
Nucleopeptides
An Ung peptidexdT nuclease digestion mixture was separated by HPLC
and two elution fractions were collected (Figure 4.3). The fractionswere
characterized by MALDI MS revealing that fraction A (Figure 4.4) contained the
tentatively identified nucleopeptide series of T18 (m/z 1795.0, 2098.7,Table 4.2.Analysis of nuclease P1 digestion products.
Nucleopeptide
-[Predicted DNA mass+ H']8=PeptidemassPredicted peptide massPeptide ID.
1796.0 - 627.4 = 1168.6 1169.3 T18
2100.4 - 931.6 = 1168.8 1169.3 T18
2405.1 - 1235.8 = 1169.3 1169.3 118
2315.2 - 627.4 = 1687.8 1687.9
2619.6 - 931.6 = 1688.0 1687.9 T6( 2924.6 - 1235.8 = 1688.8 1687.9 T6(..l)b
2486.0 - 627.4 = 1858.6 1858.1 T6(..5)° 2791.6 - 931.6 = 1860.0 1858.1
T6(5)c
3094.4 - 1235.8 = 1858.6 1858.1
T6(..5)c
2567.7 - 627.4 - 1940.3 1943.1 111
2874.2 - 931.6 = 1942.6 1943.1 TIl
3178.8 - 1235.8 = 1943.0 1943.1 111
3482.1 - 1540.0 = 1942.1 1943.1 111
2704.1 - 627.4 = 2076.7 2076.4 T6(3)" 3008.0 - 931.6 = 2076.4 2076.4 T6(..3)°' 3313.3 - 1235.8 = 2077.5 2076.4 T6(..3)" 3616.1 - 1540.0 = 2076.1 2076.4 T6(3)°' 3920.1 - 1844.2 = 2075.9 2076.4 T6(..3)°'
Co
C.')Table 4.2 (continued)
a
The protonated molecular weights of di-, tn-, tetra-,penta-, and hexadeoxyribothymidylic acidare 627.4, 931.6,
1235.8, 1540.0, and 1844.2, respectively.
b,c,dDigestion products corresponding to tryptic fragment T6less seven, five, and three C-terminal amino acids,
respectively.
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Figure 4.3. HPLC chromatogram of nuclease P1-digestednucleopeptides.
Ung peptidexdT20 complexes were nucleolytically digested and the resulting
peptidexdT complexes (Figure 4.2) were separated by HPLC,as described
under "Experimental Procedures." Two fractions, labeled A and B,were
collected and subsequently analyzed by MALDI MS and ESI MS/MS.U,
C
>
U,
I.-
1000 mlz 3500
Figure 4.4. MALDI MS spectrum of HPLC fraction A. An Ung-peptidex dT
mixture was separated by HPLC and a collected elution fraction, fraction A
(Figure 4.3), was analyzed by MALDI MS, as described under "Experimental
Procedures."97
2402.6, 2707.1, and 3012.1). A second ion series was present (mlz 2018.4,
2322.4, 2627.4 and 2933.5) that differed from the first ion series by 80 mass
units, the mass of a phosphate group. Nuclease P1 digestion produces 5'-
phosphorylated nucleotides during digestion; therefore, the mass difference
observed in this second ion series may have occurred if the nucleopeptide
digestion products contained the initial 5'-terminus of dT20 that was lacking a
phosphate group. An ion species corresponding to free T18 (m/z 1167.6) was
also observed. Fraction B (Figure 4.5) was tentatively identified as a mixture of
T6(..7), T6(..5), and T6(..3) crosslinked to dT2 (m/z 2316.6, 2487.1, and 2704.8,
respectively), T6(..7) crosslinked todT4(m/z 3314.5), and TI I crosslinked to dT2,
dT3, anddT4(m/z 2571.7, 2875.9, and 3181.6).
4.1.4 Nanospray/ESI MS/MS Amino Acid Sequencing of HPLC Purified
Ung-peptidexdT Nucleopeptides
4.1.4.1 Nanospray/ESI MS/MS of T18 x dT4
A nanospray/ESI QI (MS) spectrum was obtained for HPLC fraction A
(Figure 4.6). In comparing this spectrum to the MALDI MS spectrum for fraction
A (Figure 4.4), the ions observed in the Ql spectrum corresponded to triply
charged TI 8xdT nucleopeptides, where n increased from 3 to 6 (mlz 700.8,
802.4, 903.6, and 1005.2). Also associated with the triply charged nucleopeptide
TI 8xdT ions, where n increased from 4 to 6, were triply charged species
corresponding to a difference of a phosphate group (m/z 775.6, 876.8, and
978.4). From this spectrum, ion species 802.4, tentatively identified as triplyU)
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Figure 4.5. MALDI MS spectrum of HPLC fraction B.An Ung-peptidexdT
mixture was separated by HPLC and a collected elution fraction, fraction B
(Figure 4.3), was analyzed by MALDI MS, as described under "Experimental
Procedures."U)
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Figure 4.6. Nanospray ESI MS spectrum of HPLC elution fraction A. HPLC
purified fraction A (Figures 4.3 and 4.4) was analyzed by nanospray/ESI MS,as
described under "Experimental Procedures." The ion signals adjacent to each
labeled peak on the high m/z-side are due to sodium adduction.100
charged TI 8xdT4, was selected as a precursor ion for tandem mass analysis
since it was the most intense ion signal in the QI analysis. The resulting tandem
mass spectrum (Figure 4.7) produced weak b- (n4-7,9,10) and yn-series ions
(n=1-4,6,8) that confirmed the identity of the nucleopeptide as being T18xdT4,
as well as strong ion signals that resulted from fragmentation taking place along
the oligonucleotide portion of the nucleopeptide (see Appendix for fragmentation
nomenclature). The fragmentation pattern did not indicate any amino acid(s)
containing the site(s) of covalent attachment.
4.1.4.2Nanospray/ES! MS/MS of T6(..7) x dT2 and T6(..5) x dT2
A nanospray QI spectrum was also obtained for HPLC fraction B (Figure
4.8) and compared to the corresponding MALDI MS spectrum for this fraction
(Figure 4.5). The ions observed in the QI spectrum corresponded to triply
charged nucleopeptides which had been tentatively identified as T6(..l)xdT, T6(.
5) xdT2, TilxdT3, and TilxdT4 (mlz 772.4, 829.2, 958.8, and 1060.4,
respectively). Tandem mass spectra of T6(..7)xdT2 (Figure 4.9) showed both
extensive b- (n=2-7) and Yn10I series (n=1-6) that clearly identified this
nucleopeptide species as T6(..7)xdT2. A y*.. ion series (n=9-1 5) was also
present contributing to the conformation of the nucleopeptide. The combination
ofbe-, ye-,and yn*..ions observed in this spectrum localized the site(s) of
crosslinking within the Ung T6(..7) peptide to Pro65, Tyr, and His67. A similar
interpretation was also made for the spectrum ofT6(..5) xdT2. In this spectrum,101
Figure 4.7. Nanospray/ESI MS/MS spectrum of triply charged T18xdT4.
Ion m/z 802.4 from the nanospray/ESI MS spectrum of HPLC elution fraction A
(Figure 46) was selected as a precursor ion for MS/MS analysis, as described
under "Experimental Procedures." Fragment ions for the peptide portion of the
nucleopeptide are labeled as b (n4-7, 9,10) and y (1-4, 6 to 8). Fragment ions
from the oligonucleotide part of the nucleopeptide are labeled with italicized
letters and fragment ions containing the point of covalent attachment are
indicated with an asterisk.12.
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Figure 4.8. Nanospray/ESI MS spectrum of HPLC elution fraction B. HPLC
purified fraction B (Figure 4.3) was analyzed by nanospray ESI MS as described
under "Experimental Procedures." The ion signals adjacent to each peak on the
high m/z-side are due to sodium adduction.104
Figure 4.9. Nanospray/ESI MS/MS spectrum of triply charged
T6(..7)xdT2.
ton mlz 772.4 from the nanospray/ESI MS spectrum of HPLC elution fraction B
(Figure 4.8) was selected as a precursor ion for MS/MS analysis, as described
under "Experimental Procedures." Fragment ions from the peptide portion of the
nucleopeptide are labeled as b (n=2 to 7). y (n1 to 6), and(n9 to 15).
Fragment ions containing the oligonucleotide portion of the nucleopeptide are
indicated with an asterisk.105
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Figure 4.9. NanospraylESl MS/MS spectrum of triply chargedT6(..7) xdT2.1bI
fragmentation corresponding to b- (2-6,8),yr,-(3,4,7,8), and ions (n10-
12,14-16) identified this nucleopeptide. The fragment ions of[b711and[y15J3
had predicted m/z of 725.9 and 725.2, respectively. Thus ion species 725.6
observed in the spectrum could not be interpreted due to inadequate resolution
of the instrument. Analysis of this spectrum also localized the site(s) of
crosslinking to Pro65, Try66, and His67 (Figure 4.10).It is interesting to note that
b*series ions for either 16 nucleopeptide specieswere absent. Also absent in
these spectra were fragmentation products resulting from cleavage along the
oligonucleotide portion of the nucleopeptide.
4.1.5 LC MS Analysis of Ung- peptidexdT Complexes
An Ung-peptidexdT nuclease digestion mixture was injected intoa LC
system and chromatographic separation of the nucleopeptide mixturewas
conducted in-line with an ESI ion-trap mass spectrometer. Analysis ofa base
peak ion chromatogram (Figure 4.1 IA) of the nucleopeptide mixture showed
multiple elution peaks. The tentatively identified nucleopeptide species TI 8x
dT2,T6(..7) xdT2, TI IxdT2, andT6(..3) xdT2 were located from extracted ion
chromatograms (Figure 4.11 B through E). Analysis of the extracted ions
showed M+2H and M+3H ion species (Figure 4.12) thatwere selected for
collisionally induced dissociation (C ID) experiments.107
Figure 4.10. Nanospray/ESI MSIMS spectrum of triply charged T6(.5) xdT2.
Ion mlz 829.2 from the nanospray/ESI MS spectrum of HPLC elution fraction B
(Figure 4.8) was selected as the precursor ion for MS/MS analysis, as described
under "Experimental Procedures." Fragment ions from the peptide portion of the
nucleopeptide are labeled as b (n2 to 6, 8), y (n=3,4,7,8), and y* (n10-12,
14,16). Fragment ions containing the oligonucleotide portion of the
nucleopeptide are indicated with an asterisk.50
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Figure 4.10. Nanospray/ESI MS/MS spectrum of triply charged T6(..5)x dT2.21.5
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Figure 4.11. LC/ESI MS base peak ion chromatogram of Ung-peptidex dT
complexes. A mixture of Ung-peptidexdT complexes produced from a
nuclease P1 digestion (Figure 4.2) were directly analyzed by LC/ESI tandem
mass spectrometry as described under "Experimental Procedures." A base peak
ion chromatogram is shown for the entire chromatographic separation (A) and
extracted ion chromatograms are shown for elution peaks corresponding 118x
dT2 (B), T6(..7)xdT2, (C), TI IxdT2 (D), andT6(..3) x dT2 (E).110
Figure 4.12. LC/ESI MS spectra of Ung-peptidexdT complexes. Ung-
peptidexdT complexes were chromatographically separated and the elution
peaks (Figure 4.11 B through E) were analyzed in-line by ESI MS as described
under "Experimental Procedures." Doubly and triply charged ion species are
labeled for T18xdT2 (A), T6(..7)xdT2(B), TI I xdT2 (C), andT6(..3) xdT2 (D).100iA
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Figure 4.12. LC/ESI MS spectra of Ung-peptide x dT complexes.
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4.1.6 LC MS/MS Peptide Sequencing of Ung-peptidexdT Complexes
4.1.6.1 LC MS/MS of T18 x dT2
The CID mass spectrum of doubly charged T18xd12 (Figure 4.13)
revealed fragmentation taking place along the peptide backbone to producey-
series ions (y to yio) that confirmed the identity of this ion species.
Fragmentation taking place along the peptide backbone to produce y'-.ionswas
also present to yg*) as was fragmentation taking place along the
oligonucleotide portion of the nucleopeptide. Three ion species from thismass
spectrum, m/z 745.7, 1393.4, and 1490.5, corresponded to nucleopeptide
fragments that could have been produced from cleavage of either the peptide
backbone or the DNA backbone (italicized lettering). The ion species m/z
1490.5 and 745.7 could be predicted to be [y8*J(calculated M+H=1490.6) and
[y8*]2+ (calculated M+2H=745.8),respectively, or could be predicted to be[w111
(calculated M+H1490.7) and [wi*J2+ (calculated M+2H745.8), respectively.
Similarly, ion species m/z 1393.4 could be predicted to be[y7*J14(calculated
M+H=1393.5) or[z111(calculated M+W=1393.7), respectively. The mass
correlations between these predicted fragmentation productsare all within 0.2
mass units, thus making identification of these ion species ambiguous. The CID
fragmentation pattern produced for this nucleopeptide was extensive enoughto
confirm its identity, but the overlap iny- and y*ions and the lack of b- and b*ions
prevented the identification of any amino acids within TI 8xdT2 that contained a
covalent crosslink.113
Figure 4.13. LC/ESI MS/MS spectrum of T18xdT2. The doubly charged ion
m/z 898.5 was observed in the ESI MS spectrum (Figure 4.12A) as wellas
observed as a singly charged ion in the MALDI MS spectrum (Figure 4.2) of the
nucleopeptide mixture. To confirm the identity of this ion species and to
structurally characterize the nucleopeptide, it was selected as a precursor for
LC/ESI MS/MS, as described under "Experimental Procedures." Fragmentation
peaks m/z 1571.4, 1490.5, 1393.8, 889.5, 849.4, 745.7, 737.3, and 648.3were
consistent with predictions of cleavage along the DNA backbone of the
nucleopeptide. The identity of this ion species was confirmed byYn (n2,41 0)
b- (n=3,5,7,9), yn*ion (n=2-6, 9), and bn*ion series (n=9,10).indicates ion
species that can not be differentiated from fragmentation of the peptide backbone (y* andy8*2+)or fragmentation of the DNA backbone (zi*, w1, andwi*2+).114
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Figure 4.13. LC/ESJ MSIMS spectrum of 118 x dT2.115
4.1.6.2 LC MS/MS of T6(..7) x dT2
The doubly and triply charged precursor ions ofT6(..l) x dT2were selected
for CID analysis. Analysis of the fragmentation pattern for the triply charged
precursor (Figure4.14)revealed a series of six b-ions (b3 through b7, and bg), a
series of four b*ions (b12* through bis*), a series of two y-ions (y and y6), and a
series of eight y.-ions
9*throughyj5*)The difference between 7* and y6
results in the combined mass of dT2 and histidine, identifying His67 as a site of
crosslinking. A continuous conversion of b- to b*ions was not observed, which
would have also identified His67 as a site of crosslinking, but the b- and b*ion
fragments that were present localized the site of crosslinking between His67 and
Pro6g. The CID spectrum of the doubly charged precursor of T6(7)xdT2 (Figure
4.15)was about an order of magnitude less intense than for the triply charged
precursor, but still yielded significant structural information about the
nucleopeptide. This spectrum showed three y-series ions (y to y6) andseven y
series ions (y7* to ylo* and y12* toy14*)that definitively identified this ion species.
The mass difference between 7* andY6 indicated His67 as the site of
crosslinking, thus supporting the fragmentation pattern interpretation for the triply
charged ion species of T6(..7)xdT2.116
Figure 4.14 LC/ESI MS/MS spectrum of triply charged T6(..7) xdT2. The triply
charged ion of m/z 772.5 was observed in the ESI MS spectrum (Figure 4.128)
as wet I as observed as a singly charged ion in the MALDI MS spectrum (Figure
4.2) of the nucleopeptide mixture. To confirm the identity of this ion species and
to structurally characterize the nucleopeptide, it was selected as a precursor for
LC/ESl MS/MS, as described under "Experimental Procedures." The identity of
this ion species was confirmed by b- (n=3-7,9), y-(n=5,6), and yfl*ion series
(n=7,9-1 5). Fragment ions containing the dinucleotide portion of the
nucleopeptide are indicated with an asterisk. The location of the covalent
crosslink toHis67is determined from the difference in mass betweenand y.117
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Figure 4.15. LC/ESI MS/MS spectrum of doubly chargedT6(..7) xdT2.
Peptide sequencing of isolated nucleopeptide species was conducted by LC/ESI
MS/MS, as described under "Experimental Procedures." The doubly charged ion
species of putatively identified T6(..7) x dT2(M+2H=1 157.4) was selected as a
precursor ion for tandem mass analysis. The resulting mass spectrum produced
y,1-(n=4-6) and yn*ions (n=7-9, 11-14) ions that confirmed the identity of the
nucleopeptide. The mass difference between y* andY6 indicatedHis67as the
site of crosslinking.119
4.1.6.3 LCMS/MSofTII xdT2
The CID spectrum of the triply charged ion species of TI Ix dT2revealed
series of y-ions (y through Yii, and yi), (y14* andy15*),b-ions(b4to b6,
b8 to b11, b13, and b15) and b*ions (bi* to b13*) that identify this ion species as
TI I xdT2 (Figure 4.16). In addition to these peptide fragments, intense
fragmentation peaks corresponding to cleavage along the dinucleotide backbone
were present. Cleavage at the covalent crosslink bond(s) that produced a doubly
charged TI I fragment (mlz972.1)was also present. The mass difference
between
yj4*and Y13 results in the combined mass of dT2 and histidine indicating
His133 as being crosslinked to dT2, but there is no corresponding conversion of b-
to b*ions to support this amino acid as being crosslinked. Similarly, the mass
difference between b7* and b6 indicatesHis135as an amino acid crosslinked to
dT2, but there are no corresponding y- and to support this identification.
The overlap of b- and b*ions also suggests the presence of additional
crosslinked amino acids between Ala138 and Trp142.
4.1.6.4 LC MS/MS of T6(..3) X dT2
Both doubly and triply charged precursor ions of tentatively identified T6(..3)
xdT2 were selected for CID experiments. The triply charged precursor (Figure
4.17)showed a series of seven b-ions (b3 through b7, bg, and bio) anda series of
seven y-ions (y through yii) that definitively identified the peptide portion of this
nucleopeptide. Series of y*.. ions (y* through yg*) and b*ions (bg*, bio*, and120
Figure 4.16. LC/ESI MSIMS spectrum of TIlxdT2. The triply charged ion of
m/z 857.3 was observed in the ESI-MS spectrum (Figure 4.12C)as well as the
singly charged ion in the MALDI MS spectrum (Figure 4.2) of the nucleopeptide
mixture. To confirm the identity of this ion species and to structurally
characterize the nucleopeptide, it was selected as a precursor for LC/ESI
MS/MS, as described under "Experimental Procedures." The major
fragmentation peaks m/z 1173.1, 1164.4, 1124.0, 1035.3, 750.0, and 690.4
correspond to cleavage along the DNA backbone and are labeled with italicized
letters. The ion at m/z 972.1 corresponds to doubly charged TI I (less the
nucleotide). The peptide sequence is represented by b- (n=4-6, 8-1 1,13, 15),
b* (n=7-13),yn-(n=3-II, 13), and y*.. ion series (n=14,15). An asterisk
indicates fragment ions containing the covalent attachment.100
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Figure 4.16. LC/ESI MS/MS spectrum of Til x dT2.122
Figure 4.17. LC/ESI MSIMS spectrum of T6(4)xdT2. The tnply charged ion of
m/z 901.9 was observed in the ESI-MS spectrum (Figure 4.120) and was
observed as a the singly charged ion form in the MALDI-MS spectrum (Figure
4.2) of the nucleopeptide mixture and was putatively identified as T6(..3)xdT2
(Table 4.2). To confirm the identity of this ion species and structurally
characterized the nucleopeptide, it was selected as a precursor for LC/ESI
MS/MS, as described under "Experimental Procedures." The identity of this ion
species was confirmed by b- (n=3-7,9,10), b* (n=9,10,16-19),yn-(n=5-11), and
yn*..ion series (n=11-19). Fragment ions containing the dinucleotide portion of the
nucleopeptide are indicated with an asterisk. The location of the covalent
crosslink to Tyr andHis67is determined from the difference in mass between
yll* andyio and the difference in mass betweeny12* andyii, respectively.123
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Figure 4.17. LCIESI MS/MS spectrum of 16(4) x dT2.124
b16* through b19*), which represent those ion fragments containing the
crosslinked dinucleotide, were consistent with the nucleopeptide complex being
T6(..3) xdT2. The positions of covalent crosslinks within the peptide were
determined from the difference in mass between yll* andYband the difference
in mass between Yii and y12*. These mass differences, respectively,
corresponded to Tyr66 and His67 crosslinked to dT2. The mass difference
between bio* and b9 also confirmed the location of a crosslink to His67 as
identified in the y- and y*ion fragmentation series. The b7 and bg* ions
suggested Tyras a site of crosslinking, but the lack of a b8 ion prevented
confirmation. The doubly charged fragmentation spectrum ofT6(..3) xdT2 was
almost an order of magnitude less intense than the triply charged fragmentation
spectrum (Figure 4.18). This spectrum revealed three y-ions (y6,y9, yio), seven
(y1*toy13and y16* to yi9*), three b-ions (b6, b7 and b9) and three b*ions
(bio*, b18*, and big*), which confirmed the identity of the nucleopeptide.The
mass difference between yjl* andy0,as well as the mass difference between
blQ* and b9, identified the site of crosslinking to His67. The fragmentationpattern
interpretation of the doubly charged ion species ofT6(..3) xdT2 supports the
fragmentation pattern interpretation of the triply charged ion species in locating
His67 as the site of crosslinking. The data from the doubly charged ion species,
however, do not support the identification of Tyr66 as a crosslinked amino acid
withinT6(..3) xdT2, as was suggested by the fragmentation pattern of the triply
charged ion species.100
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Figure 4.18. LC/ESI MS/MS spectrum of doubly charged T6(..3)xdT2.
Peptide sequencing of the isolated nucleopeptide species was conducted by
LC/ESI MS/MS, as described under "Expenmental Procedures." The doubly
charged ion species of putatively identifiedT6(.3) x dT2(M+2H=1 352.7) was
selected as a precursor for tandem mass analysis. The resultingmass spectrum
produced y- (ye, yg,yb),(y* toy13*andy16*to ylg*), b- (b6, b7, and bg) and
b*ions (bio*, b18*, and big*) that confirmed the identity of thenucleopeptide.
The mass difference between yll* andyio and the mass difference between bio*
and b9 indicated the site of crosslinking as His67.126
4.2 Discussion
The sensitivity, the short analysis time, and the ability to simultaneously
analyze complex mixtures of nucleopeptides made MALDI MS an invaluable tool
over the course of these experiments. MALDI MS was used as a rapid screen of
purified material to verify the presence of peptidex dT20complexes and to
monitor the nuclease P1 digestion products for optimizing and determining the
extent of digestion. MALDI MS was also used for the tentative identification of
peptidexdT samples (Table 4.1). With seven ion species observed from the
MALDI MS analysis of the peptidex dT0mixture, it seemed likely that a
complete digestion of the nucleopeptides by concerted endo- and exonucleolytic
action of riuclease P1 would have produced seven ion species; each peptide with
a deoxyribothymidylic acid covalently attached. This scenario was not observed,
but instead after nucleolytic digestion produced five ion series (Figure 4.2). Each
ion species within a series increased in mass by one deoxyribothymidylic acid
clearly indicating that these ion series were peptides crosslinked to
oligonucleotides of increasing sizes. The smallest digestion product observed
was a peptide crosslinked to dinucleotide.It is likely that steric interference
between the peptide portion of the nucleopeptide and the nuclease may have
prevented the digestion from reaching the level of a peptide crosslinked to a
mononucleotide. In fact, others have reported this observation (38). The extent
of nuclease digestion may have also been limited by the presence of cyclobutane
pyrimidine dimers and/or 6-4 photoproducts in the dT20 portion of the isolated
nucleopeptides in which these UV-induced photoproducts interfered with the127
action of nuclease P1(145). Even with the heterogeneity of the nuclease
digestion products, MALDI MS still provided a thorough analysis of the
nucleopeptide species. Recent advances in the development of MALDI tandem
time of flight (TOF/TOF) instruments will potentially allow for the complete
characterization of nucleopeptide species (tentative identification, definitive
identification, and locating covalent crosslinks) witha single MALDI analysis (62,
84, 102).
The data collected from MALDI MS provided a priori knowledge about the
nucleopeptide species for nanospray/ESI MS/MS and LC/ESI MS/MS analysis.
This a priori knowledge greatly facilitated interpreting tandemmass spectra for
definitive identification of the nucleopeptide species. For this project,two types
of tandem mass analyses were conducted, nanospray/ESI MS/MS andLC/ESI
MS/MS. Initial tandem mass spectrometry experimentswere conducted by
nanospray/ESI MS/MS using a triple quadrupole instrument. This analytical
methodology was tedious since the complexity of the peptidexdT mixtures
(Figure 4.2) required prior separation and concentration by micro-HPLCbefore
analysis. The resulting separations were never extensive enough to isolatea
single nucleopeptide. At best, they were capable of producing fractionsthat were
enriched for nucleopeptides that contained the same peptide portion, but varying
sizes of oligonucleotide (Figures 4.4 and 4.6).At worst, the HPLC separations
produced fractions enriched for multiple peptide species with varyinglengths of
oligonucleotides (Figures 4.5 and 4.8). Regardless of the degree ofseparation,128
micro-HPLC elution fractions could be analyzed by nanospray tandemmass
spectrometry.
The reported virtues of nanospray tandem mass spectrometry, primarily
the sensitivity of the technique towards analyzing peptides at sub-pmol quantities
and sub-pL volumes of sample (147, 148), made this an attractive form ofmass
spectrometry for analyzing isolated Ung-nucleopeptides. From the experiments
performed here, it was found that HPLC-enriched fractions of nucleopeptides
produced very simple MALDI MS spectra, but very complicatednanospray QI
spectra (compare Figure 4.4 vs. 4.6 and Figure 4.5 vs. 4.8). The complexity of
the nanospray Qi spectra arose partly from the multiple charge states of the
individual nucleopeptides that is characteristic of electrospray ionization. In
general, the charge states of a nucleopeptide were observed between +2 and +4,
usually with the +3 charge state being most abundant. Additional complexity in
these spectra came from impurities in the sample, primarily cations of sodium
and potassium. Since the HPLC-purified fractions analyzed by MALDI MS prior
to nanospray analysis revealed no significant cation adduction, the strong metal
adduction observed in the nanospray Qi spectra was most likelya result of
contamination of the sample while in the nanospray needle. Metal ions could
have been leached from the needle by the acidified solvent into the sample.The
combination of multiple charge states and cation adduction greatly reducedthe
effective concentration of a nucleopeptide species that could be selectedas a
precursor ion for nanospray tandem mass spectrometry experiments.129
Nanospray/ESI MS/MS spectra were collected and interpreted for the
nucleopeptidesT6(..7) xdT2,T6(..5) xdT2, and T18xdT4. Comparing these three
spectra to one another shows that the information content of the spectra forT6(7)
xdT2 andT6(..5) xdT2 is distinctly different than that of the spectrum of TI 8xdT4
Figure 4.19). Triply charged precursors of bothT6(..7) xdT2 andT6(..5) xdT2
producedba-,yn-,yn*.IOnS during nanospray tandemmass spectrometry
experiments (Figures 4.9, 4.10, 4.19A, and 4.19B). This allowed for the definitive
identification of these nucleopeptides and localized the position(s) of crosslinking
toTyrandHis67forT6(..7) xdT2 andPro65, Tyr66,andHis67forT6(..5) xdT2.
Oddly, b*ions were absent from both spectra, for which no explanation can be
given. In contrast to these two nucleopeptides of T6, the doubly charged ion
species of 118xdT produced the strongest ion signals from fragmentations
taking place along the oligonucleotide portion of the nucleopeptide (Figures 4.7
and 4.19C). Of the diagnostic ions required to identify the peptide portion of the
nucleopeptide and the site(s) of crosslinking, only yn- and ba-ions were present.
These fragmentation ions were very weak in intensity, but were adequate to
definitively identify this nucleopeptide. The lack of b* and yn*ions prevented
the identification of crosslinked amino acids within the nucleopeptide.
It became obvious from conducting multiple nanospray experiments that
tandem mass spectrometry should be conducted via LC/ESI MS. In-line HPLC
purification and mass spectrometric analysis of the nucleopeptides would be
considerably less tedious and time consuming and elution peaks would be
directly eluted into the mass spectrometer to minimize cation adduction.130
Figure 4.19. Summary of fragmentation patterns observed in
nanospray/ESI MS/MS spectra of Ung nucleopeptides. Peptide (b- and y-
ions) and nucleopeptide (b* and y*ions) fragmentation patterns of Ung-peptide
xdT complexes from Figures 4.7, 4.9, and 4.10 are summarized. For clarity,
fragmentation taking place along the oligonucleotide portion of the nucleopeptide
has been omitted. (A) The fragmentation pattern of triply charged T6(..5)xdT2
showed a series of b-ions (b2 to b8) that identified the nucleopeptide species. A
continuous conversion of a y- to y*ion (Y8 to yio*) was observed localizing the
position of the crosslink(s) between Try and His67. Fragmentation
corresponding to b*ions were not observed. (B) The fragmentation pattern of
the triply charged T6(..7)xdT2 produced b- (b2 to b7) and y-ions (Yi to Y6) that
identified this nucleopeptide. A non-continuous conversion of y- to y*ions (Y6 to
yg*) localized the sites of crosslinking to Pro65, Try66, and His67. (C) Analysis of
the y- and b-ion series of doubly charged TI 8xdT4 confirmed the identity of the
nucleopeptide, but did not locate the postion of crosslinked amino acid(s).
Fragmentations producing b- and b*ions were not observed.A.
B.
C.
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Figure 4.19. Summary of fragmentation patterns observed in
nanospray/ESI MS/MS spectra of Ung nucleopeptides.132
Moreover, the LC/ESI configuration would allow for multiple tandem mass
spectrometric analyses of various nucleopeptides during a single
chromatographic separation. Upon installation of an LCQ ion-trap mass
spectrometer at the OSU Mass Spectrometry Core Facility, nucleopeptide
mixtures (similar to Figure 4.2) were analyzed on this instrument in the LC
tandem mass spectrometry configuration.
The complexity of the peptidexdT mixture is underscored by the base
peak chromatogram of this sample (Figure 4.1 IA). The majority of the ion
chromatogram peaks observed did not correspond to predicted nucleopeptides,
but peaks corresponding to predicted nucleopeptides could be extracted from
this chromatogram (Figure 4.11 B through E) for subsequent MS and MS/MS
analysis. The charge state distribution of the nucleopeptide species observed
during LC/ESI MS experiments were similar to those observed for nanospray/ESI
experiments (charge states distributed over +2 to +4, with the +3 charge state
being most abundant), but cation adduction to the nucleopeptide species was not
observed (Figure 4.12). Of the five peptide species observed in the peptidex
dT MALDI MS spectrum, four of them were characterized during a single LC
MS/MS analysis. The missing nucleopeptide, T6(..5) xdT2, may have been of low
enough quantity that it was not observed during analysis. The ease of
conducting MS/MS analysis and the ability to analyze an entire mixture of
nucleopeptides in a single LC MS/MS analysis made the LC format of tandem
mass spectrometry the preferred method for characterizing nucleopeptides.133
The LC tandem mass spectrometry format was used in the analysis of
doubly and triply charge nucleopeptides of T6(..3)xdT2, T6(.7)xdT2, TI 1xdT2,
and TI 8xdT2 (Figure 4.20). The identity of these nucleopeptides was confirmed
by b- and YnI0flS series sequence tags. Locating amino acid(s) containing a
covalently attached oligonucleotide was performed by looking for the conversion
of y- to y-.ions or b- to b*ions that would represent the mass addition of the
oligonucleotide to an amino acid. Sites of crosslinking could only be definitively
identified in the nucleopeptides of T6. Sites of crosslinking in the triply charged
ion species of T6(..3)xdT2 were identified as Tyr and His67 while a site of
crosslinking in the doubly charged ion species of T6(..3)xdT2 was identified as
His67. Both the doubly and triply charged ion species of T6(..l)xdT2 showed His67
as a site of crosslinking. The triply charged ion species of TI IxdT2 strongly
suggested His1and His136 as sites of crosslinking, but the complexity of this
spectrum prevented definitive identification. A conversion of b-to b*ions or a
conversion of y- to y-.ioris were absent from the spectra of Tl 8xdT2, thus
preventing the localization of crosslinked amino acids.
Comparing the nucleopeptides analyzed by LCIESI MS/MS shows that the
major fragmentation pathway for the 16 nucleopeptides took place along the
peptide backbone while the major fragmentation pathway for the nucleopeptides
of TI I and TI 8 took place along the DNA backbone. Fragmentation of the DNA
backbone yields no useful information in identifying the amino acid(s) involved in
crosslinking, but could prove useful in identifying the DNA sequence context in
which crosslinking takes place. The CID spectra of TI IxdT2 and Tl 8xdT2 are134
Figure 4.20. Summary of fragmentation patterns observed in LC/ESI
MS/MS analysis of Ung nucleopeptides. Peptide (b- and y-ions) and
nucleopeptide (b* and y*..ions) LC/ESI MS/MS fragmentation of Ung-peptidex
dT complexes from Figures 4.13 through 4.18 are summarized. For clarity,
fragmentation taking place along the oligonucleotide portion of the nucleopeptide
has been omitted. (A) The fragmentation pattern of triply charged T6(..3)xdT2
showed two continous conversions of y- toy*Ic(yio to yll* and yli to y12*)
locating the position of two crosslinks to Tyrand His67. Fragments of b- and b*
ions showed a noncontinuous conversion of the ion series (b7 to b9*) that
indicated the position of a covalent crosslink betweenPro65and Tyr. A
continuous conversion of b- to b*ions was observed (bg to bio*), supporting the
y-ion series identification of His67 as a crossJinked amino acid. (B) The doubly
charged T6(..3)xdT2 ion species showed a conversion of y- to y*ions(Ybto yjj*)
and b- to b*ions (y9 to yj*) in which the site of crosslinking was located to His67.
An additional site of crosslinking to Tyrcould not be identified. (C) The
fragmentation pattern of the triply charged T6(..l)xdT2 ion species showed a
single continuous conversion of y- to y*..ions (y to y7*) locating the site of
crosslinking to His67. A noncontinuous conversion of b- to b*ions (bg to b12*)
supports His67 as the site of crosslinking, but does not directly identify this amino
acid as being crosslinked. (D) The fragmentation pattern of the doubly charged
T6(..7)xdT2 ion species also showed a single continuous conversion of y- to y*..
ions (y to y7*) locating the site of crosslinking to His67, but b-series fragmentation
ions were absent from the spectrum. (if) The triply charged TI IxdT2
fragmentation pattern showed one continuous conversion of y- to y*.ions (y13 to
y14)and one continuous conversion of b- to b*ions (b6 to b7*). These
conversions,respectively, suggestedHis1andHis1as the sites of crosslinking.
The combination of b- and b*ions (b8 to b11 and b8* to b12*) also indicates
another crosslinked amino acid(s) between Ala137 andTrp141.(F) Analysis of
fragments of TI 8xdT2 confirmed the identity of the nucleopeptide and and over
lap of y- andy*Icsuggests multiple sites of crosslinking across the peptide.
in the positions for y7* and y8* indicate that the assignments of these ions is
uncertain because of possible iosbaric conflicts.135
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Figure 4.20 Summary of fragmentation patterns observed in LCIESI
MS/MS analysis of Ung nucleopeptides.136
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Figure 4.20 (continued). Summary of fragmentation patterns observed in
LCIESI MSIMS analysis of Ung nucleopeptides.137
considerably more difficult to interpret since peptide ion series (b- and y-ions)
overlap crosslink ion series (b* and y*ions). Three possible routes may have
produced this overlap. First, varying populations of a nucleopeptide may have
undergone internal fragmentation in which one cleavage takes place at the
covalent crosslink and another takes place along the peptide backbone.
Resulting fragment ions from the population of crosslink ions added to the
population of peptide ions would yield the observed overlap. A second possible
route is that multiple sites of crosslinking are present within a nucleopeptide
population such that a site of crosslinking might be present at various amino
acids. The resulting CID spectrum for this heterogeneous structural population
would have the potential to produce overlaps in the peptide and crosslink ion
series. A third possible route is that a nucleopeptide contained multiple sites of
crosslinking and a populationofthe nucleopeptide underwent cleavage at the
crosslink with subsequent cleavage of the peptide while a populationofthe
nucleopeptide only underwent cleavage along the peptide backboneofthe
nucleopeptide.
It is interesting to note that Tii xdT2 and Ti 8xd12 are true tryptic
peptides in the sense that they contain a C-terminal arginine or lysine. The T6
nucleopeptides were generated from a tryptic digestionofUng, but lost three,
five, or seven C-terminal amino acids during work-upofthe sample and therefore
do not contain a fixed charged amino acid at the C-terminus. The two
nucleopeptides that contained C-terminal-fixed charged amino acids showed
directed fragmentation towards the DNA backbone whereas the nucleopeptides138
that had no fixed charges at the C-terminus showed directed fragmentation
towards the peptide backbone. The preference of fragmentation towards the
oligonucleotide portion versus the peptide portion of a nucleopeptide has been
reported previously (38). A likely explanation for the observed nucleopeptide
fragmentation pathways comes from CID studies of multiply-protonated peptides
(21, 30, 31, 132, 133). From these studies it has become generally accepted
that highly basic sites (such as arginine and lysine) act in immobilizing protons on
the peptide. Mobilization of protons to less basic sites along the peptide
backbone is required in order to promote peptide fragmentation mechanisms
under low-energy CID. In the case of nucleopeptides of TI I and 118, it is
possible that the highly basic C-terminal amino acids were able to anchor an
ionizing proton causing Coulombic repulsion of additional protons to be directed
from the peptide portion to the oligonucleotide portion of the nucleopeptides. The
repelled protons become mobile along the oligonucleotide inducing fragmentation
(43). Without the highly basic amino acids of arginine or lysine present in the
nucleopeptides of T6, ionizing protons are mobile to protonate along the peptide
backbone of these nucleopeptides to induce the fragmentation pathways that
produced b-, y-, b* and y*.ion series.
The complexity of the CID spectra observed in this work is inherent to the
nature of a nucleopeptide. The peptide portion of a nucleopeptide has three
potential sites of cleavage per peptide bond that can produce six types of
fragments, namely a, b, c, x, y, and z ions (see Appendix). Fragmentation can
also take place along the side chains of the peptide. The oligonucleotide portion139
of the nucleopeptide has four potential sites of cleavage per phosphodiester
bond that can produce eight types of fragments, namely a, b, c, d, w, x, y, and z
ions. The multiple types of fragments within a nucleopeptide lead to a greater
probability of producing isobaric fragment ions during the CID process. This was
seen during the LC MS/MS analysis of TI 8xdT2 with m/z ion species 1393.4
and 1490.5. Ion species 1393.4 could be interpreted as either singly charged
(MH=1393.519) or singly chargedz1(MH= 1393.697). Likewise, ion species
1490.5 could be interpreted as either singly charged y8* (MH4=1490.571) or
singly chargew1(MH=149O.666). To distinguish between these isobaric
fragments or resolve these fragments, a mass accuracy of about 10 partsper
million and resolving powers of about 10,000 would be required. These
specifications are outside the capabilities of the LCQ ion-trap instrument, but
could be achieved with either MALDI FTICR or ESI Q-TOF instruments.
Additional ambiguity can arise in the nucleopeptide CID spectra from the
sequence context of the peptide. Two of the nucleopeptides analyzed in this
study contain multiple proline residues, which can directly influence the CID
fragmentation of peptides. Cleavage of the proline amide bond is highly
favorable and often dominates the CID spectra of peptides that contain this
amino acid, while b-ions formed from the cleavage at the C-terminal side of the
proline are generally weak or absent (2, 54, 106, 133). The absence of b8-ions
for the nucleopeptides of T6 (Figures 4.19B and 4.20A-C) is consistent with this
expectation. Interestingly, the nucleopeptide of TI 8 contains three prolines that140
alternate from the N-terminus. The lack of b-ions in this spectrum may be a
result of the "proline effect" (Figure 4.20F).
Along with characterizing the fragmentation pattern of nucleopeptides, an
equally important objective of this research was to identify regions of Ung that
take part in crosslinking and to locate specific amino acids within those regions
that are photochemically crosslinked. Three tryptic peptides, 16, TI 1, and TI 8,
were definitively identified by tandem mass spectrometry to be involved in
crosslinking. Within those peptides, T6 amino acid residueHis67was
unambiguously identified as taking part in crosslinking (Figure 4.21). Other sites
of crosslinking were tentatively identified as Tyrwithin T6 and His,33 andHis135
within Ill.
Peptides 16 and T18 contain highly conserved amino acid sequences that
have been identified as important regions for either DNA binding or catalytic
activity of human UDG. The water-activating loop of the protein, containing the
DPYH region (an identical region between Ung and UDG), is located in the T6
peptide of Ung. Along with its catalytic importance, this region also contains the
specificity-determining tyrosine. The orientation in the catalytic pocket of this
amino acid side has been shown to exclude thymine in human UDG (64, 91).
One of three Ser-Pro loops that takes part in compressing DNA in the "pinch-
push-pull" mechanism of the proteins is located in the 118 peptide of Ung
(APHPSPLSAHR). The serines in this region have been proposed to take part in
orienting the protein for DNA scanning. Also located within this region is the
leucine involved in minor groove reading (96). Based on these crystallographic141
Figure 4.21. Correlation of LC/ESI MS/MS nucleopeptide mapping with the
crystal structures of uracil-DNA glycosylase. Peptides ofE.co/i uracil-DNA
glycosylase identified by LC/ESI MS/MS as taking part in crosslinking are shown
in the crystal structure of the enzyme (A). Based on the sequence homology
betweenE.co/i Ung and human Ung, regions of the E. co/i crystal structure that
were identified as being crosslinked are highlighted in the crystal structure of the
human enzyme co-crystallized with DNA (96) (B). Residues corresponding to T6
are highlighted in purple, TI I residues are in orange, T18 residues are in blue,
Tryand His67 (E. co/i Ung) and Try147 and His1(human Ung) are in green, and
DNA is in yellow.-.
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findings, it is reasonable that these regions of the protein took part in
crosslinking.
The involvement of TI I in the crosslinking was not predictable from
crystallographic data. Previous co-crystal structures of human UDG with uracil
containing substrates did not identify this portion of the enzyme as being
important structurally or catalytically (96, 128). Within the region defined by Ti 1,
there are three highly conserved amino acids (Ser135, His136, and Trp142 in E. co/i)
which is normally an indicator of an important role in the enzyme's function.
Close examination of the co-crystal structure of UDG with duplex DNA indicates
that the region in this protein corresponding to Ung's Ti 1 is too far from the
duplex DNA (>3A)for it to take part in crosslinking. This discrepancy between
crosslinking of Ti I in Ung and the crystallographically predicted non-binding
behavior of TI I in UDG can be explained in two ways. First, structural
anomalies in the human Ung/DNA co-crystal structure, such as crystal packing
effects, could have resulted in the region of the protein being unnaturally shifted
away from the DNA (or the DNA unnaturally shifted away from the protein).
Second, since a crystallographic structure represents a static molecule/complex,
it is also possible that conformational changes that take place in the protein
during its binding to DNA may shift this region of the protein to be in sufficient
contact for the formation of a crosslink. This potential conformational change
could go undetected/predicted based on the interpretation of the static crystal
structure.144
5. SULFONIC ACID DERIVATIZATION OF PEPTIDES FOR ENHANCED
SEQUENCING BY ELECTROSPRAY IONIZATION
MASS SPECTROMETRY
A common method for producing peptide sequence mass spectra is
collision-induced dissociation (C ID) within an ion-trap or within the collision cell of
an electrospray ionization (ESI) mass spectrometer. Sequence spectra of
peptides produced from these instruments are often complex due to the nature of
the peptide backbone. Three types of bonds are present in the peptide
backbone that can undergo cleavage to produce six possible fragments per
amino acid residue; three containing the N-terminus (a-, b-, and c-ions) and three
containing the C-terminus (x-, y-, and z-ions) (9). There are other complexities
associated with sequence spectra. These include internal fragmentation of the
peptide, fragmentation along peptide side chains, loss of neutral species during
fragmentation such as water and ammonia, and fragment ions having multiple
charge states. The complex nature of these spectra often makes interpretation
difficult, if not impossible.
Placement of a fixed charge at the N-terminus of a peptide has been
shown to direct the fragmentation pattern of post-source decay (PSD) and CID
mass spectra simplifying sequence interpretation (111). Recently, Keough and
colleagues reported a derivatization method that involved the addition of a
sulfonic acid group to the N-terminus of tryptic peptides (65). Addition of this
fixed negative charge was able to alter the MALDI PSD fragmentation pathways
in favor of abundant y-series fragment ions allowing for simple and unambiguous145
de novopeptide sequencing. This peptide derivatization procedure was adapted
to simplify the CID spectra produced in ESI mass spectra and its application with
protein and peptide models was investigated.
5.1 Results
5.1.1The Derivatization Reaction
Initial derivatization experiments were conducted using 2-sulfobenzoic
acid cyclic anhydride or chlorosulfonylacetyt chloride as derivatizing agents
similar to the procedure of Keough and colleagues (65). Chlorosulfonylacetyl
chloride was found to be the derivatization reagent of choice due to its ease of
handling and higher coupling efficiency. All derivatized peptides reported here
were generated using the chlorosulfonylacetyl chloride reagent. Derivatization
was found to be fast and simple enough to be used routinely for isolated peptides
as well as mixtures of tryptic peptides produced from in-gel digestions. Sample
cleanup after derivatization, beyond the capabilities of the LC system coupled in-
line to the mass spectrometer, was not required. Based on the chemistry of
derivatization, a derivatized peptide increases in mass by 122.0 mass units, the
mass of a sulfoacetyl group (Figure5.1).When compared to a native peptide, a
mass increase should be observed for b-ions of derivatized peptides produced
from do experiments, but since the derivatization takes place at the N-terminus
of a peptide no mass increase would be expected for y-ions.146
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Figure 5.1 N-terminal peptide derivatization scheme. Model peptides or
peptides produced from tryptic in-gel digestions of proteins were derivatized with
chiorosulfonylacetyl chloride, as described under "Experimental Procedures."
The derivatized peptides contain a sulfoacetyl group at the N-terminus of the
peptide that increased the molecular weight of a native peptide by 122.0 mass
units.147
5.1.2 Tandem Mass Spectra of Singly Charged, Derivatized, Tryptic
Peptides
Mixtures of peptides produced from in-gel tryptic digestions of human
replication protein A (hRPA) and E. co/i uracil-DNA glycosylase (Ung) were
derivatized and analyzed by LC tandem mass spectrometry. The effects of
derivatization on the CID spectra of singly charged peptides were investigated.
The singly charged tryptic peptide LFSLELVDESGEIR from hRPA was selected
for tandem mass analysis and the resulting fragmentation spectrum produced a
molecular ion and twelve fragment ions: six b-ions and six y-ions (Figure 5.2A).
After N-terminal sulfonic acid derivatization, the singly charged peptide
underwent fragmentation to produce an abundant, consecutive, y-ion series that
covered the peptide fromy5to the N-terminus (Figure 5.2B). The fragmentation
peaks were easily identified in the spectrum and the mass difference between
consecutive peaks readily yield the amino acid sequence of the peptide; thus,
derivatization greatly simplified de novo sequencing. A less prominent ion series
was also observed corresponding to a water loss of the y-ion series. Sequence
information beforey5was not present due to the low-mass range limitation of the
ion-trap instrument (11). In general, native, singly charged tryptic peptides that
produced mixtures of incomplete b- and y-ion series underwent extensive
fragmentation after derivatization to produce abundant y-ions.
During the ion-trap tandem mass analysis of an in-gel tryptic digestion of
Ung, it was found that the singly charged peptide QGVLLLNTVLTVR was100
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Figure 5.2. Effect of derivatization on the CID spectra of singly charged
peptide LFSLELVDESGEIR. An in-gel tryptic digestion mixture of the 70 kDa
subunit of hRPA was analyzed by LC ion-trap tandem mass spectrometry as
described under "Experimental Procedures." The singly charged tryptic peptide
LFSLELVDESGEIR was selected from the mixture for tandem mass analysis
both before (A) and after (B) derivatization.149
refractory to fragmentation (Figure 5.3A); this phenomenon is not uncommon for
singly charged peptides. The fragmentation spectrum of this peptide showed a
strong MH-NH3 ion and weak signal strength for other fragmentation species
that made sequence interpretation challenging. After derivatization, extensive y-
series fragmentation that covered the peptide sequence fromy4to the N-
terminus was observed (Figure 5.3B). Sulfonic acid derivatization resulted in
making the peptide more susceptible to fragmentation and produced a
continuous y-ion series (within the mass limit of the ion-trap) with high signal to
noise that allowed for unambiguous sequence determination.
A concern in derivatizing a peptide's N-terminal x-amine is the possibility of
also derivatizing the lysine side chain -amine. Analysis of LC/ESI spectra of C-
terminal lysine containing peptides (produced from proteolytic digestion with
trypsin) indicated that the predominant species produced was mono-derivatized
peptides with bis-derivatized peptides as the minor products. The retention time
of a mono-derivatized peptide was usually different from its bis-derivatized
counterpart making, isolation of these species for data-dependent analysis facile.
Tandem mass analysis of the mono-derivatized peptide QSGVTIYPPQK showed
a mass increase of the molecular ion after derivatization that was consistent with
the addition of a sulfoacetyl group to the peptide (compare MH1-NH3 ion species
between Figure 5.4A and Figure 5.4B). The mass of the y-series fragment ions
(ions containing the C-terminus) after derivatization revealed that they did not
contain the derivatizing reagent, thereby locating the site of derivatization to theA.
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Figure 5.3. Effect of derivatization on the CID spectrum of the singly
charged peptide QGVLLLNTVLTVR. An in-gel tryptic digestion mixture of E.
coil Ung was analyzed by LC ion-trap tandem mass spectrometry, as described
under "Experimental Procedures." The singly charged tryptic peptide
QGVLLLNTVLTVR was selected from the mixture for tandem mass analysis
before (A) and after (B) derivatization.>.
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Figure 5.4. Effect of derivatization on tryptic peptides containing C-
terminal lysine. An in-gel tryptic digestion mixture of E. co/i Ung was analyzed
by LC ion-trap tandem mass spectrometry, as described under "Experimental
Procedures." The peptide QSGVTIYPPQK was selected from the mixture for
tandem mass analysis before (A) and after (B) derivatization.
H3152
N-terminal amine rather than to lysine (Figure 5.4). The tandem mass spectra of
bis-derivatized peptides showed no regular fragmentation pattern and
interpretation of these spectra was not possible.
5.1.3 Tandem Mass Spectra of Doubly Charged, Derivatized, Tryptic
Peptides
Peptide precursor ions produced by ESI are generally a heterogeneous
mixture of multiply charged ions. For tryptic peptides containing basic amino
acids the ion formation tendency is usually towards a greater population of ions
in higher charge states. The higher the charge state of an ion, the higher the
kinetic energy and thus the more energy available during the CID process (106).
The effect of the increased charged state on the fragmentation spectra of sulfonic
acid-derivatized tryptic peptides was examined. The Ung tryptic peptide
ELENTIPGFTRPNHGYLESWAR was selected for analysis because the
precursor ion was doubly charged. This peptide was produced from incomplete
digestion of the protein, a common occurrence that results from the protease not
recognizing a cleavage site. The LC tandem mass spectrum of this peptide
showed a strong, doubly charged molecular ion and weak, non-consecutive
fragment ions that made it difficult to identify a sequence tag (Figure 5.5A).
Tandem mass analysis of the doubly charged precursor after derivatization
showed that the molecular ion had undergone much more extensive
fragmentation and the y-ion fragments were significantly enhanced (Figure 5.5B).40
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Figure 5.5. Effect of derivatization on the CID spectrum of the doubly
charged peptide ELENTIPGFTRPNHGYLESWAR. An in-gel tryptic digestion of
E. coil Ung was analyzed by LC ion-trap tandem mass spectrometry,as
described under "Experimental Procedures." The doubly charged tryptic peptide
ELENTIPGFTRPNHGYLESWAR was selected from the mixture for tandemmass
analysis both before (A) and after (B) derivatization.154
The strong, consecutive y-ion series fromY16toY21produced a sequence tag that
clearly confirmed the identity of the peptide.
5.1.4 Tandem Mass Spectra of Derivatized, Non-tryptic Peptides
The peptide angiotensin (DRVYIHPFHL) was used as a model to test the
effect of sulfonic acid denvatization on the fragmentation spectra of non-tryptic
peptides. A doubly charged precursor ion of the native peptide was selected for
fragmentation and showed a total of seven fragmentation ions, four b-ions and
three y-ions (Figure 5.6A). Derivatized angiotensin was also selected as a
doubly charged precursor and the resulting fragmentation spectrum showed a
total of sixteen fragment ions: eight b-ions and eight y-ions (Figure 5.6B). For
this model non-tryptic peptide, derivatization did not enhance a specific
fragmentation group (e.g. solely y-ions) but enhanced fragmentation as a whole
(enhanced both b- and y-ions). Even though the derivatized fragmentation
spectrum is complicated by the overlap of multiply charged b- and y-ions,
computerized database algorithms, such as SEQUEST (33, 155-157), can easily
deconvolute the spectrum to aid in identifying the peptide.
5.2 Discussion
Sulfonic acid derivatization of the N-terminus of peptides was used on
model peptides and on tryptic peptides produced from in-gel digests of the
proteins Ung and hRPA. Similar to the results of Keough and coworkers (65),100
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Figure5.6.Effectofderivatization on the CID spectrumof doublycharged
angiotensin. The model peptide angiotensin (DRVYIHPFHL) was analyzed by
LC ion-trap tandem mass spectrometry, as described under "Experimental
Procedures." The doubly charged percursor ion was selected for tandem mass
analysis before (A) and after (B) sulfonic acid derivatization.156
electrospray CID spectra of denvatized tryptic peptides showed an enhancement
in mainly y-ion signals and a loss of b-ion signals in comparison to CID spectra of
nonderivatized tryptic peptides that produced multiple ion types. This finding can
be explained based on the proposed fragmentation pathways of tryptic peptides.
It is generally accepted that tryptic peptides undergo protonation at the C-
terminal basic amino acid (either lysine or arginine). An additional proton yields a
heterogeneous population of structures resulting from rapid intramolecular proton
transfer across the peptide backbone (21, 133).If Coulombic repulsions are
strong enough, the additional proton needed to ionize the peptide backbone may
not readily bind, preventing fragmentation of the peptide.It is for this reason that
singly charged tryptic peptides often resist low energy CID fragmentation
whereas doubly charged tryptic peptides fragment easily. During ionization, the
basic C-terminal amino acid of derivatized peptides is protonated first (Figure
5.7). With the sulfoacetyl group present at the N-terminus of the peptide, the
deprotonated derivatization group forms a zwitterionic peptide species with a
negative charge at the N-terminus and a positive charge at the C-terminus. An
additional proton is then needed to ionize the peptide. The ionizing proton can
freely migrate across the peptide backbone to ionize amide groups since the
most basic residue at the C-terminus is already occupied, promoting thorough
fragmentation of the peptide. The resulting b-ion fragments produced will be in a
zwitterionic form and the resulting y-ion fragments will contain a fixed charge at
the basic C-terminal amino acid. Overall, this will suppress the presence of b-
type ions and enhance the presence of y-type ions.o ,0 0
J1I ItH\ II
HO3S CH2C-lCHC NJ-NH--COH
HR nR1
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Figure 5.7. Proposed ESI CID fragmentation scheme for tryptic peptides N-
terminally derivatized with sulfonic acid.158
The simplification of tandem mass spectra is of great utility for the de novo
sequencing of peptides. Clearly, N-terminal sulfonic acid derivatization could be
used as an aid in identifying peptides produced from in-gel digestion of an
unknown protein. Unambiguous sequencing of peptides or identifying
unambiguous sequence tags within peptides would increase the confidence in
determining the identity of an unknown protein. Also, derivatization of peptide
mixtures produced from in-gel digestions of known proteins may lead to more
peptides being sequenced, increasing the coverage of peptide maps (47, 137).
Along with playing a role in protein identification, the virtues of this
derivatization procedure may also have utility in the mass spectrometric analysis
of protein-nucleic acid complexes. The complexity of nucleopeptide
fragmentation spectra produced from ESI tandem mass spectrometry has been
clearly shown in Chapter 4. Any technique that could simplify these spectra
would increase the likelihood of identifying sites of crosslinking within
nucleoprotein complexes. It may be possible to use sulfonic acid derivatization
of nucleopeptides produced from the tryptic digestion of nucleoprotein complexes
to increase the fragmentation of the peptide portion of the nucleopeptide and
minimize the fragmentation of the DNA portion of the nucleopeptide. The
fragmentation spectra of sulfonic acid derivatized nucleopeptides may also show
an enhancement in y-ions and a suppression of b-ions, similar to that of
derivatized tryptic peptides, to simplify the interpretation of these compounds.
Other derivatizing reagents could be used, such as S-pentafluorophenyl-
[tris(2,4,6-tnmethoxyphenyl)phosphoniumjacetate bromide, to enhance b-ions159
and suppress y-ions, to provide fragmentation spectra that corroborate those
produced from sulfonic acid derivatization (2, 53, 112). The use of derivatizing
agents to enhance and simplify nucleopeptide fragmentation spectra is certainly
a novel idea; however, the feasibility of this approach requires further studies.160
6. UV-CATALYZED CROSSLINKING OF HUMAN REPLICATION PROTEIN A
TO SINGLE-STRANDED DNA SUBSTRATES
There are three interesting questions about the structure/function
relationship of hRPA that have yet to be resolved by other studies. Namely, what
structural features of the protein modulate the increased association of the
protein for increasing lengths of oligonucleotides? What is the importance of
specific aromatic amino acids in binding single-stranded DNA? Do the hRPAI4
and hRPA32 subunits both take part in binding to DNA? Based on the results
obtained from crosslinking studies of E. co/i Ung, similar studies applied to hRPA
have the potential to answer these questions.
To test the feasibility of using UV crosslinking to study this protein, three
experiments were identified that, if successful, would indicate the likelihood of
success in pursuing future biological characterization. These experiments were
to: 1) purify sufficient quantities of active hRPA, 2) determine optimum irradiation
times for crosslinking hRPA to various otigonucleotides, and 3) produce a peptide
map of the protein and a nucleopeptide map of an hRPA-oligonucleotide
complex. This chapter discusses the results from these experiments and lays a
foundation for future crosslinking studies of hRPA.161
6.1 Results
6.1.1 Overproduction of Recombinant hRPA
The overproduction of recombinant hRPA inE.co/i BLR2I(DE3) cells was
tested by transforming these cells with the p1 ld-tRPA plasmid (46). The plasmid
contains a single T7 RNA polymerase promoter followed by the coding sequence
of hRPA7O, hRPAI4, and hRPA32. Transformants were induced with IPTG,
lysed, and examined for the expression of the recombinant subunits by
denaturing polyacrylamide gel electrophoresis (Figure 6.1).It was found that
upon induction, cells containing p1 ld-tRPA synthesized the 70-kDa and 32-kDa
subunits of hRPA. The 14-kDa subunit could not be identified due to the high
density of protein at the dye front of the gel.
6.1.2 Purification of hRPA
Subsequent to initial overproduction experiments, a survey of the coding
sequences of hRPA7O, hRPA32, and hRPAI4 revealed the presence of 22
arginine codons (AGA and AGG). These codons are common in eukaryotic
genes, but are relatively rare inE.co/i (158).It was suspected that high-level
expression of these genes containing codons rarely used byE.coil would result
in depletion of the internal aminoacyl tRNA pools. This in turn could lead to the
formation of aborted translation products that would be observed as proteolytic
fragments or it could lead to misincorporation of lysine at arginine codons during
overexpression inE.coil (23, 36). To avoid the formation of aborted translation162
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Figure 6.1. Overexpression of hRPA. A mini-culture of E. co/i BLR2I(DE3)
cells that had been transformed with plld-tRPA was split into two fractions which
were either induced with IPTG or left uninduced. The cells from both fractions
were lysed, the soluble protein was separated on a 12.5% denaturing
polyacrylamide gel, and protein bands were visualized by Coomassie staining,as
described under "Experimental Procedures." The lanes of uninduced (U) and
induced (I) cultures were compared to identify unique bands. Arrows to the left of
the gel indicate the positions of molecular weight standards andarrows to the
right of the gel indicate the overexpressed 70 kDa and 32 kDa subunits of hRPA.163
products and the misincorporation of lysine for arginine in hRPA, the plasmid p-
RIL was co-transformed with p1 ld-tRPA into the E. co/i BLR2I(DE3) cell line.
The plasmid pRIL (Stratagene) contains the tRNA gene (argu), whose product
recognizes the two rare arginine codons AGA and AGG, and it was also coded
for tRNA genes of isoluecine and luecine.
Initially, the hRPA purification procedure of Wold and colleagues (46) was
attempted which called for the use of Affi-gel Blue, hydroxylapatite, and Mono Q
columns. Using this scheme, it was difficult to recover the protein from the
hydroxylapatite column. This result led to the development of a new purification
scheme (Figure 6.2). Using the newly developed scheme, the cell lysate from
induced BLR2I(DE3) cells transformed with the p1 ld-tRPA overexpression
plasmid and p-RIL was applied to an Affi-Gel Blue column and washed with
buffers of increasing chaotropic strength. Individual proteins of approximate
molecular weights 70 kDa, 32 kDa, and 14 kDa, as observed by denaturing
polyacrylamide gel electrophoresis, were abundant in column washes with 1.5 M
sodium thiocyanate (Fig 6.3). The chaotropic strength required to elute proteins
of these molecular weights strongly indicated that these fractions contained
enriched recombinant heterotrimeric hRPA. Elution fractions containing the
proposed subunits of hRPA were pooled and dialyzed against Hl-500 mM NaCI
buffer, which took the place of the hyrdoxylapatite column used in the purification
procedure by Wold and colleagues (46).It was reasoned that hRPA would have
a natural affinity for single-stranded DNA agarose, making it a logical
fractionation step to obtain active protein. The dialyzed fraction was further164
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Figure 6.2. Purification scheme for hRPA.165
Figure 6.3. Affigel Blue purification of hRPA. A soluble protein lysate of E.
co/i BLR2I(DE3) cells transformed with p1 ld-tRPA and pRIL was loaded ontoan
Affigel Blue column and eluted fractions were visualized on 15% SDS-
polyacrylamide gels by Coomassie stain, as described under "Experimental
Procedures." The lysate fraction was visualized on the gel and is designated L
and fractions 4 and 7 were collected during loading of the column. Fractions 12-
17 were collected during washing with HI-50 mM KCI, fractions 20-27 during
washing with Hl-800 mM KCl, fractions 30-36 during washing with Hl-O.5 M
NaSCN, fractions 39-49 during washing with HI-I .0 M NaSCN, and fractions 52-
91 during elution with HI-I .5 M NaSCN. The positions of molecular weight
markers are indicated by affows. From analysis of these gels, fractions 6 1-81
were pooled for further purification.97.4
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Figure 6.3. Affigel Blue purification of hRPA.
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purified by using a single-stranded DNA agarose column. An elution peak
containing proteins of approximately 70 kDa, 32 kDa, and 14 kDa began at 700
mM NaCI (Fig 6.4), again indicating that these fractions contained recombinant
heterotrimeric hRPA. After pooling the peak of elution and concentration, the
purified sample contained the three proposed subunits of hRPA as well as a
minor bands at approximately 23 kDa and two bands around 66 kDa (Fig 6.5A).
Typically, about 1.0 mg of protein was purified per liter of cultured cells.
Pet-forming proteolytic digestions in-gel and sequencing the resulting
peptides identified the purified proteins by mass spectrometry (125). Initially, the
14-kDa band was cut from a SDS-polyacrylamide gel containing the purified
proteins (Figure 6.5A). The protein band was digested in-gel with trypsin and
then surveyed by MALDI MS to identify tryptic fragments (Figure 6.5B). An ion
species of m/z 2039.7 was observed and tentatively identified as the C-terminal
tryptic fragment of hRPAI4. The in-gel digestion mixture was analyzed by
LC/ESI MS and the[M+2HJ2and[M+3H]3ion species of 2039.7 were present
(Figure 6.5C). Tandem mass analysis was conducted on the[M+2HJ2ion
species (Figure 6.5D) and the resulting data were used in a peptide sequence
database search algorithm. The results of the database search (Figure 6.6)
revealed that this peptide was in fact the C-terminal tryptic peptide of hRPAI4,
thus identifying this protein. A similar protein identification scheme was used to
identify the five other protein bands (Figure 6.5A). This analysis revealed that
the 70-kDa and the 32-kDa protein bands corresponded to hRPA7O and
hRPA32. The two protein bands of approximately 66 kDa and 57 kDa were bothI:
Figure 6.4. Single-stranded DNA agarose column purification of hRPA.
Elution fractions 61-81 from an Affigel Blue column (Figure 6.3) containing hRPA
were pooled, dialyzed against 500 mM NaCI, loaded onto a single-stranded DNA
agarose column, and collected fractions were visualized on 15% SDS-
polyacrylamide gels by Coomassie stain, as described under "Expenmental
Procedures." A fraction of the sample loaded onto the column was visualized on
the gel and is designated L. Fractions 5-11 were collected during loading of the
column, fractions 13-22 during washing with Hl-500 mM NaCl, and fractions 25-
69 during elution with a linear gradient of 500 mM NaCl to 3 M NaCI in HI buffer.
The concentration of NaCI in collected fractions was determined from
conductivity measurements and indicated by M NaCI. The positions of molecular
weight markers are indicated by arrows. Fractions 31-60 were pooled, buffer
exchanged to HI-200 mM KCI, and concentrated.97.4
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Figure 6.4. Single-stranded DNA agarose column purification of hRPA.
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Figure 6.5. Mass spectrometric analysis of purified hRPA. A, fractions 31-
60 from a single-stranded DNA agarose column (Figure 6.4) containing highly
purified proteins of - 70 kDa, - 32 kDa, and - 14 kDa (thought to be subunits of
hRPA) were pooled, exchanged with Hl-200 mM KCI buffer, and concentrated to
300 pg/mI. The concentrated sample was analyzed by loading 2.5 pg (20 pmol)
of protein onto a 15% SDS-polyacrylamide gel and visualizing with silver stain.
Arrows indicate the positions of molecular weight markers.B, the visualized
protein bands were excised from the gel, digested with trypsin, and the resulting
tryptic peptides were analyzed by MALDI-MS. The tryptic in-el digestion of the
- 14 kDa protein is shown. C, electrospray ionization LC-MS (ion-trap) of the -
14 kDa tryptic digestion was conducted and peaks corresponding to the[M+2H]2
(m/z 1020.3) and[M+3H]3(mlz 680.6) ion species of mass 2038.6 were
identified. D,LC-MS2analysis was then conducted on the m/z 1020.3 ion
species, as observed in theMS1analysis (panel C), in order to produce peptide
sequence information for subsequent use in the peptide database search
algorithm Protein Prospector.A.
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Figure 6.5. Mass spectrometric analysis of purified hRPA.
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Figure 6.6. Database search results for identification of the 14 kDa purifiedprotein. A list of the electrospray
ionization LC-MS/MS m/z data from Figure 6.5, panel Dwas entered into the Protein Prospector protein database search
engine and the results of that search against the SwissProt protein data bankare shown.
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identified as being related to hRPA7O, most likely proteolytic fragments of
hRPA7O. The 23-kDa protein band was identified as the E. co/i single-stranded
DNA-binding protein (Ecssb). Densitometry experiments (data not shown)
estimated that the hRPA7O, hRPA32, and hRPAI4 made up greater than 90% of
the purified protein.
6.1.3 Single-Stranded DNA Binding Capability of hRPA
An electrophoretic mobility shift analysis was used to characterize the
DNA binding capability of purified recombinant hRPA. A constant quantity of
oligonucleotide [32P]dT3o was incubated with increasing amounts of hRPA, and
mobility-shifted bands on a polyacrylamide gel corresponding to complexes
between hRPA and [32PJdT30 were observed (Figure 6.7). At hRPA:dT3o mixture
ratios less than one, a distinct mobility-shifted band was observed. Starting at
protein to oligonucleotide mixture ratios of one, additional shifted bands of altered
mobility were observed and, close to 100% of the oligonucleotide had been
bound by the protein. At a hRPA to dT30 mixture ratio of 5, 100% of the mobility-
shifted complex was of altered mobility. This result shows that essentially the
entire production of the purified recombinant protein was capable of binding
DNA.MC
s-*
F -*
174
Ratio hRPA:dT30
0.1 0.2 0.5 1.0 2.0 5.0 0
Figure 6.7. Electrophoretic mobility shift analysis to measure the capability
of hRPA to bind DNA. Varying amounts (0 to 50 pmol) of purified hRPA were
incubated with 10 pmol [32P]dT3o for 30 mmat room temperature. The reactions
were separated on a 5% polyacrylamide gel and the gel was dried and subjected
to autoradiograhy, as described under "Experimental Procedures." Location of
free [32P]dT3o, [2P]dT3o bound to a single hRPA molecule, and [32P]dT3o bound
by multiple hRPA molecules are indicated by (F), (S), and (M), respectively.175
6.1.4 UV-Catalyzed Crosslinking of hRPA to dT30
The ability to form UV-catalyzed crosslinks between hRPA and dT30 was
tested by irradiating a mixture of hRPA and [32P]dT3o and analyzing the products
by SDS polyacrylamide gel electrophoresis (Figure 6.8). Silver staining of the gel
showed the presence of a new mobility shifted protein band that was dependent
on both DNA and UV irradiation (Figure 6.8A, lane 6). The position of the
mobility shifted band suggested that it corresponded to the 70-kDa subunit of
hRPA crosslinked to [32PJdT30. The gel was also analyzed by autoradiography,
which showed the presence of four components in the gel that contained
[32P]dT3o. One of the components was free [32PJdT30 (Figure 6.8B, lane 4) while
the other three components were formed only after UV-irradiation (Figure 6.8,
lane 6), suggesting these components were crosslinked nucleoprotein
complexes. The first nucleoprotein complex, labeled XL-1, was shifted in mobility
to the same extent as the crosslinking product observed after silver staining
(compare Figure 6.8A, lane 6 and Figure 68B, lane 6) also suggesting that this
crosslinked species was hRPA7O covalently attached to [32P]dT3o. The second
crosslinking product, XL-2, was visible only by autoradiography and was shifted
in mobility to a lesser extent than XL-1. It was possible that this second
crosslinking product resulted from crosslinking of the proteolytic fragments of
hRPA7O (Figure 6.8a, lanes 1, 2, and 3; apparent molecular weights less than
66.2 kDa) to [32PJdT30. The third crosslinking product, XL-3, migrated in the gel
with an apparent molecular weight of 31 kDa. Since hRPA32 was retarded in the
gel slightly more than XL-3, it was unlikely that this crosslinking product is176
Figure 6.8. Dependence of UV light for the formation of UV-catalyzed
crosslinks between hRPA and dT. Seven samples (20 pL) were prepared
containing either 20 pmol hRPA, 20 pmol [32PJdT30, 20 pmol [32P]dT3o and 20
pmol hRPA, or 20 pmol [32P]dT3o and 20 pmol heat-denatured hRPA (denoted by
*)The samples were either unirradiated or irradiated for I mm with 254-nm light
as indicated. Each sample was loaded onto a 12.5% SDS polyacrylamide mini-
gel and electrophoresis was carried out. The gel was stained with silver (panel
A), then dried, and subjected to autoradiography (panel B). The positions of
hRPA7O, hRPA32, hRPAI4, [32P]dT3o, and hRPAx[32PJdT30 crosslinking
products (XL) are indicated by arrows to the right of the panels. The position of
molecular weight markers are indicated by arrows to the left of the panels.hRPA + + +
*
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Figure 6.8. Dependence of UV light for the formation of UV-catalyzed
crosslinks between hRPA and dT30.178
associated with hRPA32. A faint protein band was observed in the silver stained
gel with an apparent molecular weight of 23 kDa (Figure 6.8A, lanes 1, 2, and 3)
and was identified as Ecssb (Section 6.t2). The covalent attachment of
[32PJdT30 to Ecssb as a result of crosslinking could give a predicted molecular
weight close to 31 kDa; thus, the faint crosslinking product XL-3 was possibly
Ecssb crosslinked to [32PJdT30. The specificity of crosslinking was also
investigated by heat denaturing purified hRPA, incubating the denatured protein
with [32P]dT3o, irradiating with UV-Iight, and then anaJyzing the photoproducts by
SDS-polyacrylamide gel electrophoresis. Silver staining and autoradiography of
the gel did not indicate the formation of a crosslinking product associated with
hRPA7O (Figure 6.8A, lane 7 and Figure 6.8B, lane 7). A crosslinking product,
however, was observed in a region of the gel suggesting Ecssb crosslinked to
dT30 (Figure 6.8B, lane 7). When taken together, the results of the silver stained
gel and the autoradiogram establish that hRPA7O, and the proteolytic fragments
of hRPA7O, is the only subunit of the hRPA heterotrimer that takes part in
crosslinking to dT30 under the conditions tested.
6.1.5 UV-Dose Response of Crosslinking hRPA to dT10, dT30, anddT70
In order to determine the optimum crosslinking time for hRPA to
oligonucleotides dT10, dT30, and dT70, these oligonucleotides were mixed
individually with hRPA and crosslinked for increasing doses of UV light. The
photoproducts were analyzed on dried SDS polyacrylamide gels. For
oligonucleotide dT10 (Figure 6.9A), only a single crosslinking product was present179
Figure 6.9. Dose response of Crosslinking hRPA todT10,dT30, dT70.
Crosslinking reaction mixtures (200 pL) containing 50 pmol of hRPA, 50 pmol of
a [32P] oligonucleotide, and buffer Hl-30 mM KCI were irradiated with UV light for
0, 1, 2, 5, 10, and 15 mm(lanes 2 through 7, respectively), as described under
"Experimental Procedures." At each time point, 5-iL samples were removed and
subsequently analyzed by SDS-polyacrylamide gel electrophoresis. Gels were
dried and crosslmnking products were visualized by autoradiography. A, the
oligonucleotide [32P]dT10 was used in the crosslinking reaction and the
photoproducts were analyzed by 15% SDS polyacrylamide gel electrophoresis.
Lane I contains 1.4 pmol of unirradiated [32P]dT1o. B, the oligonucleotide
[32PJdT30 was used in the crosslinking reaction and the photoproductswere
analyzed by 12% SDS polyacrylamide gel electrophoresis. Lane I contains 1.4
pmol of unirradiated [32P]dT3o. C, the oligonucleotide [32P]dT70 was used in a
crosslinking reaction and the photoproducts were analyzed by 8% SDS
polyacrylamide gel electrophoresis. Lane I contains 1.4 pmol of unirradiated
[32PJdT70. Arrows in each figure panel indicate the photoproducts used for
subsequent quantitation (Figure 6.10). Asterisks indicate the position of
secondary crosslinking products and P indicates the positions of oligonucleotide
probes.1 234567
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Figure 6.9. Dose response of crosslinking hRPA to dT10, dT30, and dT70.
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whereas for oligonucleotides dT30 anddT70multiple crosslinkirig products were
present (Figure 6.9B and C). The intensity of the mobility-shifted bands (as
indicated by arrows in Figure 6.9) were quantified from Phosphorlmages and
plotted versus the irradiation time (Figure 6.10). In the case of all three
oligonucleotides, the product yield was at a maximum after 1 minute of UV
exposure. From this result, an optimum crosslinking time of I mmfor preparative
reactions between hRPA and dT10, dT, and dT70 was established.
6.1.6 Peptide Mapping of hRPA7O
Crosslinking analysis identified hRPA7O as the major subunit involved in
crosslinking to dT30 (Figure 6.8). Therefore, the 70-kDa subunit of hRPA was
digested in-gel with trypsin and the products were analyzed by LC/ESI ion trap
mass spectrometry to produce a map of the subunit. The massesof the tryptic
fragments were compared to a predicted tryptic digestion of the 70-kDa subunit
to identify regions of the subunit covered in the map. Mass spectrometry
detected 31 tryptic peptides of which 26 were sequenced by tandem mass
analysis (Table 6.1). The detected peptides covered 63% of the amino acid
sequence of hRPA7O.
6.1.7 MALDI MS Analysis of hRPA7OxdT30 Nucleopeptides
A preparative crosslinking reaction of hRPA with dT30 was conducted and
the products of the photoreaction were analyzed by a 10% SDS polyacrylamide50000
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Figure 6.10. Quantitation of UV dose response during crosslinking of
hRPA to dT10, dT30, and dT70. Individual crosslinking reaction mixtures between
hRPA and 32P labeled dT1o, dT30, and dT70 were analyzed on dried SOS
polyacrylamide gels (Figure 6.9) by using Phosphorimager analysis. The
photoproducts (as indicated by arrows in Figure 6.9) were quantified and plotted.
(), (),and(A)indicate quantified photoproducts at various time points of dT10,
dT, anddT70,respectively.183
Table 6.1. Tryptic peptide mapping of carboxyamidomethylated human
RPA7O by LC-ESI/IT-MS.
No. Peptide PositionPredicted Mass(M+H)8 ESI/IT-MS (M+H) MS/MS
I 1 - 16 1646.9 1646.6
2,3,4 17-41 13588b 1358.1° -'1
5 42-43 338.2 N.D.0
6 44-81 4348.1(2)d N.D.
7 82-88 834.5 834.4 '1
8 89-91 347.2 N.D.
9 92-92 175.1 N.D.
10 93-103 1285.8 N.D.
11 104-111 760.4 760.4 SI
12,13 112-157 1486.48 1486.88 1
14 158-163 596.3 596.3 11
15 167-167 452.3 N.D.
16 168-183 1485.7 1485.5 1/
17 184-196 1402.8 1402.5
18 197-202 806.4 (1) 806.4 (1)
19 203-206 461.3 N.D.
20 207-210 503.3 503.3 SI
21,22 211 -216 1121.6 1121.4 SI
23 221-234 1606.8 1606.7
24,25 235-253 1105.6 1106.6 SI
26 254-259 806.4 806.3 SI
27 260-263 418.3 N.D.
28 264-267 445.3 N.D.
29 268-273 693.3 693.4
30 274- 311 4517.9 (1) N.D.
31,32 312-324 1448.8(1) 1448.6(1) SI
33 325-331 813.4 813.3 SI
34 332-335 488.3 488.3 SI
35 336-339 490.2 N.D.
36 340-343 446.3 N.D.
37 344-344 175.1 N.D.
38 345-354 1141.6 1141.5 SI
39,40 355 372 1968.0 1967.8 SI
39,40,41 355-379 13598b 1359.8° SI
42 380- 382 303.2 N.D.
43 383-389 737.4 737.4 1/
44 390-410 2205.2 N.D.
45 411 -412 288.2 N.D.
46 413-431 2008.0 N.D.
47 432-443 1163.5 1163.4 SI184
Table 6.1 (continued)
No. Peptide Position Predicted Mass (M+HT ESI/IT-MS (M+FV) MS/MS
48 444-449 752.4 752.4
49,50 450-458 12736b 12734b
51 473-473 147.1 N.D.
52 474-488 1918.7 (3) 1918.6 (3)
53 489-489 147.1 N.D.
54 490-499 1205.6 1205.5
55 500-502 436.2 (1) N.D.
56 503-511 1157.5 (1) 1157.4
57 512-513 338.2 N.D.
58 514-551 4301.1 (1) N.D.
59,60 552-568 10440b 10439b
61 569-573 669.4 669.4
62 574-575 274.2 N.D.
63,64 576-586 1340.7 1339.6
65 587-588 260.2 N.D.
66,67 589-600 1393.6 1393.6
68 601-604 524.3 N.D.
69 605-605 175.1 N.D.
70 606 -611 718.4 N.D.
71 612-612 175.1 ND.
72 613-616 421.2 N.D.
aPredicted peptide masses (monoisotopic) calculated using the computer
program GPMAW, version 3.1, Lighthouse Data.
Predicted Mass for[M+2H]2ion species.
CN.D. refers to not detected.
dValues in parentheses indicate the number of cysteine residues within the
peptide modified by carbox'amidomethylation.
° PredictedMass for [M+3H] + ion species.185
gel. Two mobility-shifted bands retarded in the gel above hRAP7O were
observed after silver staining. The reaction products were also analyzed on a
7.5% SOS polyacrylamide gel (Figure 6.11). Correlating the mobility of these
bands to the position of molecular weight markers suggested that these bands
were not multiple hRPA7O molecules bound to a single oligonucleotide. If this
were the case, a mobility-shifted band would be expected around 140 kDa
(missing in Figure 6.11, lane 2). Instead, these bands might be either 1) a single
hRPA7O molecule crosslinking to multiple oligonucleotides or 2) crosslinking
products of hRPA7O and a proteolytic fragment of hRPA7O (M.W. -66 kDa)
containing a single oligonucleotide.
The two bands from the 10% SDS polyacrylamide gel were separately
excised and proteolytically digested in gel with trypsin. Using a nucleopeptide
isolation and purification procedure identical to that of the Ung nucleoprotein
complex (Figure 3.9), resulting hRPA7O nucleopeptide species from each
mobility-shifted band were analyzed by MALDI MS (Figure 6.12). The molecular
weight (average) of dT3o is 9064.0; therefore, the ion species observed above
m/z 9065.0 were presumed to be nucleopeptides of hRPA7O. Comparing the
nucleopeptide mass spectra produced from the two mobility-shifted bands
showed ion species common to both spectra (compare ion species 9107.9,
9820.2, and 10215 and 11329 in Figure 6.12A with ion species 9113.9, 9816.9,
10200, and 11342, respectively, in Figure 6.12B). An ion signal corresponding to
chemically adducted, free dT30 is present in both spectra (m/z 9107.9 for Figure
6.12A and m/z 9113.9 for Figure 6.12B). There are ion species that are unique200 -
116 -
97.4 -
' XL-2
' XL-1
hRPA7O
66.2 -
I I
1 2
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Figure 6.11. Analysis of a preparative scale crosslinking reaction of hRPA
to dT30. Ten mixtures (200 pL each) containing 800 pmol of hRPA and 800 pmol
of dT30 were irradiated at 254 nm for 1 mm and separated by denaturing
polyacrylamide gel electrophoresis for subsequent nucleopeptide isolation,as
described under "Methods and Materials." Aliquots (10 pL) were removed from
a crosslinking mixture both before(Lane 1)and after irradiation(Lane 2),
analyzed on a 8% denaturing polyacrylamide gel, and protein bands were
visualized by Coomassie stain. The positions of molecular weight markers
indicated by arrows to the left of the gel. The position of hRPA7O,a lower
mobility shifted band(XL-1),and an upper mobility shifted band(XL-2)are
indicated byarrowsto the right of the gel.187
Figure 6.12. MALDI mass spectrum of purified hRPA7OxdT30 tryptic
nucleopeptides. Crosslinking reaction mixtures of hRPA (8nmol total) and dT30
(8nmol total) were separated on a 10%sospolyacrylamide gel and protein
bands were visualized by silver staining. Two mobility shifted bands relative to
the 70-kDa subunit of hRPA were cut from the gel, reduced,
carboxyamidomethylated, and digested with trypsin (Figure 6.11). Extracted
nucleopeptides were eluted from a NAC-52 anion exchange cartridge,
concentrated and desalted using a Centricon-3, further concentrated by vacuum
centrifugation to approximately 10 pL, and analyzed by MALDI MS, as described
under "Experimental Procedures." (A) MALDI mass spectrum of nucleopeptides
purified from a crosslinked gel band of lowest gel mobility(XL-1from Figure
6.11). (B) MALDI mass spectrum of nucleopeptides purified from a crosslinked
band of second lowest gel mobility(XL-2from Figure 6.12).>
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Figure 6.12. MALDI mass spectrum of purified hRPA7OxdT tryptic
nucleopeptides.189
to the gel band XL-1 (ion species 10553, 10949, 12068, and 12492 in Figure
6.12 A).
Tentative identification of the nucleopeptides was attempted by
subtracting the molecular weight of dT30 from the measured ion species and then
comparing the resulting molecular weights to a tryptic map of hRPA7O. Closer
analysis of the nucleopeptide spectrum showed that the mass assignments were
made to very broad peaks (-150 m.u. at FWHM) which drastically reduces the
accuracy of the assignments. This lack of mass accuracy coupled with the
potential for truncation of the peptide portion of the nucleopeptide (as observed
for the T6 nucleopeptide of Ung; Table 4.1 and Table 4.2) prevented the tentative
identification of the nucleopeptides with any level of certainty. More thorough
purification of the hRPA7OxdT30 nucleopeptides will be required in order to use
MALDI MS in the nucleopeptide identification.
6.1.8 Tandem Mass Spectrometry of Nuclease P1-digested hRPA7OxdT
Nucleopeptides
Even though tentative identification of the hRPA7OxdT nucleopeptides
by MALDI MS could not be made due to issues of sample purity, LC/ESI ion-trap
mass spectrometry experiments were attempted. The hRPA7OxdT3o
nucleopeptides were digested with nuclease P1 and then analyzed. The LCIESI
MS spectrum of this sample did not provide any mass spectra that could be190
identified as potential nuclease digested species. This lack of information could
be a result of low sample quantity or a result of labile crosslinks breaking during
the nuclease P1 digestion.
6.2 Discussion
The work here begins UV catalyzed crosslinking experiments to
structurally characterize the DNA binding domain of hRPA. This characterization
was conducted in the same manner as that of Ung; covalent protein-DNA
complexes were formed by UV-crosslinking, the complexes were proteolytically
and nucleolytically digested, and peptide-DNA fragments were isolated and
analyzed by mass spectrometry. The ultimate goal was to use collected mass
spectrometry data to identify peptide regions and specific amino acids within
hRPA that take part in crosslinking.
As part of pursuing this goal, experiments to purify the protein, determine
an optimum crosslinking time, and generate a nucleopeptide map of a hRPA-
oligonucleotide complex were performed to gauge the feasibility of this project.
From these experiments it was found that milligram quantities of hRPA could be
readily purified, an optimum irradiation time of one minute for crosslinking hRPA
to dT10,dT30,and dT70 was established, and both peptide and nucleopeptide
maps of the protein were generated. The combination of these results indicates
a strong likelihood of success to using UV-catalyzed crosslinking to map the
DNA-binding domain of hRPA.191
The presence of multimeric protein-DNA complexes forming between
hRPA and single-stranded oligonucleotides was not expected. An
electrophoretic mobility shift analysis used to measure the DNA capability of
purified hRPA revealed three distinct mobility shifted bands (Figure 6.7). The
formation of super-mobility shifted complexes increased with saturating amounts
of hRPA, as compared to oligonudeotide, suggesting these complexes were
multiple hRPA molecules bound to single dT30 molecules. Other research groups
have reported the formation of multimeric hRPA complexes with oligonucleotides.
EMSA and gel permeation chromatography studies have shown the presence of
two hRPA molecules bound to oligonucleotides of 70 nucleotides in length, but
they have not shown the presence of multimeric complexes with oligonucleotides
30 nucleotides in length (46, 66). From glutaraldehyde crosslinking studies,
however, up to three hRPA molecules crosslinked a 30-mer oligonucleotide (12).
This study estimated the minimum DNA binding size of a single hRPA molecule
to be 8-10 nucleotides in length and it also detected an hRPA complex that
bound single-stranded DNA in 30-nucleotide steps. The minimum DNA binding
site size suggests the possibility of up to three hRPA molecules binding to one 30
mer oligonucleotide. This is one possible explanation of the electrophoretic
mobility analysis results observed here (Figure 6.7). A major deficiency in the
electrophoretic mobility, gel permeation, and glutaraldehyde crosslinking analysis
is that these techniques do not reveal the specific nature of the multimeric hRPA-
dT30 complex. These analyses can not fully distinguish between the possibility of
three hRPA molecules each directly interacting with a single oligonucleotide192
molecule or the possibility of three hRPA molecules interacting with one another
(protein-protein interactions) and only one of the hRPA molecules directly
interacting with an oligonucleotide molecule. The later possibility is a second
explanation of the electrophoretic mobility results observed here.
Crosslinking experiments of hRPA with oligonucleotides of increasing size
also showed the presence of multiple protein-DNA complexes. Crosslinking
complexes were observed on denaturing polyacrylamide gels; thus, these
complexes were separated into subunits of hRPA that contained covalently
attached oligonucleotides.Asthe size of the oligonucleotide increased,
additional crosslinking products were observed. For dT10, a single crosslinking
product was observed (Figure6.9A).Compared to other crosslinking
experiments analyzed on gels of this acrylamide percentage, this product was
presumed to be a hRPA7OxdTo complex.Asthe size of the oligonucleotide
increased to dTor dT70, three distinct crosslinking products were observed
(Figure6.9Band Figure6.9C).Since these gels were not stained to observe the
protein bands, molecular weight standards were not available to estimate the
molecular weight of the crosslinking products. Therefore, it is difficult to ascertain
the identity of these products, but it is obvious that multimeric complexes form as
the length of the oligonucleotide increases. Similar to the electrophoretic shift
analysis, these complexes could be explained as either multiple oligonucleotides
attached to a subunit of hRPA or multiple hRPA subunits attached to a single
oligonucleotide.193
Currently, structural information at the amino acid level for hRPA is limited
to a x-ray crystal structure of a truncated form of hRPA7O (14), a x-ray crystal
structure of the hRPA32-hRPAI4 complex (13), and characterization of
deletion/site-directed mutants of hRPA. Even though these studies have
provided valuable insight into the structural elements of hRPA that bind to
oligonucleotides, very few structural experiments have been performed on
heterotrimeric hRPA. Future crosslinking studies have the potential to uncover
the structural features of the heterotnmeric protein that facilitate the increased
binding affinity of the protein to oligonucleotides of increasing size, reveal the role
that aromatic amino acids within hRPA7O play in the amino acid-nudeic acid
interactions of this protein, as well as give insight into the roles each subunit
plays in binding to DNA. A better understanding of how hRPA binds to DNA will
elucidate the function of this protein in DNA metabolism.194
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Figure Al. Nomenclature for common peptide backbone fragments
produced from collisionally induced dissociation. As described by Beimann
(10), fragment ions that retain charge on the N-terminal portion of the original
peptide are labeled a, b, and Cn while fragment ions that retain charge on the C-
terminal portion of the original peptide are labeled x, y,, and z,. As described by
Jensen et al. (59), peptide fragments of a nucleopeptide are also designatedan,
b, c, xi,, y,,, and z, while peptide fragments of a nucleopeptide that contain
covalently crosslinked oligonucleotide are designated an*, b*, cn*,y* anda1
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Figure A.2. Nomenclature for common oligonucleotide backbone
fragments produced from low energy collisionally induced dissociation.
Oligonucleotide fragment ions were labeled using the nomenclature proposed by
McLuckey, eta!(83). Due to the similarities between the nomenclature of
peptide and oligonucleotide fragmentation, oligonucleotide fragmentation
products are italicized. The four possible cleavages along the phosphodiester
backbone are indicated bya,,bn, c,,, and dnfor fragments containing the 5'-OH
group and w,, x,,Yn,and z, for fragments containing the 3'-OH group.
Oligonucleotide fragments of a nucleopeptide are also designatedan, b, Cn, dn,
W,,, Xn, Yn,andZn,while oligonucleotide fragments from a nucleopeptide that
contain covalently crosslinked peptide are designatedan*, bn*, Cn,d*,We, Xr,
and z' (59).